https://biopharmsignal.com/index.md 2026-07-20 https://biopharmsignal.com/blog.md 2026-07-20 https://biopharmsignal.com/livefeed.md 2026-07-20 https://biopharmsignal.com/pdufa-calendar.md 2026-07-20 https://biopharmsignal.com/pricing.md 2026-07-20 https://biopharmsignal.com/sector.md 2026-07-20 https://biopharmsignal.com/compare.md 2026-07-20 https://biopharmsignal.com/compare/biopharmsignal-vs-biopharmcatalyst.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-catalystalert.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-biotechsign.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-biopharmawatch.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-bpiq-biopharmiq.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-biotech-pulse.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-marketbeat-fda-calendar.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-google-alerts.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-feedly.md 2026-07-19 https://biopharmsignal.com/blog/how-to-read-biotech-earnings-releases-when-revenue-is-not-the-main-story.md 2026-07-17 https://biopharmsignal.com/blog/how-to-monitor-biotech-reverse-splits-offerings-and-nasdaq-compliance-news.md 2026-07-16 https://biopharmsignal.com/blog/how-to-use-ticker-based-alerts-and-keyword-alerts-together.md 2026-07-15 https://biopharmsignal.com/blog/how-to-separate-commercial-launch-updates-from-clinical-development-news.md 2026-07-14 https://biopharmsignal.com/blog/how-to-follow-asco-esmo-and-medical-conference-news-as-a-biotech-investor.md 2026-07-13 https://biopharmsignal.com/blog/how-to-tell-whether-a-biotech-partnership-headline-changes-the-investment-story.md 2026-07-10 https://biopharmsignal.com/blog/how-to-build-a-watchlist-around-clinical-readout-dates.md 2026-07-09 https://biopharmsignal.com/blog/how-to-compare-two-biotech-press-releases-from-the-same-company.md 2026-07-08 https://biopharmsignal.com/blog/how-to-monitor-small-cap-biotech-financing-news-without-overreacting.md 2026-07-07 https://biopharmsignal.com/blog/how-to-track-fda-approval-risk-before-a-pdufa-date.md 2026-07-06 https://biopharmsignal.com/blog/why-small-teams-still-need-biotech-alert-tools.md 2026-06-10 https://biopharmsignal.com/blog/how-biotech-alerts-help-when-you-only-follow-a-few-companies.md 2026-06-09 https://biopharmsignal.com/blog/why-biotech-alerts-are-more-valuable-for-busy-people.md 2026-06-08 https://biopharmsignal.com/blog/what-types-of-biotech-news-people-tracking-clinical-progress-are-most-afraid-to-miss.md 2026-06-07 https://biopharmsignal.com/blog/fda-real-time-trial-data-ai-plan-could-change-biotech-timelines.md 2026-06-06 https://biopharmsignal.com/blog/why-biotech-investors-need-alerts-more-than-refreshing-pages.md 2026-06-05 https://biopharmsignal.com/blog/how-much-time-can-biotech-alerts-save.md 2026-06-04 https://biopharmsignal.com/blog/why-do-i-keep-missing-biotech-company-news.md 2026-06-03 https://biopharmsignal.com/blog/aacr-2026-is-still-moving-biotech-stocks-what-investors-should-watch.md 2026-06-02 https://biopharmsignal.com/blog/company-news-vs-event-news-in-biotech-which-is-more-efficient.md 2026-06-01 https://biopharmsignal.com/blog/pure-news-products-vs-event-alert-products.md 2026-05-31 https://biopharmsignal.com/blog/why-lightweight-biotech-tools-are-easier-to-use.md 2026-05-30 https://biopharmsignal.com/blog/why-some-biotech-users-only-need-alerts-not-a-database.md 2026-05-29 https://biopharmsignal.com/blog/how-do-biotech-news-products-differ-from-investment-research-products.md 2026-05-28 https://biopharmsignal.com/blog/alerting-vs-aggregation-in-biotech-news-products.md 2026-05-27 https://biopharmsignal.com/blog/what-should-a-researcher-biotech-information-tool-include.md 2026-05-26 https://biopharmsignal.com/blog/what-should-a-retail-biotech-news-product-include.md 2026-05-25 https://biopharmsignal.com/blog/who-are-biotech-information-products-for.md 2026-05-24 https://biopharmsignal.com/blog/how-to-choose-between-news-websites-email-newsletters-and-alert-tools.md 2026-05-23 https://biopharmsignal.com/blog/what-is-the-difference-between-biotech-news-and-biotech-alert-tools.md 2026-05-22 https://biopharmsignal.com/blog/how-to-use-tags-to-manage-biotech-news.md 2026-05-21 https://biopharmsignal.com/blog/how-to-let-a-team-view-the-same-biotech-news.md 2026-05-20 https://biopharmsignal.com/blog/how-to-build-a-biotech-news-archive-system.md 2026-05-19 https://biopharmsignal.com/blog/how-to-build-a-single-biotech-timeline-from-many-announcements.md 2026-05-18 https://biopharmsignal.com/blog/how-to-read-investor-presentations-in-biotech.md 2026-05-17 https://biopharmsignal.com/blog/how-to-pull-value-from-conference-coverage.md 2026-05-16 https://biopharmsignal.com/blog/how-to-scan-many-biotech-headlines-fast.md 2026-05-15 https://biopharmsignal.com/blog/how-to-set-different-news-priorities-for-different-stages-of-companies.md 2026-05-14 https://biopharmsignal.com/blog/how-to-tell-if-clinical-news-is-progress-or-noise.md 2026-05-13 https://biopharmsignal.com/blog/how-to-recognize-regulatory-language-in-biotech-news.md 2026-05-12 https://biopharmsignal.com/blog/how-to-understand-biotech-news-without-a-science-background.md 2026-05-11 https://biopharmsignal.com/blog/how-to-combine-multiple-news-sources-into-one-habit.md 2026-05-10 https://biopharmsignal.com/blog/how-to-use-a-timeline-to-understand-biotech-news.md 2026-05-09 https://biopharmsignal.com/blog/how-to-read-a-biotech-press-release.md 2026-05-08 https://biopharmsignal.com/blog/how-to-pull-key-points-from-a-company-news-release.md 2026-05-07 https://biopharmsignal.com/blog/how-to-reduce-noise-in-biotech-news.md 2026-05-06 https://biopharmsignal.com/blog/how-to-build-a-biotech-news-filtering-method.md 2026-05-05 https://biopharmsignal.com/blog/how-to-set-biotech-keyword-rules.md 2026-05-04 https://biopharmsignal.com/blog/how-to-turn-headlines-into-trackable-events.md 2026-05-03 https://biopharmsignal.com/blog/how-to-use-excel-for-clinical-trial-events.md 2026-05-02 https://biopharmsignal.com/blog/how-to-tell-if-an-fda-update-is-important.md 2026-05-01 https://biopharmsignal.com/blog/how-to-spot-a-real-biotech-catalyst.md 2026-04-30 https://biopharmsignal.com/blog/how-to-categorize-biotech-news-by-event-type.md 2026-04-29 https://biopharmsignal.com/blog/how-to-build-a-biotech-watchlist-from-company-names.md 2026-04-28 https://biopharmsignal.com/blog/how-to-build-a-biotech-news-reading-workflow.md 2026-04-27 https://biopharmsignal.com/blog/what-is-a-monoclonal-antibody.md 2026-04-26 https://biopharmsignal.com/blog/what-is-a-small-molecule.md 2026-04-25 https://biopharmsignal.com/blog/what-does-moa-mean-in-biotech-news.md 2026-04-24 https://biopharmsignal.com/blog/what-is-a-companion-diagnostic.md 2026-04-23 https://biopharmsignal.com/blog/what-is-combination-therapy.md 2026-04-22 https://biopharmsignal.com/blog/what-is-label-expansion.md 2026-04-21 https://biopharmsignal.com/blog/what-is-an-exclusivity-period.md 2026-04-20 https://biopharmsignal.com/blog/what-is-a-patent-cliff.md 2026-04-19 https://biopharmsignal.com/blog/what-is-a-biosimilar.md 2026-04-18 https://biopharmsignal.com/blog/what-is-best-in-class-drug.md 2026-04-17 https://biopharmsignal.com/blog/what-is-first-in-class-drug.md 2026-04-16 https://biopharmsignal.com/blog/what-is-line-of-therapy.md 2026-04-15 https://biopharmsignal.com/blog/what-is-an-indication.md 2026-04-14 https://biopharmsignal.com/blog/what-is-a-biomarker.md 2026-04-13 https://biopharmsignal.com/blog/what-is-a-surrogate-endpoint.md 2026-04-12 https://biopharmsignal.com/blog/what-is-a-secondary-endpoint.md 2026-04-11 https://biopharmsignal.com/blog/what-is-a-primary-endpoint.md 2026-04-10 https://biopharmsignal.com/blog/what-is-a-clinical-trial-endpoint.md 2026-04-09 https://biopharmsignal.com/blog/what-is-post-marketing-study.md 2026-04-08 https://biopharmsignal.com/blog/what-is-accelerated-approval.md 2026-04-07 https://biopharmsignal.com/blog/what-is-priority-review.md 2026-04-06 https://biopharmsignal.com/blog/what-is-fast-track-designation.md 2026-04-05 https://biopharmsignal.com/blog/what-is-breakthrough-therapy-designation.md 2026-04-04 https://biopharmsignal.com/blog/what-is-orphan-drug-designation.md 2026-04-03 https://biopharmsignal.com/blog/what-is-bla-in-biotech.md 2026-04-02 https://biopharmsignal.com/blog/what-is-nda-in-biotech.md 2026-04-01 https://biopharmsignal.com/blog/what-is-ind-in-drug-development.md 2026-03-31 https://biopharmsignal.com/blog/biotech-drug-development-overview-from-discovery-to-approval.md 2026-03-30 https://biopharmsignal.com/blog/why-biotech-is-ideal-for-event-driven-news-products.md 2026-03-29 https://biopharmsignal.com/blog/what-does-catalyst-mean-in-biotech-news.md 2026-03-28 https://biopharmsignal.com/blog/what-is-interim-data.md 2026-03-27 https://biopharmsignal.com/blog/what-is-top-line-data.md 2026-03-26 https://biopharmsignal.com/blog/what-is-data-lock.md 2026-03-25 https://biopharmsignal.com/blog/why-financing-news-matters-in-biotech.md 2026-03-24 https://biopharmsignal.com/blog/why-partnership-announcements-matter.md 2026-03-23 https://biopharmsignal.com/blog/news-to-track-before-and-after-commercialization.md 2026-03-22 https://biopharmsignal.com/blog/public-information-before-fda-approval.md 2026-03-21 https://biopharmsignal.com/blog/why-clinical-trial-dates-change.md 2026-03-20 https://biopharmsignal.com/blog/what-is-a-catalyst-window.md 2026-03-19 https://biopharmsignal.com/blog/why-biotech-news-clusters-around-key-dates.md 2026-03-18 https://biopharmsignal.com/blog/biotech-company-earnings-signals-to-watch.md 2026-03-17 https://biopharmsignal.com/blog/what-is-phase-3-data-release.md 2026-03-16 https://biopharmsignal.com/blog/what-is-phase-2-data-release.md 2026-03-15 https://biopharmsignal.com/blog/what-is-phase-1-data-release.md 2026-03-14 https://biopharmsignal.com/blog/what-is-a-clinical-trial-readout.md 2026-03-13 https://biopharmsignal.com/blog/what-is-a-crl.md 2026-03-12 https://biopharmsignal.com/blog/what-is-an-adcom.md 2026-03-11 https://biopharmsignal.com/blog/what-does-pdufa-mean.md 2026-03-10 https://biopharmsignal.com/blog/what-is-an-fda-calendar.md 2026-03-09 https://biopharmsignal.com/blog/what-is-a-biotech-catalyst.md 2026-03-08 https://biopharmsignal.com/company/AEON.md 2026-07-02 https://biopharmsignal.com/company/APGE.md 2026-07-02 https://biopharmsignal.com/company/UNH.md 2026-07-02 https://biopharmsignal.com/company/JNJ.md 2026-07-02 https://biopharmsignal.com/company/LLY.md 2026-07-02 https://biopharmsignal.com/company/NVO.md 2026-07-02 https://biopharmsignal.com/company/MRK.md 2026-07-02 https://biopharmsignal.com/company/ABBV.md 2026-07-02 https://biopharmsignal.com/company/AZN.md 2026-07-02 https://biopharmsignal.com/company/NVS.md 2026-07-02 https://biopharmsignal.com/company/PFE.md 2026-07-02 https://biopharmsignal.com/company/BMY.md 2026-07-02 https://biopharmsignal.com/company/SNY.md 2026-07-02 https://biopharmsignal.com/company/AMGN.md 2026-07-02 https://biopharmsignal.com/company/TMO.md 2026-07-02 https://biopharmsignal.com/company/ELV.md 2026-07-02 https://biopharmsignal.com/company/SYK.md 2026-07-02 https://biopharmsignal.com/company/ISRG.md 2026-07-02 https://biopharmsignal.com/company/GILD.md 2026-07-02 https://biopharmsignal.com/company/REGN.md 2026-07-02 https://biopharmsignal.com/company/BSX.md 2026-07-02 https://biopharmsignal.com/company/GSK.md 2026-07-02 https://biopharmsignal.com/company/HUM.md 2026-07-02 https://biopharmsignal.com/company/EW.md 2026-07-02 https://biopharmsignal.com/company/MRNA.md 2026-07-02 https://biopharmsignal.com/company/KVUE.md 2026-07-02 https://biopharmsignal.com/company/DXCM.md 2026-07-02 https://biopharmsignal.com/company/A.md 2026-07-02 https://biopharmsignal.com/company/ALC.md 2026-07-02 https://biopharmsignal.com/company/GEHC.md 2026-07-02 https://biopharmsignal.com/company/KR.md 2026-07-02 https://biopharmsignal.com/company/IQV.md 2026-07-02 https://biopharmsignal.com/company/RMD.md 2026-07-02 https://biopharmsignal.com/company/MTD.md 2026-07-02 https://biopharmsignal.com/company/ZBH.md 2026-07-02 https://biopharmsignal.com/company/VEEV.md 2026-07-02 https://biopharmsignal.com/company/GMAB.md 2026-07-02 https://biopharmsignal.com/company/ALNY.md 2026-07-02 https://biopharmsignal.com/company/BNTX.md 2026-07-02 https://biopharmsignal.com/company/ARGX.md 2026-07-02 https://biopharmsignal.com/company/CAH.md 2026-07-02 https://biopharmsignal.com/company/HOLX.md 2026-07-02 https://biopharmsignal.com/company/COO.md 2026-07-02 https://biopharmsignal.com/company/BMRN.md 2026-07-02 https://biopharmsignal.com/company/WAT.md 2026-07-02 https://biopharmsignal.com/company/MOH.md 2026-07-02 https://biopharmsignal.com/company/AXON.md 2026-07-02 https://biopharmsignal.com/company/RVTY.md 2026-07-02 https://biopharmsignal.com/company/DGX.md 2026-07-02 https://biopharmsignal.com/company/INCY.md 2026-07-02 https://biopharmsignal.com/company/SNN.md 2026-07-02 https://biopharmsignal.com/company/FMS.md 2026-07-02 https://biopharmsignal.com/company/EPAM.md 2026-07-02 https://biopharmsignal.com/company/TECH.md 2026-07-02 https://biopharmsignal.com/company/EXAS.md 2026-07-02 https://biopharmsignal.com/company/TFX.md 2026-07-02 https://biopharmsignal.com/company/SRPT.md 2026-07-02 https://biopharmsignal.com/company/LEGN.md 2026-07-02 https://biopharmsignal.com/company/BRKR.md 2026-07-02 https://biopharmsignal.com/company/AGL.md 2026-07-02 https://biopharmsignal.com/company/APLS.md 2026-07-02 https://biopharmsignal.com/company/QGEN.md 2026-07-02 https://biopharmsignal.com/company/HSIC.md 2026-07-02 https://biopharmsignal.com/company/VTRS.md 2026-07-02 https://biopharmsignal.com/company/TEVA.md 2026-07-02 https://biopharmsignal.com/company/SWAV.md 2026-07-02 https://biopharmsignal.com/company/MASI.md 2026-07-02 https://biopharmsignal.com/company/UTHR.md 2026-07-02 https://biopharmsignal.com/company/CRL.md 2026-07-02 https://biopharmsignal.com/company/NBIX.md 2026-07-02 https://biopharmsignal.com/company/RDY.md 2026-07-02 https://biopharmsignal.com/company/JAZZ.md 2026-07-02 https://biopharmsignal.com/company/XRAY.md 2026-07-02 https://biopharmsignal.com/company/RGEN.md 2026-07-02 https://biopharmsignal.com/company/THC.md 2026-07-02 https://biopharmsignal.com/company/ROIV.md 2026-07-02 https://biopharmsignal.com/company/RCM.md 2026-07-02 https://biopharmsignal.com/company/PRI.md 2026-07-02 https://biopharmsignal.com/company/DOCS.md 2026-07-02 https://biopharmsignal.com/company/MEDP.md 2026-07-02 https://biopharmsignal.com/company/CTLT.md 2026-07-02 https://biopharmsignal.com/company/ACHC.md 2026-07-02 https://biopharmsignal.com/company/TXG.md 2026-07-02 https://biopharmsignal.com/company/EHC.md 2026-07-02 https://biopharmsignal.com/company/EXEL.md 2026-07-02 https://biopharmsignal.com/company/ITCI.md 2026-07-02 https://biopharmsignal.com/company/NTRA.md 2026-07-02 https://biopharmsignal.com/company/GMED.md 2026-07-02 https://biopharmsignal.com/company/MDGL.md 2026-07-02 https://biopharmsignal.com/company/ASND.md 2026-07-02 https://biopharmsignal.com/company/GRFS.md 2026-07-02 https://biopharmsignal.com/company/ENSG.md 2026-07-02 https://biopharmsignal.com/company/CERE.md 2026-07-02 https://biopharmsignal.com/company/OPCH.md 2026-07-02 https://biopharmsignal.com/company/IONS.md 2026-07-02 https://biopharmsignal.com/company/TGTX.md 2026-07-02 https://biopharmsignal.com/company/MMSI.md 2026-07-02 https://biopharmsignal.com/company/PRGO.md 2026-07-02 https://biopharmsignal.com/company/PCVX.md 2026-07-02 https://biopharmsignal.com/company/ICUI.md 2026-07-02 https://biopharmsignal.com/company/CRSP.md 2026-07-02 https://biopharmsignal.com/company/ARWR.md 2026-07-02 https://biopharmsignal.com/company/TDOC.md 2026-07-02 https://biopharmsignal.com/company/SHC.md 2026-07-02 https://biopharmsignal.com/company/IART.md 2026-07-02 https://biopharmsignal.com/company/HALO.md 2026-07-02 https://biopharmsignal.com/company/PRTA.md 2026-07-02 https://biopharmsignal.com/company/YOU.md 2026-07-02 https://biopharmsignal.com/company/EVH.md 2026-07-02 https://biopharmsignal.com/company/IRTC.md 2026-07-02 https://biopharmsignal.com/company/NTLA.md 2026-07-02 https://biopharmsignal.com/company/SEM.md 2026-07-02 https://biopharmsignal.com/company/NARI.md 2026-07-02 https://biopharmsignal.com/company/CNMD.md 2026-07-02 https://biopharmsignal.com/company/CERT.md 2026-07-02 https://biopharmsignal.com/company/NEOG.md 2026-07-02 https://biopharmsignal.com/company/CYTK.md 2026-07-02 https://biopharmsignal.com/company/DNLI.md 2026-07-02 https://biopharmsignal.com/company/AMN.md 2026-07-02 https://biopharmsignal.com/company/PRVA.md 2026-07-02 https://biopharmsignal.com/company/FOLD.md 2026-07-02 https://biopharmsignal.com/company/BPMC.md 2026-07-02 https://biopharmsignal.com/company/PGNY.md 2026-07-02 https://biopharmsignal.com/company/VIR.md 2026-07-02 https://biopharmsignal.com/company/LFST.md 2026-07-02 https://biopharmsignal.com/company/EVO.md 2026-07-02 https://biopharmsignal.com/company/AZTA.md 2026-07-02 https://biopharmsignal.com/company/SAGE.md 2026-07-02 https://biopharmsignal.com/company/PACB.md 2026-07-02 https://biopharmsignal.com/company/IMGN.md 2026-07-02 https://biopharmsignal.com/company/OMCL.md 2026-07-02 https://biopharmsignal.com/company/INMD.md 2026-07-02 https://biopharmsignal.com/company/IMCR.md 2026-07-02 https://biopharmsignal.com/company/AXNX.md 2026-07-02 https://biopharmsignal.com/company/OLK.md 2026-07-02 https://biopharmsignal.com/company/AMED.md 2026-07-02 https://biopharmsignal.com/company/RVMD.md 2026-07-02 https://biopharmsignal.com/company/INSM.md 2026-07-02 https://biopharmsignal.com/company/IMVT.md 2026-07-02 https://biopharmsignal.com/company/ALVO.md 2026-07-02 https://biopharmsignal.com/company/BEAM.md 2026-07-02 https://biopharmsignal.com/company/HIMS.md 2026-07-02 https://biopharmsignal.com/company/MORF.md 2026-07-02 https://biopharmsignal.com/company/GH.md 2026-07-02 https://biopharmsignal.com/company/TMDX.md 2026-07-02 https://biopharmsignal.com/company/VKTX.md 2026-07-02 https://biopharmsignal.com/company/KRYS.md 2026-07-02 https://biopharmsignal.com/company/ATRC.md 2026-07-02 https://biopharmsignal.com/company/VTYX.md 2026-07-02 https://biopharmsignal.com/company/PROK.md 2026-07-02 https://biopharmsignal.com/company/AKRO.md 2026-07-02 https://biopharmsignal.com/company/BBIO.md 2026-07-02 https://biopharmsignal.com/company/HRMY.md 2026-07-02 https://biopharmsignal.com/company/NUVL.md 2026-07-02 https://biopharmsignal.com/company/ACLX.md 2026-07-02 https://biopharmsignal.com/company/AMLX.md 2026-07-02 https://biopharmsignal.com/company/SDGR.md 2026-07-02 https://biopharmsignal.com/company/DYN.md 2026-07-02 https://biopharmsignal.com/company/PCRX.md 2026-07-02 https://biopharmsignal.com/company/CVAC.md 2026-07-02 https://biopharmsignal.com/company/CPRX.md 2026-07-02 https://biopharmsignal.com/company/GDRX.md 2026-07-02 https://biopharmsignal.com/company/AMPH.md 2026-07-02 https://biopharmsignal.com/company/ATEC.md 2026-07-02 https://biopharmsignal.com/company/EYE.md 2026-07-02 https://biopharmsignal.com/company/FGEN.md 2026-07-02 https://biopharmsignal.com/company/EMBC.md 2026-07-02 https://biopharmsignal.com/company/SILK.md 2026-07-02 https://biopharmsignal.com/company/XNCR.md 2026-07-02 https://biopharmsignal.com/company/VCYT.md 2026-07-02 https://biopharmsignal.com/company/IRWD.md 2026-07-02 https://biopharmsignal.com/company/BCRX.md 2026-07-02 https://biopharmsignal.com/company/TMCI.md 2026-07-02 https://biopharmsignal.com/company/CLDX.md 2026-07-02 https://biopharmsignal.com/company/VCEL.md 2026-07-02 https://biopharmsignal.com/company/KYMR.md 2026-07-02 https://biopharmsignal.com/company/USPH.md 2026-07-02 https://biopharmsignal.com/company/SWTX.md 2026-07-02 https://biopharmsignal.com/company/LMAT.md 2026-07-02 https://biopharmsignal.com/company/FNA.md 2026-07-02 https://biopharmsignal.com/company/RCUS.md 2026-07-02 https://biopharmsignal.com/company/GERN.md 2026-07-02 https://biopharmsignal.com/company/SNDX.md 2026-07-02 https://biopharmsignal.com/company/HLF.md 2026-07-02 https://biopharmsignal.com/company/PRME.md 2026-07-02 https://biopharmsignal.com/company/ALHC.md 2026-07-02 https://biopharmsignal.com/company/ADUS.md 2026-07-02 https://biopharmsignal.com/company/SMMT.md 2026-07-02 https://biopharmsignal.com/company/LGND.md 2026-07-02 https://biopharmsignal.com/company/FIGS.md 2026-07-02 https://biopharmsignal.com/company/RLAY.md 2026-07-02 https://biopharmsignal.com/company/MDRX.md 2026-07-02 https://biopharmsignal.com/company/PLRX.md 2026-07-02 https://biopharmsignal.com/company/ZNTL.md 2026-07-02 https://biopharmsignal.com/company/USNA.md 2026-07-02 https://biopharmsignal.com/company/KROS.md 2026-07-02 https://biopharmsignal.com/company/ETNB.md 2026-07-02 https://biopharmsignal.com/company/TVTX.md 2026-07-02 https://biopharmsignal.com/company/PRCT.md 2026-07-02 https://biopharmsignal.com/company/CRNX.md 2026-07-02 https://biopharmsignal.com/company/BMEA.md 2026-07-02 https://biopharmsignal.com/company/INBX.md 2026-07-02 https://biopharmsignal.com/company/MD.md 2026-07-02 https://biopharmsignal.com/company/MODN.md 2026-07-02 https://biopharmsignal.com/company/CDMO.md 2026-07-02 https://biopharmsignal.com/company/NAMS.md 2026-07-02 https://biopharmsignal.com/company/VRDN.md 2026-07-02 https://biopharmsignal.com/company/IDYA.md 2026-07-02 https://biopharmsignal.com/company/RXRX.md 2026-07-02 https://biopharmsignal.com/company/ATRI.md 2026-07-02 https://biopharmsignal.com/company/SANA.md 2026-07-02 https://biopharmsignal.com/company/NRC.md 2026-07-02 https://biopharmsignal.com/company/QURE.md 2026-07-02 https://biopharmsignal.com/company/MNKD.md 2026-07-02 https://biopharmsignal.com/company/REPL.md 2026-07-02 https://biopharmsignal.com/company/VERV.md 2026-07-02 https://biopharmsignal.com/company/MIRM.md 2026-07-02 https://biopharmsignal.com/company/ME.md 2026-07-02 https://biopharmsignal.com/company/OM.md 2026-07-02 https://biopharmsignal.com/company/NVRO.md 2026-07-02 https://biopharmsignal.com/company/SAVA.md 2026-07-02 https://biopharmsignal.com/company/DAWN.md 2026-07-02 https://biopharmsignal.com/company/ADPT.md 2026-07-02 https://biopharmsignal.com/company/RYTM.md 2026-07-02 https://biopharmsignal.com/company/MRUS.md 2026-07-02 https://biopharmsignal.com/company/ALLO.md 2026-07-02 https://biopharmsignal.com/company/ARDX.md 2026-07-02 https://biopharmsignal.com/company/VREX.md 2026-07-02 https://biopharmsignal.com/company/ARQT.md 2026-07-02 https://biopharmsignal.com/company/NHC.md 2026-07-02 https://biopharmsignal.com/company/ACCD.md 2026-07-02 https://biopharmsignal.com/company/SIBN.md 2026-07-02 https://biopharmsignal.com/company/CCRN.md 2026-07-02 https://biopharmsignal.com/company/COGT.md 2026-07-02 https://biopharmsignal.com/company/GPCR.md 2026-07-02 https://biopharmsignal.com/company/BLFS.md 2026-07-02 https://biopharmsignal.com/company/HROW.md 2026-07-02 https://biopharmsignal.com/company/SLP.md 2026-07-02 https://biopharmsignal.com/company/MRSN.md 2026-07-02 https://biopharmsignal.com/company/PRTC.md 2026-07-02 https://biopharmsignal.com/company/RGNX.md 2026-07-02 https://biopharmsignal.com/company/ELVN.md 2026-07-02 https://biopharmsignal.com/company/RNA.md 2026-07-02 https://biopharmsignal.com/company/ADMA.md 2026-07-02 https://biopharmsignal.com/company/MOR.md 2026-07-02 https://biopharmsignal.com/company/KURA.md 2026-07-02 https://biopharmsignal.com/company/TWST.md 2026-07-02 https://biopharmsignal.com/company/INVA.md 2026-07-02 https://biopharmsignal.com/company/ANIP.md 2026-07-02 https://biopharmsignal.com/company/MODV.md 2026-07-02 https://biopharmsignal.com/company/IMTX.md 2026-07-02 https://biopharmsignal.com/company/TERN.md 2026-07-02 https://biopharmsignal.com/company/HSTM.md 2026-07-02 https://biopharmsignal.com/company/ENTA.md 2026-07-02 https://biopharmsignal.com/company/TBPH.md 2026-07-02 https://biopharmsignal.com/company/MCRB.md 2026-07-02 https://biopharmsignal.com/company/HCAT.md 2026-07-02 https://biopharmsignal.com/company/EHAB.md 2026-07-02 https://biopharmsignal.com/company/FDMT.md 2026-07-02 https://biopharmsignal.com/company/MDXG.md 2026-07-02 https://biopharmsignal.com/company/BLTE.md 2026-07-02 https://biopharmsignal.com/company/EDIT.md 2026-07-02 https://biopharmsignal.com/company/ALEC.md 2026-07-02 https://biopharmsignal.com/company/MLYS.md 2026-07-02 https://biopharmsignal.com/company/RXST.md 2026-07-02 https://biopharmsignal.com/company/CHRS.md 2026-07-02 https://biopharmsignal.com/company/AMAM.md 2026-07-02 https://biopharmsignal.com/company/GNLX.md 2026-07-02 https://biopharmsignal.com/company/RAPT.md 2026-07-02 https://biopharmsignal.com/company/BCYC.md 2026-07-02 https://biopharmsignal.com/company/NVAX.md 2026-07-02 https://biopharmsignal.com/company/EXAI.md 2026-07-02 https://biopharmsignal.com/company/EWTX.md 2026-07-02 https://biopharmsignal.com/company/LXRX.md 2026-07-02 https://biopharmsignal.com/company/IRON.md 2026-07-02 https://biopharmsignal.com/company/PIII.md 2026-07-02 https://biopharmsignal.com/company/IRMD.md 2026-07-02 https://biopharmsignal.com/company/AORT.md 2026-07-02 https://biopharmsignal.com/company/ACRS.md 2026-07-02 https://biopharmsignal.com/company/TYRA.md 2026-07-02 https://biopharmsignal.com/company/LYEL.md 2026-07-02 https://biopharmsignal.com/company/JANX.md 2026-07-02 https://biopharmsignal.com/company/ANAB.md 2026-07-02 https://biopharmsignal.com/company/AMWL.md 2026-07-02 https://biopharmsignal.com/company/HLVX.md 2026-07-02 https://biopharmsignal.com/company/IGMS.md 2026-07-02 https://biopharmsignal.com/company/AVTE.md 2026-07-02 https://biopharmsignal.com/company/AGEN.md 2026-07-02 https://biopharmsignal.com/company/AMRN.md 2026-07-02 https://biopharmsignal.com/company/PHAT.md 2026-07-02 https://biopharmsignal.com/company/FATE.md 2026-07-02 https://biopharmsignal.com/company/STOK.md 2026-07-02 https://biopharmsignal.com/company/OSUR.md 2026-07-02 https://biopharmsignal.com/company/SHCR.md 2026-07-02 https://biopharmsignal.com/company/MTLS.md 2026-07-02 https://biopharmsignal.com/company/HUMA.md 2026-07-02 https://biopharmsignal.com/company/SGHT.md 2026-07-02 https://biopharmsignal.com/company/ITOS.md 2026-07-02 https://biopharmsignal.com/company/MESO.md 2026-07-02 https://biopharmsignal.com/company/THRX.md 2026-07-02 https://biopharmsignal.com/company/OCUL.md 2026-07-02 https://biopharmsignal.com/company/LQDA.md 2026-07-02 https://biopharmsignal.com/company/MXCT.md 2026-07-02 https://biopharmsignal.com/company/BTMD.md 2026-07-02 https://biopharmsignal.com/company/OMGA.md 2026-07-02 https://biopharmsignal.com/company/CYH.md 2026-07-02 https://biopharmsignal.com/company/LUNG.md 2026-07-02 https://biopharmsignal.com/company/GHRS.md 2026-07-02 https://biopharmsignal.com/company/BLUE.md 2026-07-02 https://biopharmsignal.com/company/EBS.md 2026-07-02 https://biopharmsignal.com/company/MRNS.md 2026-07-02 https://biopharmsignal.com/company/MGNX.md 2026-07-02 https://biopharmsignal.com/company/CMPX.md 2026-07-02 https://biopharmsignal.com/company/NRIX.md 2026-07-02 https://biopharmsignal.com/company/TCMD.md 2026-07-02 https://biopharmsignal.com/company/ERAS.md 2026-07-02 https://biopharmsignal.com/company/BFLY.md 2026-07-02 https://biopharmsignal.com/company/TNYA.md 2026-07-02 https://biopharmsignal.com/company/CNTA.md 2026-07-02 https://biopharmsignal.com/company/DSGN.md 2026-07-02 https://biopharmsignal.com/company/NVTA.md 2026-07-02 https://biopharmsignal.com/company/CLOV.md 2026-07-02 https://biopharmsignal.com/company/TARS.md 2026-07-02 https://biopharmsignal.com/company/SRRK.md 2026-07-02 https://biopharmsignal.com/company/AXGN.md 2026-07-02 https://biopharmsignal.com/company/ALVR.md 2026-07-02 https://biopharmsignal.com/company/CUTR.md 2026-07-02 https://biopharmsignal.com/company/SIGA.md 2026-07-02 https://biopharmsignal.com/company/RCEL.md 2026-07-02 https://biopharmsignal.com/company/SCPH.md 2026-07-02 https://biopharmsignal.com/company/OABI.md 2026-07-02 https://biopharmsignal.com/company/CERS.md 2026-07-02 https://biopharmsignal.com/company/VNDA.md 2026-07-02 https://biopharmsignal.com/company/WVE.md 2026-07-02 https://biopharmsignal.com/company/TRDA.md 2026-07-02 https://biopharmsignal.com/company/CMPS.md 2026-07-02 https://biopharmsignal.com/company/AURA.md 2026-07-02 https://biopharmsignal.com/company/CGEM.md 2026-07-02 https://biopharmsignal.com/company/ALLK.md 2026-07-02 https://biopharmsignal.com/company/VYGR.md 2026-07-02 https://biopharmsignal.com/company/OCS.md 2026-07-02 https://biopharmsignal.com/company/ALPN.md 2026-07-02 https://biopharmsignal.com/company/PEPG.md 2026-07-02 https://biopharmsignal.com/company/NUVB.md 2026-07-02 https://biopharmsignal.com/company/ANGO.md 2026-07-02 https://biopharmsignal.com/company/PNTG.md 2026-07-02 https://biopharmsignal.com/company/ASRT.md 2026-07-02 https://biopharmsignal.com/company/CABA.md 2026-07-02 https://biopharmsignal.com/company/VIGL.md 2026-07-02 https://biopharmsignal.com/company/ATAI.md 2026-07-02 https://biopharmsignal.com/company/XERS.md 2026-07-02 https://biopharmsignal.com/company/STRO.md 2026-07-02 https://biopharmsignal.com/company/AUTL.md 2026-07-02 https://biopharmsignal.com/company/SENS.md 2026-07-02 https://biopharmsignal.com/company/SMTI.md 2026-07-02 https://biopharmsignal.com/company/PGEN.md 2026-07-02 https://biopharmsignal.com/company/NGM.md 2026-07-02 https://biopharmsignal.com/company/DBVT.md 2026-07-02 https://biopharmsignal.com/company/OMER.md 2026-07-02 https://biopharmsignal.com/company/PHVS.md 2026-07-02 https://biopharmsignal.com/company/SOPH.md 2026-07-02 https://biopharmsignal.com/company/GBIO.md 2026-07-02 https://biopharmsignal.com/company/PRLD.md 2026-07-02 https://biopharmsignal.com/company/PLSE.md 2026-07-02 https://biopharmsignal.com/company/RPHM.md 2026-07-02 https://biopharmsignal.com/company/AIRS.md 2026-07-02 https://biopharmsignal.com/company/NAUT.md 2026-07-02 https://biopharmsignal.com/company/YMAB.md 2026-07-02 https://biopharmsignal.com/company/OTLK.md 2026-07-02 https://biopharmsignal.com/company/URGN.md 2026-07-02 https://biopharmsignal.com/company/HRTX.md 2026-07-02 https://biopharmsignal.com/company/ICVX.md 2026-07-02 https://biopharmsignal.com/company/MGTX.md 2026-07-02 https://biopharmsignal.com/company/ACET.md 2026-07-02 https://biopharmsignal.com/company/KPTI.md 2026-07-02 https://biopharmsignal.com/company/GOCO.md 2026-07-02 https://biopharmsignal.com/company/VAXX.md 2026-07-02 https://biopharmsignal.com/company/AVIR.md 2026-07-02 https://biopharmsignal.com/company/ORGO.md 2026-07-02 https://biopharmsignal.com/company/ACRV.md 2026-07-02 https://biopharmsignal.com/company/ANNX.md 2026-07-02 https://biopharmsignal.com/company/VOR.md 2026-07-02 https://biopharmsignal.com/company/VRCA.md 2026-07-02 https://biopharmsignal.com/company/INGN.md 2026-07-02 https://biopharmsignal.com/company/ZIMV.md 2026-07-02 https://biopharmsignal.com/company/GLUE.md 2026-07-02 https://biopharmsignal.com/company/OLMA.md 2026-07-02 https://biopharmsignal.com/company/CRBU.md 2026-07-02 https://biopharmsignal.com/company/INZY.md 2026-07-02 https://biopharmsignal.com/company/KOD.md 2026-07-02 https://biopharmsignal.com/company/CVRX.md 2026-07-02 https://biopharmsignal.com/company/IKNA.md 2026-07-02 https://biopharmsignal.com/company/ALXO.md 2026-07-02 https://biopharmsignal.com/company/AKYA.md 2026-07-02 https://biopharmsignal.com/company/MOLN.md 2026-07-02 https://biopharmsignal.com/company/IPHA.md 2026-07-02 https://biopharmsignal.com/company/ALT.md 2026-07-02 https://biopharmsignal.com/company/NVCT.md 2026-07-02 https://biopharmsignal.com/company/TELA.md 2026-07-02 https://biopharmsignal.com/company/SLQT.md 2026-07-02 https://biopharmsignal.com/company/ORIC.md 2026-07-02 https://biopharmsignal.com/company/ADAP.md 2026-07-02 https://biopharmsignal.com/company/CARA.md 2026-07-02 https://biopharmsignal.com/company/MASS.md 2026-07-02 https://biopharmsignal.com/company/PMVP.md 2026-07-02 https://biopharmsignal.com/company/CDXS.md 2026-07-02 https://biopharmsignal.com/company/SEER.md 2026-07-02 https://biopharmsignal.com/company/FHTX.md 2026-07-02 https://biopharmsignal.com/company/RLYB.md 2026-07-02 https://biopharmsignal.com/company/NKTX.md 2026-07-02 https://biopharmsignal.com/company/SVRA.md 2026-07-02 https://biopharmsignal.com/company/QIPT.md 2026-07-02 https://biopharmsignal.com/company/BNGO.md 2026-07-02 https://biopharmsignal.com/company/IFRX.md 2026-07-02 https://biopharmsignal.com/company/EYPT.md 2026-07-02 https://biopharmsignal.com/company/INO.md 2026-07-02 https://biopharmsignal.com/company/WGS.md 2026-07-02 https://biopharmsignal.com/company/GNFT.md 2026-07-02 https://biopharmsignal.com/company/RANI.md 2026-07-02 https://biopharmsignal.com/company/IMRX.md 2026-07-02 https://biopharmsignal.com/company/FENC.md 2026-07-02 https://biopharmsignal.com/company/LRMR.md 2026-07-02 https://biopharmsignal.com/company/RIGL.md 2026-07-02 https://biopharmsignal.com/company/AADI.md 2026-07-02 https://biopharmsignal.com/company/CELC.md 2026-07-02 https://biopharmsignal.com/company/CTXR.md 2026-07-02 https://biopharmsignal.com/company/ABOS.md 2026-07-02 https://biopharmsignal.com/company/XFOR.md 2026-07-02 https://biopharmsignal.com/company/BGXX.md 2026-07-02 https://biopharmsignal.com/company/AKBA.md 2026-07-02 https://biopharmsignal.com/company/THRD.md 2026-07-02 https://biopharmsignal.com/company/AVAH.md 2026-07-02 https://biopharmsignal.com/company/IPSC.md 2026-07-02 https://biopharmsignal.com/company/LBPH.md 2026-07-02 https://biopharmsignal.com/company/KZR.md 2026-07-02 https://biopharmsignal.com/company/FULC.md 2026-07-02 https://biopharmsignal.com/company/NBTX.md 2026-07-02 https://biopharmsignal.com/company/TRVI.md 2026-07-02 https://biopharmsignal.com/company/ACIU.md 2026-07-02 https://biopharmsignal.com/company/GRPH.md 2026-07-02 https://biopharmsignal.com/company/MACK.md 2026-07-02 https://biopharmsignal.com/company/KRMD.md 2026-07-02 https://biopharmsignal.com/company/LMDXF.md 2026-07-02 https://biopharmsignal.com/company/SMLR.md 2026-07-02 https://biopharmsignal.com/company/RVPH.md 2026-07-02 https://biopharmsignal.com/company/ADCT.md 2026-07-02 https://biopharmsignal.com/company/EYEN.md 2026-07-02 https://biopharmsignal.com/company/PRQR.md 2026-07-02 https://biopharmsignal.com/company/XAIR.md 2026-07-02 https://biopharmsignal.com/company/OCGN.md 2026-07-02 https://biopharmsignal.com/company/GMDA.md 2026-07-02 https://biopharmsignal.com/company/JSPR.md 2026-07-02 https://biopharmsignal.com/company/CCCC.md 2026-07-02 https://biopharmsignal.com/company/ACHV.md 2026-07-02 https://biopharmsignal.com/company/AUGX.md 2026-07-02 https://biopharmsignal.com/company/BCAB.md 2026-07-02 https://biopharmsignal.com/company/ASXC.md 2026-07-02 https://biopharmsignal.com/company/ADXS.md 2026-07-02 https://biopharmsignal.com/company/GTHX.md 2026-07-02 https://biopharmsignal.com/company/INMB.md 2026-07-02 https://biopharmsignal.com/company/PBYI.md 2026-07-02 https://biopharmsignal.com/company/PSTX.md 2026-07-02 https://biopharmsignal.com/company/MREO.md 2026-07-02 https://biopharmsignal.com/company/GLSI.md 2026-07-02 https://biopharmsignal.com/company/GRTX.md 2026-07-02 https://biopharmsignal.com/company/ZURA.md 2026-07-02 https://biopharmsignal.com/company/PRPH.md 2026-07-02 https://biopharmsignal.com/company/ANVS.md 2026-07-02 https://biopharmsignal.com/company/STXS.md 2026-07-02 https://biopharmsignal.com/company/AFMD.md 2026-07-02 https://biopharmsignal.com/company/ABSI.md 2026-07-02 https://biopharmsignal.com/company/MNMD.md 2026-07-02 https://biopharmsignal.com/company/GOSS.md 2026-07-02 https://biopharmsignal.com/company/EPIX.md 2026-07-02 https://biopharmsignal.com/company/HLTH.md 2026-07-02 https://biopharmsignal.com/company/BDSX.md 2026-07-02 https://biopharmsignal.com/company/TRML.md 2026-07-02 https://biopharmsignal.com/company/AQST.md 2026-07-02 https://biopharmsignal.com/company/CTSO.md 2026-07-02 https://biopharmsignal.com/company/OCUP.md 2026-07-02 https://biopharmsignal.com/company/IVA.md 2026-07-02 https://biopharmsignal.com/company/ESPR.md 2026-07-02 https://biopharmsignal.com/company/APYX.md 2026-07-02 https://biopharmsignal.com/company/DRRX.md 2026-07-02 https://biopharmsignal.com/company/RNLX.md 2026-07-02 https://biopharmsignal.com/company/VXRT.md 2026-07-02 https://biopharmsignal.com/company/FONR.md 2026-07-02 https://biopharmsignal.com/company/STTK.md 2026-07-02 https://biopharmsignal.com/company/ATYR.md 2026-07-02 https://biopharmsignal.com/company/PYXS.md 2026-07-02 https://biopharmsignal.com/company/BCTX.md 2026-07-02 https://biopharmsignal.com/company/GALT.md 2026-07-02 https://biopharmsignal.com/company/KRON.md 2026-07-02 https://biopharmsignal.com/company/GNTA.md 2026-07-02 https://biopharmsignal.com/company/CTMX.md 2026-07-02 https://biopharmsignal.com/company/CVM.md 2026-07-02 https://biopharmsignal.com/company/ANTX.md 2026-07-02 https://biopharmsignal.com/company/SERA.md 2026-07-02 https://biopharmsignal.com/company/ATHA.md 2026-07-02 https://biopharmsignal.com/company/SCYX.md 2026-07-02 https://biopharmsignal.com/company/MDXH.md 2026-07-02 https://biopharmsignal.com/company/BCLI.md 2026-07-02 https://biopharmsignal.com/company/MNOV.md 2026-07-02 https://biopharmsignal.com/company/PSNL.md 2026-07-02 https://biopharmsignal.com/company/SLDB.md 2026-07-02 https://biopharmsignal.com/company/CLLS.md 2026-07-02 https://biopharmsignal.com/company/AKLI.md 2026-07-02 https://biopharmsignal.com/company/HOWL.md 2026-07-02 https://biopharmsignal.com/company/HYPR.md 2026-07-02 https://biopharmsignal.com/company/STRM.md 2026-07-02 https://biopharmsignal.com/company/SEEL.md 2026-07-02 https://biopharmsignal.com/company/SPRO.md 2026-07-02 https://biopharmsignal.com/company/CAPR.md 2026-07-02 https://biopharmsignal.com/company/ELEV.md 2026-07-02 https://biopharmsignal.com/company/FBIO.md 2026-07-02 https://biopharmsignal.com/company/ARAV.md 2026-07-02 https://biopharmsignal.com/company/CDTX.md 2026-07-02 https://biopharmsignal.com/company/GLYC.md 2026-07-02 https://biopharmsignal.com/company/DTIL.md 2026-07-02 https://biopharmsignal.com/company/ELYM.md 2026-07-02 https://biopharmsignal.com/company/SPRB.md 2026-07-02 https://biopharmsignal.com/company/BLPH.md 2026-07-02 https://biopharmsignal.com/company/ATOS.md 2026-07-02 https://biopharmsignal.com/company/BLI.md 2026-07-02 https://biopharmsignal.com/company/XLO.md 2026-07-02 https://biopharmsignal.com/company/RZLT.md 2026-07-02 https://biopharmsignal.com/company/FORA.md 2026-07-02 https://biopharmsignal.com/company/VSTM.md 2026-07-02 https://biopharmsignal.com/company/LYRA.md 2026-07-02 https://biopharmsignal.com/company/APLT.md 2026-07-02 https://biopharmsignal.com/company/HOOK.md 2026-07-02 https://biopharmsignal.com/company/CRDF.md 2026-07-02 https://biopharmsignal.com/company/OSA.md 2026-07-02 https://biopharmsignal.com/company/IMUX.md 2026-07-02 https://biopharmsignal.com/company/AXDX.md 2026-07-02 https://biopharmsignal.com/company/DMTK.md 2026-07-02 https://biopharmsignal.com/company/CRIS.md 2026-07-02 https://biopharmsignal.com/company/OMIC.md 2026-07-02 https://biopharmsignal.com/company/CYT.md 2026-07-02 https://biopharmsignal.com/company/MYNZ.md 2026-07-02 https://biopharmsignal.com/company/ETAO.md 2026-07-02 https://biopharmsignal.com/company/CLNN.md 2026-07-02 https://biopharmsignal.com/company/XTNT.md 2026-07-02 https://biopharmsignal.com/company/IMNM.md 2026-07-02 https://biopharmsignal.com/company/BDTX.md 2026-07-02 https://biopharmsignal.com/company/LUCD.md 2026-07-02 https://biopharmsignal.com/company/CLSD.md 2026-07-02 https://biopharmsignal.com/company/NWBO.md 2026-07-02 https://biopharmsignal.com/company/LGVN.md 2026-07-02 https://biopharmsignal.com/company/DCTH.md 2026-07-02 https://biopharmsignal.com/company/GANX.md 2026-07-02 https://biopharmsignal.com/company/SONX.md 2026-07-02 https://biopharmsignal.com/company/INAB.md 2026-07-02 https://biopharmsignal.com/company/CSBR.md 2026-07-02 https://biopharmsignal.com/company/STIM.md 2026-07-02 https://biopharmsignal.com/company/PRAX.md 2026-07-02 https://biopharmsignal.com/company/SYRS.md 2026-07-02 https://biopharmsignal.com/company/BOLT.md 2026-07-02 https://biopharmsignal.com/company/PIRS.md 2026-07-02 https://biopharmsignal.com/company/CRVS.md 2026-07-02 https://biopharmsignal.com/company/ICCM.md 2026-07-02 https://biopharmsignal.com/company/ANEB.md 2026-07-02 https://biopharmsignal.com/company/IOBT.md 2026-07-02 https://biopharmsignal.com/company/FIXX.md 2026-07-02 https://biopharmsignal.com/company/LTRN.md 2026-07-02 https://biopharmsignal.com/company/ABEO.md 2026-07-02 https://biopharmsignal.com/company/PASG.md 2026-07-02 https://biopharmsignal.com/company/TCRX.md 2026-07-02 https://biopharmsignal.com/company/VANI.md 2026-07-02 https://biopharmsignal.com/company/OKYO.md 2026-07-02 https://biopharmsignal.com/company/ALGS.md 2026-07-02 https://biopharmsignal.com/company/GLTO.md 2026-07-02 https://biopharmsignal.com/company/MOVE.md 2026-07-02 https://biopharmsignal.com/company/TRNR.md 2026-07-02 https://biopharmsignal.com/company/HCWB.md 2026-07-02 https://biopharmsignal.com/company/PAVM.md 2026-07-02 https://biopharmsignal.com/company/ALZN.md 2026-07-02 https://biopharmsignal.com/company/HEPA.md 2026-07-02 https://biopharmsignal.com/company/SABS.md 2026-07-02 https://biopharmsignal.com/company/LFVN.md 2026-07-02 https://biopharmsignal.com/company/SNSE.md 2026-07-02 https://biopharmsignal.com/company/PMCB.md 2026-07-02 https://biopharmsignal.com/company/ARMP.md 2026-07-02 https://biopharmsignal.com/company/CADL.md 2026-07-02 https://biopharmsignal.com/company/XGN.md 2026-07-02 https://biopharmsignal.com/company/CGTX.md 2026-07-02 https://biopharmsignal.com/company/SNTI.md 2026-07-02 https://biopharmsignal.com/company/MEIP.md 2026-07-02 https://biopharmsignal.com/company/LPTX.md 2026-07-02 https://biopharmsignal.com/company/TSHA.md 2026-07-02 https://biopharmsignal.com/company/DMAC.md 2026-07-02 https://biopharmsignal.com/company/NXTC.md 2026-07-02 https://biopharmsignal.com/company/LVTX.md 2026-07-02 https://biopharmsignal.com/company/NRXP.md 2026-07-02 https://biopharmsignal.com/company/NLSP.md 2026-07-02 https://biopharmsignal.com/company/CRBP.md 2026-07-02 https://biopharmsignal.com/company/GNPX.md 2026-07-02 https://biopharmsignal.com/company/BCDA.md 2026-07-02 https://biopharmsignal.com/company/BCEL.md 2026-07-02 https://biopharmsignal.com/company/KA.md 2026-07-02 https://biopharmsignal.com/company/CCEL.md 2026-07-02 https://biopharmsignal.com/company/TXMD.md 2026-07-02 https://biopharmsignal.com/company/ACHL.md 2026-07-02 https://biopharmsignal.com/company/UTRS.md 2026-07-02 https://biopharmsignal.com/company/AQB.md 2026-07-02 https://biopharmsignal.com/company/ICCC.md 2026-07-02 https://biopharmsignal.com/company/AWH.md 2026-07-02 https://biopharmsignal.com/company/SYBX.md 2026-07-02 https://biopharmsignal.com/company/BYSI.md 2026-07-02 https://biopharmsignal.com/company/SURF.md 2026-07-02 https://biopharmsignal.com/company/AZYO.md 2026-07-02 https://biopharmsignal.com/company/SSKN.md 2026-07-02 https://biopharmsignal.com/company/NCNA.md 2026-07-02 https://biopharmsignal.com/company/IRIX.md 2026-07-02 https://biopharmsignal.com/company/RMTI.md 2026-07-02 https://biopharmsignal.com/company/STSA.md 2026-07-02 https://biopharmsignal.com/company/EVAX.md 2026-07-02 https://biopharmsignal.com/company/ACXP.md 2026-07-02 https://biopharmsignal.com/company/GRNA.md 2026-07-02 https://biopharmsignal.com/company/COSM.md 2026-07-02 https://biopharmsignal.com/company/RPID.md 2026-07-02 https://biopharmsignal.com/company/TARA.md 2026-07-02 https://biopharmsignal.com/company/AVTX.md 2026-07-02 https://biopharmsignal.com/company/VINC.md 2026-07-02 https://biopharmsignal.com/company/OMED.md 2026-07-02 https://biopharmsignal.com/company/UBX.md 2026-07-02 https://biopharmsignal.com/company/SLNO.md 2026-07-02 https://biopharmsignal.com/company/VIRX.md 2026-07-02 https://biopharmsignal.com/company/IMMX.md 2026-07-02 https://biopharmsignal.com/company/TNXP.md 2026-07-02 https://biopharmsignal.com/company/BTCY.md 2026-07-02 https://biopharmsignal.com/company/BFRG.md 2026-07-02 https://biopharmsignal.com/company/ANPC.md 2026-07-02 https://biopharmsignal.com/company/NERV.md 2026-07-02 https://biopharmsignal.com/company/AVRO.md 2026-07-02 https://biopharmsignal.com/company/NOVN.md 2026-07-02 https://biopharmsignal.com/company/MIRO.md 2026-07-02 https://biopharmsignal.com/company/MBIO.md 2026-07-02 https://biopharmsignal.com/company/ORPH.md 2026-07-02 https://biopharmsignal.com/company/LNSR.md 2026-07-02 https://biopharmsignal.com/company/TRVN.md 2026-07-02 https://biopharmsignal.com/company/ONTX.md 2026-07-02 https://biopharmsignal.com/company/ORGS.md 2026-07-02 https://biopharmsignal.com/company/AXLA.md 2026-07-02 https://biopharmsignal.com/company/ABVC.md 2026-07-02 https://biopharmsignal.com/company/LUMO.md 2026-07-02 https://biopharmsignal.com/company/VAPO.md 2026-07-02 https://biopharmsignal.com/company/ECOR.md 2026-07-02 https://biopharmsignal.com/company/COCP.md 2026-07-02 https://biopharmsignal.com/company/RNXT.md 2026-07-02 https://biopharmsignal.com/company/TFFP.md 2026-07-02 https://biopharmsignal.com/company/VTGN.md 2026-07-02 https://biopharmsignal.com/company/AFIB.md 2026-07-02 https://biopharmsignal.com/company/NTRB.md 2026-07-02 https://biopharmsignal.com/company/RGLS.md 2026-07-02 https://biopharmsignal.com/company/IDRA.md 2026-07-02 https://biopharmsignal.com/company/LSTA.md 2026-07-02 https://biopharmsignal.com/company/ICU.md 2026-07-02 https://biopharmsignal.com/company/BTTX.md 2026-07-02 https://biopharmsignal.com/company/ANGN.md 2026-07-02 https://biopharmsignal.com/company/MITO.md 2026-07-02 https://biopharmsignal.com/company/CNTG.md 2026-07-02 https://biopharmsignal.com/company/EFTR.md 2026-07-02 https://biopharmsignal.com/company/NMRD.md 2026-07-02 https://biopharmsignal.com/company/FBRX.md 2026-07-02 https://biopharmsignal.com/company/NMTC.md 2026-07-02 https://biopharmsignal.com/company/AGE.md 2026-07-02 https://biopharmsignal.com/company/HARP.md 2026-07-02 https://biopharmsignal.com/company/TPST.md 2026-07-02 https://biopharmsignal.com/company/TNON.md 2026-07-02 https://biopharmsignal.com/company/ACST.md 2026-07-02 https://biopharmsignal.com/company/INDP.md 2026-07-02 https://biopharmsignal.com/company/HGEN.md 2026-07-02 https://biopharmsignal.com/company/BRLI.md 2026-07-02 https://biopharmsignal.com/company/IKT.md 2026-07-02 https://biopharmsignal.com/company/BRTX.md 2026-07-02 https://biopharmsignal.com/company/VCNX.md 2026-07-02 https://biopharmsignal.com/company/MODD.md 2026-07-02 https://biopharmsignal.com/company/FNCH.md 2026-07-02 https://biopharmsignal.com/company/ONCT.md 2026-07-02 https://biopharmsignal.com/company/SQZ.md 2026-07-02 https://biopharmsignal.com/company/IGC.md 2026-07-02 https://biopharmsignal.com/company/MGRX.md 2026-07-02 https://biopharmsignal.com/company/NHWK.md 2026-07-02 https://biopharmsignal.com/company/INFI.md 2026-07-02 https://biopharmsignal.com/company/SRZN.md 2026-07-02 https://biopharmsignal.com/company/SGTX.md 2026-07-02 https://biopharmsignal.com/company/GOVX.md 2026-07-02 https://biopharmsignal.com/company/BEAT.md 2026-07-02 https://biopharmsignal.com/company/AMS.md 2026-07-02 https://biopharmsignal.com/company/TCON.md 2026-07-02 https://biopharmsignal.com/company/PCSA.md 2026-07-02 https://biopharmsignal.com/company/ATHX.md 2026-07-02 https://biopharmsignal.com/company/BIAF.md 2026-07-02 https://biopharmsignal.com/company/NRBO.md 2026-07-02 https://biopharmsignal.com/company/SIEN.md 2026-07-02 https://biopharmsignal.com/company/FRLN.md 2026-07-02 https://biopharmsignal.com/company/CMRA.md 2026-07-02 https://biopharmsignal.com/company/NEPH.md 2026-07-02 https://biopharmsignal.com/company/APRE.md 2026-07-02 https://biopharmsignal.com/company/ISPC.md 2026-07-02 https://biopharmsignal.com/company/POAI.md 2026-07-02 https://biopharmsignal.com/company/TLIS.md 2026-07-02 https://biopharmsignal.com/company/ITRM.md 2026-07-02 https://biopharmsignal.com/company/CLRB.md 2026-07-02 https://biopharmsignal.com/company/PRPO.md 2026-07-02 https://biopharmsignal.com/company/IMNN.md 2026-07-02 https://biopharmsignal.com/company/EVLO.md 2026-07-02 https://biopharmsignal.com/company/APDN.md 2026-07-02 https://biopharmsignal.com/company/IBIO.md 2026-07-02 https://biopharmsignal.com/company/ALIM.md 2026-07-02 https://biopharmsignal.com/company/MNPR.md 2026-07-02 https://biopharmsignal.com/company/CYCN.md 2026-07-02 https://biopharmsignal.com/company/CYTH.md 2026-07-02 https://biopharmsignal.com/company/CING.md 2026-07-02 https://biopharmsignal.com/company/CYAD.md 2026-07-02 https://biopharmsignal.com/company/APVO.md 2026-07-02 https://biopharmsignal.com/company/AMTI.md 2026-07-02 https://biopharmsignal.com/company/BPTH.md 2026-07-02 https://biopharmsignal.com/company/GLS.md 2026-07-02 https://biopharmsignal.com/company/TTNP.md 2026-07-02 https://biopharmsignal.com/company/OBSV.md 2026-07-02 https://biopharmsignal.com/company/ELOX.md 2026-07-02 https://biopharmsignal.com/company/NDRA.md 2026-07-02 https://biopharmsignal.com/company/PULM.md 2026-07-02 https://biopharmsignal.com/company/MYO.md 2026-07-02 https://biopharmsignal.com/company/LIPO.md 2026-07-02 https://biopharmsignal.com/company/ADXN.md 2026-07-02 https://biopharmsignal.com/company/AUVI.md 2026-07-02 https://biopharmsignal.com/company/PSTV.md 2026-07-02 https://biopharmsignal.com/company/BPTS.md 2026-07-02 https://biopharmsignal.com/company/AGLE.md 2026-07-02 https://biopharmsignal.com/company/JAGX.md 2026-07-02 https://biopharmsignal.com/company/HCTI.md 2026-07-02 https://biopharmsignal.com/company/FEMY.md 2026-07-02 https://biopharmsignal.com/company/VVOS.md 2026-07-02 https://biopharmsignal.com/company/CNTX.md 2026-07-02 https://biopharmsignal.com/company/STSS.md 2026-07-02 https://biopharmsignal.com/company/KTTA.md 2026-07-02 https://biopharmsignal.com/company/ADIL.md 2026-07-02 https://biopharmsignal.com/company/CELZ.md 2026-07-02 https://biopharmsignal.com/company/LIXT.md 2026-07-02 https://biopharmsignal.com/company/XCUR.md 2026-07-02 https://biopharmsignal.com/company/VRPX.md 2026-07-02 https://biopharmsignal.com/company/NEXI.md 2026-07-02 https://biopharmsignal.com/company/LABP.md 2026-07-02 https://biopharmsignal.com/company/BLCM.md 2026-07-02 https://biopharmsignal.com/company/GRAY.md 2026-07-02 https://biopharmsignal.com/company/HSCS.md 2026-07-02 https://biopharmsignal.com/company/WINT.md 2026-07-02 https://biopharmsignal.com/company/PTIX.md 2026-07-02 https://biopharmsignal.com/company/PTPI.md 2026-07-02 https://biopharmsignal.com/company/ONCR.md 2026-07-02 https://biopharmsignal.com/company/NURO.md 2026-07-02 https://biopharmsignal.com/company/NXGL.md 2026-07-02 https://biopharmsignal.com/company/PBLA.md 2026-07-02 https://biopharmsignal.com/company/AEMD.md 2026-07-02 https://biopharmsignal.com/company/ACRX.md 2026-07-02 https://biopharmsignal.com/company/ATXI.md 2026-07-02 https://biopharmsignal.com/company/CBIO.md 2026-07-02 https://biopharmsignal.com/company/GHSI.md 2026-07-02 https://biopharmsignal.com/company/CRVO.md 2026-07-02 https://biopharmsignal.com/company/EVOK.md 2026-07-02 https://biopharmsignal.com/company/HILS.md 2026-07-02 https://biopharmsignal.com/company/CYCC.md 2026-07-02 https://biopharmsignal.com/company/VTAK.md 2026-07-02 https://biopharmsignal.com/company/FRTX.md 2026-07-02 https://biopharmsignal.com/company/QNRX.md 2026-07-02 https://biopharmsignal.com/company/ALRN.md 2026-07-02 https://biopharmsignal.com/company/REVB.md 2026-07-02 https://biopharmsignal.com/company/BJDX.md 2026-07-02 https://biopharmsignal.com/company/XBIO.md 2026-07-02 https://biopharmsignal.com/company/RSLS.md 2026-07-02 https://biopharmsignal.com/company/ARDS.md 2026-07-02 https://biopharmsignal.com/company/NBSE.md 2026-07-02 https://biopharmsignal.com/company/SNPX.md 2026-07-02 https://biopharmsignal.com/company/BNTC.md 2026-07-02 https://biopharmsignal.com/company/AGRX.md 2026-07-02 https://biopharmsignal.com/company/PHIO.md 2026-07-02 https://biopharmsignal.com/company/SQL.md 2026-07-02 https://biopharmsignal.com/company/NAVB.md 2026-07-02 https://biopharmsignal.com/company/TTOO.md 2026-07-02 https://biopharmsignal.com/company/SINT.md 2026-07-02 https://biopharmsignal.com/company/OGEN.md 2026-07-02 https://biopharmsignal.com/company/ACON.md 2026-07-02 https://biopharmsignal.com/company/HOTH.md 2026-07-02 https://biopharmsignal.com/company/VRAX.md 2026-07-02 https://biopharmsignal.com/company/SNGX.md 2026-07-02 https://biopharmsignal.com/company/BIOL.md 2026-07-02 https://biopharmsignal.com/company/KTRA.md 2026-07-02 https://biopharmsignal.com/company/GRI.md 2026-07-02 https://biopharmsignal.com/company/SLRX.md 2026-07-02 https://biopharmsignal.com/company/HTGM.md 2026-07-02 https://biopharmsignal.com/company/KPRX.md 2026-07-02 https://biopharmsignal.com/company/CWBR.md 2026-07-02 https://biopharmsignal.com/company/RNAZ.md 2026-07-02 https://biopharmsignal.com/company/TMBR.md 2026-07-02 https://biopharmsignal.com/company/ARTL.md 2026-07-02 https://biopharmsignal.com/company/SNOA.md 2026-07-02 https://biopharmsignal.com/company/HSDT.md 2026-07-02 https://biopharmsignal.com/company/OPGN.md 2026-07-02 https://biopharmsignal.com/company/ATNF.md 2026-07-02 https://biopharmsignal.com/company/FWBI.md 2026-07-02 https://biopharmsignal.com/company/ENSC.md 2026-07-02 https://biopharmsignal.com/company/ENVB.md 2026-07-02 https://biopharmsignal.com/company/INBS.md 2026-07-02 https://biopharmsignal.com/company/AVGR.md 2026-07-02 https://biopharmsignal.com/company/NVIV.md 2026-07-02 https://biopharmsignal.com/company/INM.md 2026-07-02 https://biopharmsignal.com/company/ALLR.md 2026-07-02 https://biopharmsignal.com/company/TIVC.md 2026-07-02 https://biopharmsignal.com/company/LGMK.md 2026-07-02 https://biopharmsignal.com/company/ADTX.md 2026-07-02 https://biopharmsignal.com/company/JAN.md 2026-07-02 https://biopharmsignal.com/company/HSTO.md 2026-07-02 https://biopharmsignal.com/company/AMPE.md 2026-07-02 https://biopharmsignal.com/company/BRSH.md 2026-07-02 https://biopharmsignal.com/company/BBLG.md 2026-07-02 https://biopharmsignal.com/company/LADX.md 2026-07-02 https://biopharmsignal.com/company/THMO.md 2026-07-02 https://biopharmsignal.com/company/CFRX.md 2026-07-02 https://biopharmsignal.com/company/CRXT.md 2026-07-02 https://biopharmsignal.com/company/TCBP.md 2026-07-02 https://biopharmsignal.com/company/NBY.md 2026-07-02 https://biopharmsignal.com/company/SMFL.md 2026-07-02 https://biopharmsignal.com/company/BXRX.md 2026-07-02 https://biopharmsignal.com/company/DRMA.md 2026-07-02 https://biopharmsignal.com/company/EVFM.md 2026-07-02 https://biopharmsignal.com/company/STAB.md 2026-07-02 https://biopharmsignal.com/company/SCPS.md 2026-07-02 https://biopharmsignal.com/company/ARGS.md 2026-07-02 https://biopharmsignal.com/company/TENX.md 2026-07-02 https://biopharmsignal.com/company/ESMC.md 2026-07-02 https://biopharmsignal.com/company/MTP.md 2026-07-02 https://biopharmsignal.com/company/SGMT.md 2026-07-02 https://biopharmsignal.com/company/DRMT.md 2026-07-02 https://biopharmsignal.com/company/DECI.md 2026-07-02 https://biopharmsignal.com/company/CCBS.md 2026-07-02 https://biopharmsignal.com/company/ALZH.md 2026-07-02 https://biopharmsignal.com/company/BFRI.md 2026-07-02 https://biopharmsignal.com/company/VLA.md 2026-07-02 https://biopharmsignal.com/company/CRVW.md 2026-07-02 https://biopharmsignal.com/company/QBIO.md 2026-07-02 https://biopharmsignal.com/company/BHC.md 2026-07-02 https://biopharmsignal.com/company/MATAS.md 2026-07-02 https://biopharmsignal.com/company/GRD1R.md 2026-07-02 https://biopharmsignal.com/company/PASO.md 2026-07-02 https://biopharmsignal.com/company/INTS.md 2026-07-02 https://biopharmsignal.com/company/BSEM.md 2026-07-02 https://biopharmsignal.com/company/CDXI.md 2026-07-02 https://biopharmsignal.com/company/ENDV.md 2026-07-02 https://biopharmsignal.com/company/CMXC.md 2026-07-02 https://biopharmsignal.com/company/MLNTQ.md 2026-07-02 https://biopharmsignal.com/company/IVOB.md 2026-07-02 https://biopharmsignal.com/company/ELGXQ.md 2026-07-02 https://biopharmsignal.com/company/DNCE.md 2026-07-02 https://biopharmsignal.com/company/CSTX.md 2026-07-02 https://biopharmsignal.com/company/MKT.md 2026-07-02 https://biopharmsignal.com/company/INKT.md 2026-07-02 https://biopharmsignal.com/company/RBOT.md 2026-07-02 https://biopharmsignal.com/company/NGEN.md 2026-07-02 https://biopharmsignal.com/company/SANION.md 2026-07-02 https://biopharmsignal.com/company/RCKT.md 2026-07-02 https://biopharmsignal.com/company/BDX.md 2026-07-02 https://biopharmsignal.com/company/EGTX.md 2026-07-02 https://biopharmsignal.com/company/BSLN.md 2026-07-02 https://biopharmsignal.com/company/BAVN.md 2026-07-02 https://biopharmsignal.com/company/RYZB.md 2026-07-02 https://biopharmsignal.com/company/KNSA.md 2026-07-02 https://biopharmsignal.com/company/AVDL.md 2026-07-02 https://biopharmsignal.com/company/KALV.md 2026-07-02 https://biopharmsignal.com/company/IOVA.md 2026-07-02 https://biopharmsignal.com/company/ARCT.md 2026-07-02 https://biopharmsignal.com/company/PDSB.md 2026-07-02 https://biopharmsignal.com/company/XENE.md 2026-07-02 https://biopharmsignal.com/company/BTAI.md 2026-07-02 https://biopharmsignal.com/company/AXSM.md 2026-07-02 https://biopharmsignal.com/company/IMMP.md 2026-07-02 https://biopharmsignal.com/company/ALKS.md 2026-07-02 https://biopharmsignal.com/company/IMAB.md 2026-07-02 https://biopharmsignal.com/company/NKGN.md 2026-07-02 https://biopharmsignal.com/company/APTO.md 2026-07-02 https://biopharmsignal.com/company/MIST.md 2026-07-02 https://biopharmsignal.com/company/BIVI.md 2026-07-02 https://biopharmsignal.com/company/VYNE.md 2026-07-02 https://biopharmsignal.com/company/VRTX.md 2026-07-02 https://biopharmsignal.com/company/ELDN.md 2026-07-02 https://biopharmsignal.com/company/VERA.md 2026-07-02 https://biopharmsignal.com/company/MBRX.md 2026-07-02 https://biopharmsignal.com/company/CGEN.md 2026-07-02 https://biopharmsignal.com/company/ELTX.md 2026-07-02 https://biopharmsignal.com/company/SLS.md 2026-07-02 https://biopharmsignal.com/company/MDNA.md 2026-07-02 https://biopharmsignal.com/company/FLGT.md 2026-07-02 https://biopharmsignal.com/company/ONCY.md 2026-07-02 https://biopharmsignal.com/company/TLSA.md 2026-07-02 https://biopharmsignal.com/company/CUE.md 2026-07-02 https://biopharmsignal.com/company/ATXS.md 2026-07-02 https://biopharmsignal.com/company/LPCN.md 2026-07-02 https://biopharmsignal.com/company/ATRA.md 2026-07-02 https://biopharmsignal.com/company/CRMD.md 2026-07-02 https://biopharmsignal.com/company/CKPT.md 2026-07-02 https://biopharmsignal.com/company/DARE.md 2026-07-02 https://biopharmsignal.com/company/ALDX.md 2026-07-02 https://biopharmsignal.com/company/CALT.md 2026-07-02 https://biopharmsignal.com/company/GKOS.md 2026-07-02 https://biopharmsignal.com/company/GLPG.md 2026-07-02 https://biopharmsignal.com/company/AGIO.md 2026-07-02 https://biopharmsignal.com/company/GRCL.md 2026-07-02 https://biopharmsignal.com/company/SGMO.md 2026-07-02 https://biopharmsignal.com/company/THTX.md 2026-07-02 https://biopharmsignal.com/company/EQ.md 2026-07-02 https://biopharmsignal.com/company/FUSN.md 2026-07-02 https://biopharmsignal.com/company/PTN.md 2026-07-02 https://biopharmsignal.com/company/KZIA.md 2026-07-02 https://biopharmsignal.com/company/HCM.md 2026-07-02 https://biopharmsignal.com/company/BGNE.md 2026-07-02 https://biopharmsignal.com/company/SLRN.md 2026-07-02 https://biopharmsignal.com/company/ADAG.md 2026-07-02 https://biopharmsignal.com/company/AUPH.md 2026-07-02 https://biopharmsignal.com/company/VRNA.md 2026-07-02 https://biopharmsignal.com/company/KYTX.md 2026-07-02 https://biopharmsignal.com/company/ADVM.md 2026-07-02 https://biopharmsignal.com/company/ONVO.md 2026-07-02 https://biopharmsignal.com/company/NRSN.md 2026-07-02 https://biopharmsignal.com/company/LCTX.md 2026-07-02 https://biopharmsignal.com/company/COYA.md 2026-07-02 https://biopharmsignal.com/company/MLTX.md 2026-07-02 https://biopharmsignal.com/company/ACAD.md 2026-07-02 https://biopharmsignal.com/company/SLN.md 2026-07-02 https://biopharmsignal.com/company/ASLN.md 2026-07-02 https://biopharmsignal.com/company/CYBN.md 2026-07-02 https://biopharmsignal.com/company/ENTX.md 2026-07-02 https://biopharmsignal.com/company/CNTB.md 2026-07-02 https://biopharmsignal.com/company/BDRX.md 2026-07-02 https://biopharmsignal.com/company/AIM.md 2026-07-02 https://biopharmsignal.com/company/IXHL.md 2026-07-02 https://biopharmsignal.com/company/CLPT.md 2026-07-02 https://biopharmsignal.com/company/PTCT.md 2026-07-02 https://biopharmsignal.com/company/NVCR.md 2026-07-02 https://biopharmsignal.com/company/ANL.md 2026-07-02 https://biopharmsignal.com/company/SONN.md 2026-07-02 https://biopharmsignal.com/company/TAK.md 2026-07-02 https://biopharmsignal.com/company/ENLV.md 2026-07-02 https://biopharmsignal.com/company/SUPN.md 2026-07-02 https://biopharmsignal.com/company/PMN.md 2026-07-02 https://biopharmsignal.com/company/IBRX.md 2026-07-02 https://biopharmsignal.com/company/OCEA.md 2026-07-02 https://biopharmsignal.com/company/MRKR.md 2026-07-02 https://biopharmsignal.com/company/CATX.md 2026-07-02 https://biopharmsignal.com/company/ZVRA.md 2026-07-02 https://biopharmsignal.com/company/CALC.md 2026-07-02 https://biopharmsignal.com/company/CORT.md 2026-07-02 https://biopharmsignal.com/company/ABUS.md 2026-07-02 https://biopharmsignal.com/company/BRNS.md 2026-07-02 https://biopharmsignal.com/company/ETON.md 2026-07-02 https://biopharmsignal.com/company/BHVN.md 2026-07-02 https://biopharmsignal.com/company/UNCY.md 2026-07-02 https://biopharmsignal.com/company/ATHE.md 2026-07-02 https://biopharmsignal.com/company/EVGN.md 2026-07-02 https://biopharmsignal.com/company/CARM.md 2026-07-02 https://biopharmsignal.com/company/IMRN.md 2026-07-02 https://biopharmsignal.com/company/PPBT.md 2026-07-02 https://biopharmsignal.com/company/RNAC.md 2026-07-02 https://biopharmsignal.com/company/SELB.md 2026-07-02 https://biopharmsignal.com/company/YS.md 2026-07-02 https://biopharmsignal.com/company/RARE.md 2026-07-02 https://biopharmsignal.com/company/SPRY.md 2026-07-02 https://biopharmsignal.com/company/BNOX.md 2026-07-02 https://biopharmsignal.com/company/RPTX.md 2026-07-02 https://biopharmsignal.com/company/EGRX.md 2026-07-02 https://biopharmsignal.com/company/BIIB.md 2026-07-02 https://biopharmsignal.com/company/PRFX.md 2026-07-02 https://biopharmsignal.com/company/CMMB.md 2026-07-02 https://biopharmsignal.com/company/PYPD.md 2026-07-02 https://biopharmsignal.com/company/VIRI.md 2026-07-02 https://biopharmsignal.com/company/INDV.md 2026-07-02 https://biopharmsignal.com/company/NGNE.md 2026-07-02 https://biopharmsignal.com/company/MYMD.md 2026-07-02 https://biopharmsignal.com/company/AMRX.md 2026-07-02 https://biopharmsignal.com/company/NMRA.md 2026-07-02 https://biopharmsignal.com/company/NKTR.md 2026-07-02 https://biopharmsignal.com/company/THAR.md 2026-07-02 https://biopharmsignal.com/company/TNGX.md 2026-07-02 https://biopharmsignal.com/company/DRTS.md 2026-07-02 https://biopharmsignal.com/company/ZLAB.md 2026-07-02 https://biopharmsignal.com/company/OVID.md 2026-07-02 https://biopharmsignal.com/company/KALA.md 2026-07-02 https://biopharmsignal.com/company/ASMB.md 2026-07-02 https://biopharmsignal.com/company/PXMD.md 2026-07-02 https://biopharmsignal.com/company/BIOR.md 2026-07-02 https://biopharmsignal.com/company/TIL.md 2026-07-02 https://biopharmsignal.com/company/VERU.md 2026-07-02 https://biopharmsignal.com/company/MURA.md 2026-07-02 https://biopharmsignal.com/company/RLMD.md 2026-07-02 https://biopharmsignal.com/company/GYRE.md 2026-07-02 https://biopharmsignal.com/company/CRGX.md 2026-07-02 https://biopharmsignal.com/company/XOMA.md 2026-07-02 https://biopharmsignal.com/company/CGON.md 2026-07-02 https://biopharmsignal.com/company/MDWD.md 2026-07-02 https://biopharmsignal.com/company/TLPH.md 2026-07-02 https://biopharmsignal.com/company/TSBX.md 2026-07-02 https://biopharmsignal.com/company/DERM.md 2026-07-02 https://biopharmsignal.com/company/SYRE.md 2026-07-02 https://biopharmsignal.com/company/LENZ.md 2026-07-02 https://biopharmsignal.com/company/QTTB.md 2026-07-02 https://biopharmsignal.com/company/CRDL.md 2026-07-02 https://biopharmsignal.com/company/PTGX.md 2026-07-02 https://biopharmsignal.com/company/DNA.md 2026-07-02 https://biopharmsignal.com/company/CASIF.md 2026-07-02 https://biopharmsignal.com/company/LNTH.md 2026-07-02 https://biopharmsignal.com/company/CASI.md 2026-06-25 https://biopharmsignal.com/company/SRNGU.md 2026-06-25 https://biopharmsignal.com/company/MEETING.md 2026-06-25 https://biopharmsignal.com/sector/biopharma.md 2026-07-02 https://biopharmsignal.com/sector/oncology.md 2026-07-02 https://biopharmsignal.com/sector/biologics.md 2026-07-02 https://biopharmsignal.com/sector/large-molecule-drugs.md 2026-07-02 https://biopharmsignal.com/sector/novel-therapies.md 2026-07-02 https://biopharmsignal.com/sector/pharmaceuticals.md 2026-07-02 https://biopharmsignal.com/sector/immunotherapy.md 2026-07-02 https://biopharmsignal.com/sector/life-science-tools.md 2026-07-02 https://biopharmsignal.com/sector/cns.md 2026-07-02 https://biopharmsignal.com/sector/gene-therapy.md 2026-07-02 https://biopharmsignal.com/sector/medtech.md 2026-07-02 https://biopharmsignal.com/sector/stem-cells.md 2026-07-02 https://biopharmsignal.com/sector/car-t-therapy.md 2026-07-02 https://biopharmsignal.com/sector/small-molecule-drugs.md 2026-07-02 https://biopharmsignal.com/sector/diagnostics.md 2026-07-02 https://biopharmsignal.com/sector/antibody-drugs.md 2026-07-02 https://biopharmsignal.com/sector/vaccines.md 2026-07-02 https://biopharmsignal.com/sector/nucleic-acid-drugs.md 2026-07-02 https://biopharmsignal.com/sector/cardio-metabolic.md 2026-07-02 https://biopharmsignal.com/sector/ophthalmology.md 2026-07-02 https://biopharmsignal.com/sector/rare-disease-gene-therapy.md 2026-07-02 https://biopharmsignal.com/sector/rare-disease.md 2026-07-02 https://biopharmsignal.com/sector/infectious-disease.md 2026-07-02 https://biopharmsignal.com/sector/hematology.md 2026-07-02 https://biopharmsignal.com/sector/adcs.md 2026-07-02 https://biopharmsignal.com/sector/respiratory.md 2026-07-02 https://biopharmsignal.com/sector/mrna-vaccines.md 2026-07-02 https://biopharmsignal.com/sector/apis.md 2026-07-02 https://biopharmsignal.com/sector/inherited-retinal-disease-gene-therapy.md 2026-07-02 https://biopharmsignal.com/sector/tumor-mrna-vaccines.md 2026-07-02 https://biopharmsignal.com/sector/protacs.md 2026-07-02 https://biopharmsignal.com/sector/generics.md 2026-07-02 https://biopharmsignal.com/sector/recombinant-protein-vlp-vaccines.md 2026-07-02 https://biopharmsignal.com/sector/cancer-peptide-vaccines.md 2026-07-02 https://biopharmsignal.com/sector/inactivated-vaccines.md 2026-07-02 https://biopharmsignal.com/sector/stem-cell-therapy-for-cardiac-disease.md 2026-07-02 https://biopharmsignal.com/sector/exosomes.md 2026-07-02 https://biopharmsignal.com/sector/tcr-t-therapy.md 2026-07-02 https://biopharmsignal.com/sector/tumor-dna-vaccines.md 2026-07-02 https://biopharmsignal.com/sector/tumor-synthetic-peptide-vaccines.md 2026-07-02 https://biopharmsignal.com/sector/tumor-dc-vaccines.md 2026-07-02 https://biopharmsignal.com/sector/liposomes.md 2026-07-02 https://biopharmsignal.com/pdufa-calendar/2026/july.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/2026/june.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/ACHV.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/ARQT.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/CELC.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/IONS.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/LNTH.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/MNKD.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/MRK.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/OTLK.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/SPRO.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/UNCY.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/VERA.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/VRDN.md 2026-07-06 https://biopharmsignal.com/pdufa-calendar/VTRS.md 2026-07-06 https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c.md 2026-07-20 https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9.md 2026-07-20 https://biopharmsignal.com/news/VIRI/dogwood-enrolls-first-200-patients-in-ongoing-halneuron-phase-2b-chemotherapy-in-dd9f404d.md 2026-07-20 https://biopharmsignal.com/news/MNPR/monopar-advances-launch-readiness-with-addition-of-veteran-commercial-executive--6af36ead.md 2026-07-20 https://biopharmsignal.com/news/USNA/usana-health-sciences-renews-four-year-partnership-with-nordiq-canada-deepening--7aaacadb.md 2026-07-20 https://biopharmsignal.com/news/HLF/herbalife-cfo-to-participate-in-maxim-group-health-wellness-longevity-virtual-co-145c5335.md 2026-07-20 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-to-build-the-most-powerful-ai-factory-in-life-sciences-with-eb3e7bda.md 2026-07-20 https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-clinical-updates-on-flamingo-01-99f074c4.md 2026-07-20 https://biopharmsignal.com/news/GSK/european-medicines-agency-accepts-submission-to-update-bexsero-label-for-1-dose--8906d096.md 2026-07-20 https://biopharmsignal.com/news/DMAC/diamedica-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-58a5078e.md 2026-07-17 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-esmo-2026-presentations-for-darovasertib-and-ide849-3e0620d8.md 2026-07-17 https://biopharmsignal.com/news/AMRX/amneal-expands-iohexol-injection-portfolio-with-u-s-fda-approval-of-additional-s-5f3ad56b.md 2026-07-17 https://biopharmsignal.com/news/MOR/novartis-fabhalta-iptacopan-receives-fda-traditional-approval-as-first-and-only--ec34f769.md 2026-07-17 https://biopharmsignal.com/news/GSK/gsk-provides-an-update-on-calm-1-and-calm-2-phase-iii-trials-for-camlipixant-in--0e112206.md 2026-07-17 https://biopharmsignal.com/news/INBX/inhibrx-announces-amended-loan-agreement-with-oxford-finance-expanding-total-fac-d29cd85b.md 2026-07-16 https://biopharmsignal.com/news/ARTL/artelo-biosciences-announces-results-from-a-nonclinical-osteoarthritis-study-sup-fa16911f.md 2026-07-16 https://biopharmsignal.com/news/MRK/merck-s-lipfendra-enlicitide-is-the-first-and-only-once-daily-oral-pcsk9-inhibit-1b899588.md 2026-07-16 https://biopharmsignal.com/news/INGN/inogen-to-report-second-quarter-2026-financial-results-on-august-6-2026-29d58db2.md 2026-07-16 https://biopharmsignal.com/news/ALNY/alnylam-to-webcast-conference-call-discussing-second-quarter-2026-financial-resu-458d7635.md 2026-07-16 https://biopharmsignal.com/news/VRAX/virax-biolabs-ceo-james-foster-provides-shareholder-update-following-fiscal-2026-e1b97d68.md 2026-07-16 https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-european-approval-for-combining-both-hla-popula-adf83f60.md 2026-07-16 https://biopharmsignal.com/news/RLMD/relmada-therapeutics-to-report-second-quarter-2026-financial-results-on-thursday-a5332b5c.md 2026-07-16 https://biopharmsignal.com/news/INSM/insmed-announces-positive-12-month-data-from-the-ongoing-open-label-extension-st-7880862e.md 2026-07-16 https://biopharmsignal.com/news/CCEL/cord-blood-banking-leader-cryo-cell-reports-fiscal-second-quarter-2026-financial-7072363c.md 2026-07-15 https://biopharmsignal.com/news/PRI/primerica-schedules-second-quarter-2026-financial-results-webcast-8557ad05.md 2026-07-15 https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-to-announce-second-quarter-2026-financial-results-on-augu-562a4f56.md 2026-07-15 https://biopharmsignal.com/news/GSK/gsk-completes-acquisition-of-nuvalent-inc-c44954f4.md 2026-07-15 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-announces-publication-in-the-peer-reviewed-journal-of-viro-14c8c277.md 2026-07-15 https://biopharmsignal.com/news/MRK/keytruda-pembrolizumab-as-monotherapy-significantly-improved-progression-free-su-ceac984b.md 2026-07-15 https://biopharmsignal.com/news/MRK/merck-to-present-new-data-on-daily-weekly-and-monthly-options-across-its-hiv-tre-f70a5c44.md 2026-07-15 https://biopharmsignal.com/news/LIXT/nomad-power-solutions-strengthens-subsidiary-executive-leadership-694eafe1.md 2026-07-15 https://biopharmsignal.com/news/RANI/rani-therapeutics-announces-positive-initial-phase-1a-data-for-rt-114-for-the-tr-e7d21ddc.md 2026-07-15 https://biopharmsignal.com/news/EVGN/agplenus-launches-novel-ai-model-for-predicting-antifungal-potency-expanding-che-3e490172.md 2026-07-15 https://biopharmsignal.com/news/AMRN/amarin-to-report-second-quarter-2026-financial-results-and-host-conference-call--ba7d316a.md 2026-07-15 https://biopharmsignal.com/news/ALNY/alnylam-highlights-progress-with-neuroscience-programs-at-aaic-2026-showcasing-p-508fc61d.md 2026-07-15 https://biopharmsignal.com/news/INTS/intensity-therapeutics-inc-restarts-patient-treatment-in-the-randomized-presurgi-51761e30.md 2026-07-15 https://biopharmsignal.com/news/CLRB/cellectar-biosciences-announces-publication-of-phase-1-study-of-iopofosine-i-131-1d5d4326.md 2026-07-15 https://biopharmsignal.com/news/AXGN/axogen-inc-to-report-second-quarter-2026-financial-results-on-july-29-2026-56aa71ab.md 2026-07-15 https://biopharmsignal.com/news/BRKR/bruker-expands-infection-detection-portfolio-with-acquisition-of-metagenomic-mng-36c3ebd1.md 2026-07-15 https://biopharmsignal.com/news/USNA/usana-schedules-second-quarter-2026-earnings-release-and-conference-call-d0dc753b.md 2026-07-14 https://biopharmsignal.com/news/VANI/vivani-medical-to-present-at-the-emerging-growth-conference-on-july-15-2026-793033b6.md 2026-07-14 https://biopharmsignal.com/news/XOMA/xoma-royalty-announces-closing-of-its-acquisition-by-ligand-6ca7a63d.md 2026-07-14 https://biopharmsignal.com/news/ARTL/artelo-biosciences-issues-reminder-to-shareholders-to-vote-in-advance-of-annual--371c2cf4.md 2026-07-14 https://biopharmsignal.com/news/ICCM/icecure-expands-u-s-commercial-team-to-meet-surging-demand-for-prosense-cryoabla-7980c317.md 2026-07-14 https://biopharmsignal.com/news/ZBH/zimmer-biomet-names-chintan-desai-president-of-asia-pacific-region-4a803d7f.md 2026-07-14 https://biopharmsignal.com/news/ENSC/ensysce-biosciences-awarded-5-3-million-installment-in-nida-funding-completing-m-ee1ecc0e.md 2026-07-14 https://biopharmsignal.com/news/IKT/inhibikase-therapeutics-announces-sale-of-50-million-of-shares-through-its-at-th-30edf4cb.md 2026-07-14 https://biopharmsignal.com/news/PMN/promis-neurosciences-reports-first-human-evidence-of-amyloid-beta-oligomer-targe-5218a89a.md 2026-07-14 https://biopharmsignal.com/news/IRWD/ironwood-appoints-dr-jeffrey-silber-chief-medical-officer-and-head-of-research-a-b6d13a27.md 2026-07-14 https://biopharmsignal.com/news/SPRO/spero-therapeutics-announces-105-million-non-recourse-non-dilutive-financing-bac-d8d87fa7.md 2026-07-14 https://biopharmsignal.com/news/BEAT/heartbeam-awarded-new-u-s-patent-expanding-acoustic-sensing-and-fluid-monitoring-e0c78764.md 2026-07-14 https://biopharmsignal.com/news/ACXP/acurx-pharmaceuticals-announces-scientific-poster-presentation-of-ibezapolstat-s-7d80a5a2.md 2026-07-14 https://biopharmsignal.com/news/HLF/herbalife-named-to-time-s-list-of-america-s-best-companies-2026-14afe60c.md 2026-07-13 https://biopharmsignal.com/news/ARTL/artelo-biosciences-announces-positive-results-with-art27-13-in-a-nonclinical-mod-86480dfe.md 2026-07-13 https://biopharmsignal.com/news/ENLV/enlivex-receives-fda-regenerative-medicine-advanced-therapy-rmat-designation-for-8b6ad971.md 2026-07-13 https://biopharmsignal.com/news/EWTX/edgewise-therapeutics-completes-sale-of-sevasemten-for-up-to-2-65-billion-streng-cafc855d.md 2026-07-13 https://biopharmsignal.com/news/ZBH/zimmer-biomet-announces-webcast-and-conference-call-of-second-quarter-2026-finan-eeeb31b3.md 2026-07-13 https://biopharmsignal.com/news/AEMD/aethlon-medical-continues-to-observe-directional-changes-in-second-cohort-of-aus-9cc3f8f7.md 2026-07-13 https://biopharmsignal.com/news/GLPG/lakefront-announces-paulo-fontoura-has-resigned-from-its-board-following-his-app-f92a2665.md 2026-07-13 https://biopharmsignal.com/news/BAVN/news-bavarian-nordic-b9e90c06.md 2026-07-13 https://biopharmsignal.com/news/TCMD/tactile-medical-enters-exclusive-u-s-distribution-agreement-with-elastimed-for-i-116aea64.md 2026-07-13 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-announces-major-managed-medicare-payer-agreement-for-tonmy-bb25eccc.md 2026-07-13 https://biopharmsignal.com/news/BMY/u-s-food-and-drug-administration-accepts-bristol-myers-squibb-s-new-drug-applica-b21b9788.md 2026-07-13 https://biopharmsignal.com/news/GSK/jemperli-dostarlimab-achieves-sustained-clinical-complete-responses-in-dmmr-msi--18610cf7.md 2026-07-13 https://biopharmsignal.com/news/VRAX/virax-biolabs-group-limited-announces-closing-of-exercise-of-preferred-investmen-cc034f76.md 2026-07-10 https://biopharmsignal.com/news/MRK/fda-approves-keytruda-pembrolizumab-and-keytruda-qlex-pembrolizumab-and-berahyal-7cdef535.md 2026-07-10 https://biopharmsignal.com/news/DGX/one-in-five-american-workers-tested-had-a-positive-hair-drug-test-in-2025-signal-cb4ae34e.md 2026-07-10 https://biopharmsignal.com/news/SEM/select-medical-holdings-corporation-to-be-acquired-by-consortium-led-by-robert-a-1855a81b.md 2026-07-10 https://biopharmsignal.com/news/VERA/vera-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-0ef52228.md 2026-07-10 https://biopharmsignal.com/news/GSK/gsk-s-licensor-hansoh-pharma-announces-positive-phase-iii-results-for-ris-rez-in-b379a2b1.md 2026-07-10 https://biopharmsignal.com/news/MRK/fda-approves-keytruda-pembrolizumab-and-keytruda-qlex-pembrolizumab-and-berahyal-bc1625e5.md 2026-07-10 https://biopharmsignal.com/news/MRK/merck-announces-new-agreement-with-adap-crisis-task-force-to-improve-access-and--4390af46.md 2026-07-10 https://biopharmsignal.com/news/MRK/merck-to-hold-second-quarter-2026-sales-and-earnings-conference-call-aug-4-merck-44a90bf3.md 2026-07-10 https://biopharmsignal.com/news/BBLG/bone-biologics-announces-closing-of-5-0-million-public-offering-bone-biologics-b7499bd9.md 2026-07-10 https://biopharmsignal.com/news/ELGXQ/3-year-detour2-results-demonstrate-sustained-symptom-relief-and-limb-preservatio-7b9855b1.md 2026-07-09 https://biopharmsignal.com/news/BDX/bd-to-announce-financial-results-for-its-third-quarter-of-fiscal-2026-fae7aaa2.md 2026-07-09 https://biopharmsignal.com/news/RANI/rani-therapeutics-announces-research-and-development-collaboration-with-pegbio-t-5a7630da.md 2026-07-09 https://biopharmsignal.com/news/SERA/prime-subgroup-analysis-demonstrates-22-reduction-in-nicu-admissions-in-first-ti-1eec527c.md 2026-07-09 https://biopharmsignal.com/news/AMRX/amneal-to-report-second-quarter-2026-results-on-july-30-2026-e7677e7f.md 2026-07-09 https://biopharmsignal.com/news/MRK/gilead-and-merck-announce-positive-topline-results-from-two-phase-3-studies-eval-bb1d1ada.md 2026-07-09 https://biopharmsignal.com/news/ALNY/alnylam-to-webcast-presentations-at-upcoming-investor-conferences-50fb6676.md 2026-07-09 https://biopharmsignal.com/news/ALNY/new-data-analyses-presented-at-heart-failure-2026-demonstrate-robust-and-consist-d10768e9.md 2026-07-09 https://biopharmsignal.com/news/ALNY/alnylam-issues-2025-corporate-responsibility-report-62023cfe.md 2026-07-09 https://biopharmsignal.com/news/ALNY/alnylam-and-inceptive-form-strategic-ai-collaboration-to-accelerate-the-discover-3d8b2b06.md 2026-07-09 https://biopharmsignal.com/news/ALNY/alnylam-to-host-tenth-rnai-roundtable-webcast-series-3988e623.md 2026-07-09 https://biopharmsignal.com/news/VRAX/virax-biolabs-group-limited-announces-exercise-of-preferred-investment-options-f-60095931.md 2026-07-09 https://biopharmsignal.com/news/HEPA/hepion-pharmaceuticals-successfully-completes-application-to-the-otcqb-hepion-ph-ebadb4d3.md 2026-07-09 https://biopharmsignal.com/news/EGTX/exercise-of-options-under-employee-stock-option-program-and-notification-of-insi-e6812443.md 2026-07-09 https://biopharmsignal.com/news/CRNX/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empo-2503d5d7.md 2026-07-09 https://biopharmsignal.com/news/CRNX/crinetics-presents-full-results-from-phase-2-trial-of-atumelnant-in-congenital-a-cc021e52.md 2026-07-09 https://biopharmsignal.com/news/ADXN/addex-therapeutics-to-report-2026-first-quarter-financial-results-and-host-confe-bf43b1f6.md 2026-07-09 https://biopharmsignal.com/news/ADXN/addex-therapeutics-reports-first-quarter-2026-financial-results-and-provides-cor-3735e823.md 2026-07-09 https://biopharmsignal.com/news/ADXN/addex-shareholders-approve-all-resolutions-at-annual-general-meeting-d034b014.md 2026-07-09 https://biopharmsignal.com/news/ACON/aclarion-rejects-echo-lake-capital-s-unsolicited-acquisition-proposal-1610a9fa.md 2026-07-09 https://biopharmsignal.com/news/ACON/aclarion-partners-with-pria-healthcare-to-advance-reimbursement-and-commercial-a-d8824477.md 2026-07-09 https://biopharmsignal.com/news/ACON/aclarion-to-present-at-the-planet-microcap-las-vegas-powered-by-microcapclub-07382a59.md 2026-07-09 https://biopharmsignal.com/news/WVE/wave-life-sciences-to-present-at-2026-rbc-capital-markets-global-healthcare-conf-7c9ed053.md 2026-07-09 https://biopharmsignal.com/news/WVE/wave-life-sciences-announces-positive-update-on-restoraation-2-trial-wve-006-gal-28816cd9.md 2026-07-09 https://biopharmsignal.com/news/WVE/wave-life-sciences-to-present-at-upcoming-investor-conferences-wave-life-science-1abd2202.md 2026-07-09 https://biopharmsignal.com/news/WVE/wave-life-sciences-announces-initiation-of-phase-2a-portion-of-inlight-trial-of--01c48945.md 2026-07-09 https://biopharmsignal.com/news/WVE/wave-life-sciences-announces-singapore-court-hearing-to-be-held-on-july-14-2026--089ce376.md 2026-07-09 https://biopharmsignal.com/news/VREX/varex-to-present-at-the-jefferies-global-healthcare-conference-varex-imaging-7485a79a.md 2026-07-09 https://biopharmsignal.com/news/VERA/vera-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-4bde5aa1.md 2026-07-09 https://biopharmsignal.com/news/VERA/vera-therapeutics-announces-alignment-with-u-s-fda-on-earlier-origin-phase-3-ana-10a25775.md 2026-07-09 https://biopharmsignal.com/news/VERA/vera-therapeutics-receives-fda-accelerated-approval-for-trutakna-for-adult-patie-e0ec4d90.md 2026-07-09 https://biopharmsignal.com/news/VERA/vera-therapeutics-announces-appointment-of-nancy-boman-as-chief-regulatory-offic-645725ea.md 2026-07-09 https://biopharmsignal.com/news/NVAX/novavax-reports-first-quarter-2026-financial-results-and-operational-highlights--a11612f1.md 2026-07-09 https://biopharmsignal.com/news/NVAX/novavax-to-participate-in-bofa-securities-2026-health-care-conference-may-7-2026-b9786971.md 2026-07-09 https://biopharmsignal.com/news/NVAX/novavax-to-participate-in-2026-jefferies-global-healthcare-conference-jun-1-2026-13dbcea1.md 2026-07-09 https://biopharmsignal.com/news/MRK/fda-approves-keytruda-pembrolizumab-and-keytruda-qlex-pembrolizumab-and-berahyal-e15b5e64.md 2026-07-09 https://biopharmsignal.com/news/MRK/u-s-fda-approves-an-additional-indication-for-capvaxive-pneumococcal-21-valent-c-0b81d0d3.md 2026-07-09 https://biopharmsignal.com/news/MRK/merck-s-tulisokibart-met-primary-and-key-secondary-endpoints-in-the-phase-3-atla-f40c0831.md 2026-07-09 https://biopharmsignal.com/news/MRK/european-commission-approves-keytruda-pembrolizumab-plus-padcev-enfortumab-vedot-b45629ae.md 2026-07-09 https://biopharmsignal.com/news/VRAX/virax-biolabs-signs-multi-country-commercial-supply-agreement-with-fosun-diagnos-d54171ee.md 2026-07-09 https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-european-approval-for-use-of-commercially-manuf-3adb0b48.md 2026-07-09 https://biopharmsignal.com/news/GSK/roy-jakobs-to-join-gsk-board-as-non-executive-director-560f2019.md 2026-07-09 https://biopharmsignal.com/news/NEXI/neximmune-yale-and-jdrf-extend-research-partnership-for-type-1-diabetes-neximmun-d017f773.md 2026-07-09 https://biopharmsignal.com/news/NEXI/neximmune-announces-3-67-million-registered-direct-offering-priced-at-the-market-d5bb4c90.md 2026-07-09 https://biopharmsignal.com/news/NEXI/neximmune-announces-closing-of-3-67-million-registered-direct-offering-priced-at-b57a79dd.md 2026-07-09 https://biopharmsignal.com/news/MREO/annual-jp-morgan-healthcare-conference-mereo-biopharma-4c504efb.md 2026-07-09 https://biopharmsignal.com/news/MREO/corporate-update-mereo-biopharma-e572d1f0.md 2026-07-09 https://biopharmsignal.com/news/MREO/mereo-biopharma-reports-full-year-2025-financial-results-and-provides-corporate--796792ad.md 2026-07-09 https://biopharmsignal.com/news/MREO/mereo-biopharma-reports-first-quarter-2026-financial-results-and-provides-corpor-512db839.md 2026-07-09 https://biopharmsignal.com/news/MREO/jefferies-mereo-biopharma-9fc163f8.md 2026-07-09 https://biopharmsignal.com/news/IFRX/press-release-21192d48.md 2026-07-09 https://biopharmsignal.com/news/ICAD/radnet-s-wholly-owned-subsidiary-deephealth-completes-acquisition-of-icad-icad-i-364eaa27.md 2026-07-09 https://biopharmsignal.com/news/HEPA/hepion-pharmaceuticals-announces-receipt-of-delisting-notification-from-nasdaq-h-8c99f509.md 2026-07-09 https://biopharmsignal.com/news/HEPA/hepion-pharmaceuticals-announces-dr-kaouthar-lbiati-as-interim-chief-executive-o-9422279d.md 2026-07-09 https://biopharmsignal.com/news/HEPA/hepion-pharmaceuticals-in-licenses-ctrna-biomarker-assay-to-facilitate-early-dia-ffd56961.md 2026-07-09 https://biopharmsignal.com/news/GRNA/greenlight-biosciences-2026-129baf81.md 2026-07-09 https://biopharmsignal.com/news/FNA/zimmer-biomet-announces-quarterly-dividend-for-second-quarter-of-2026-fe05ba3b.md 2026-07-09 https://biopharmsignal.com/news/FNA/zimmer-biomet-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conf-0913fd4d.md 2026-07-09 https://biopharmsignal.com/news/ESRX/pharmacy-in-focus-unlocking-the-promise-of-biosimilars-evernorth-12a93b14.md 2026-07-09 https://biopharmsignal.com/news/ESRX/cancer-is-showing-up-earlier-reshaping-life-work-and-care-for-a-new-generation-o-c6855e0f.md 2026-07-09 https://biopharmsignal.com/news/ESRX/the-hidden-cost-of-cancer-care-gaps-and-how-to-close-them-evernorth-6de77d46.md 2026-07-09 https://biopharmsignal.com/news/ESRX/cell-and-gene-therapy-pipeline-outlook-for-plan-sponsors-evernorth-3b71cebb.md 2026-07-09 https://biopharmsignal.com/news/EPZM/bylvay-odevixibat-data-shows-sustained-improvement-in-severe-itch-and-serum-bile-f3310cc8.md 2026-07-09 https://biopharmsignal.com/news/EPZM/ipsen-appoints-michelle-c-werner-as-evp-president-of-north-america-united-states-af7d5727.md 2026-07-09 https://biopharmsignal.com/news/ENVB/enveric-biosciences-reports-positive-preclinical-results-from-phototoxicity-anal-df7fb40c.md 2026-07-09 https://biopharmsignal.com/news/ENVB/enveric-biosciences-initiates-investigational-new-drug-ind-enabling-genotoxicity-f8edbc3d.md 2026-07-09 https://biopharmsignal.com/news/ENVB/enveric-biosciences-to-participate-in-the-ubs-3rd-virtual-cns-day-enveric-biosci-50e4be54.md 2026-07-09 https://biopharmsignal.com/news/ENVB/enveric-biosciences-announces-participation-in-2026-bio-international-convention-9148266a.md 2026-07-09 https://biopharmsignal.com/news/ENVB/enveric-biosciences-announces-participation-in-b-riley-securities-mind-muscle-vi-247d268d.md 2026-07-09 https://biopharmsignal.com/news/EGTX/egetis-therapeutics-to-participate-in-leading-international-medical-conferences--5e606850.md 2026-07-09 https://biopharmsignal.com/news/EGTX/egetis-to-present-healthcare-resource-drivers-and-cost-in-mct8-deficiency-at-isp-c2a98b15.md 2026-07-09 https://biopharmsignal.com/news/EGTX/egetis-therapeutics-announces-national-re-airing-of-behind-the-mystery-episode-o-f519aa28.md 2026-07-09 https://biopharmsignal.com/news/DYSL/dynasil-appoints-nirmal-parikh-vp-of-marketing-dynasil-corporation-261ff65b.md 2026-07-09 https://biopharmsignal.com/news/DYSL/dynasil-corporation-of-america-announces-results-of-tender-offer-dynasil-corpora-9e5649f0.md 2026-07-09 https://biopharmsignal.com/news/DYSL/dr-matthew-dallimore-appointed-president-of-dynasil-dynasil-corporation-61b6cb48.md 2026-07-09 https://biopharmsignal.com/news/FBRX/forte-biosciences-inc-investor-relations-news-934e172e.md 2026-07-09 https://biopharmsignal.com/news/TEVA/teva-and-polpharma-biologics-announce-global-licensing-agreement-for-a-biosimila-958342ff.md 2026-07-09 https://biopharmsignal.com/news/CSBR/champions-oncology-reports-quarterly-revenue-of-13-1-million-9f7e33ee.md 2026-07-08 https://biopharmsignal.com/news/CSBR/champions-oncology-announces-a-multi-year-agreement-strategic-collaboration-with-c65d8149.md 2026-07-08 https://biopharmsignal.com/news/CSBR/champions-oncology-announces-remarkable-lineup-of-speakers-at-its-translational--c4916c08.md 2026-07-08 https://biopharmsignal.com/news/CSBR/news-champions-oncology-349bd91b.md 2026-07-08 https://biopharmsignal.com/news/CSBR/champions-oncology-reports-quarterly-revenue-of-12-6-million-484f1741.md 2026-07-08 https://biopharmsignal.com/news/CBM/cambrex-announces-cornell-professor-song-lin-as-recipient-of-the-2025-snapdragon-355204e9.md 2026-07-08 https://biopharmsignal.com/news/CBM/cambrex-advances-us-and-european-expansions-8de0b986.md 2026-07-08 https://biopharmsignal.com/news/CBM/cambrex-snapdragon-chemistry-and-q1-scientific-recognized-for-innovation-and-sus-70782547.md 2026-07-08 https://biopharmsignal.com/news/AMRX/amneal-and-adalvo-announce-fda-acceptance-for-review-of-two-u-s-andas-for-generi-0a6b37df.md 2026-07-08 https://biopharmsignal.com/news/BSLN/basilea-receives-further-usd-6-million-from-barda-to-continue-development-of-nov-88c7eca7.md 2026-07-08 https://biopharmsignal.com/news/BSLN/basilea-announces-start-of-first-in-human-study-of-novel-antibiotic-bal2420-39f91e83.md 2026-07-08 https://biopharmsignal.com/news/BSLN/basilea-awarded-additional-carb-x-funding-of-usd-6-million-to-support-the-clinic-e451971d.md 2026-07-08 https://biopharmsignal.com/news/BSLN/basilea-shareholders-approve-all-proposals-of-the-board-of-directors-at-the-2026-d049f7ae.md 2026-07-08 https://biopharmsignal.com/news/BSLN/basilea-receives-further-usd-13-million-from-barda-to-continue-development-of-no-3aa5c68b.md 2026-07-08 https://biopharmsignal.com/news/BCDA/press-release-b8a4b5ff.md 2026-07-08 https://biopharmsignal.com/news/VREX/the-gigact-advancing-photon-counting-ct-for-next-generation-spectral-imaging-var-753f47a9.md 2026-07-08 https://biopharmsignal.com/news/ARMP/investor-relations-press-releases-d1e7fa8c.md 2026-07-08 https://biopharmsignal.com/news/ANVS/neuroscience-biotech-company-new-alzheimer-s-dementia-treatments-bf5a204e.md 2026-07-08 https://biopharmsignal.com/news/AMRN/american-college-of-cardiology-acc-scientific-sessions-2026-underscore-the-need--cb321147.md 2026-07-08 https://biopharmsignal.com/news/AMRN/amarin-reports-2026-first-quarter-financial-results-amarin-corp-eb4f060e.md 2026-07-08 https://biopharmsignal.com/news/AMRN/new-reduce-it-analysis-presented-at-the-european-atherosclerosis-society-eas-con-a5df235e.md 2026-07-08 https://biopharmsignal.com/news/AMRN/amarin-reaffirms-the-proven-guideline-recommended-role-of-vascepa-icosapent-ethy-25050b29.md 2026-07-08 https://biopharmsignal.com/news/AGIO/quality-beyond-compliance-malik-khan-hologic-vp-of-quality-280d52d0.md 2026-07-08 https://biopharmsignal.com/news/AGIO/mireille-akilian-on-women-s-health-gyn-surgical-innovation-hologic-f5dedd97.md 2026-07-08 https://biopharmsignal.com/news/AGIO/fibroid-care-innovation-listening-learning-engineering-hologic-1f5b2dec.md 2026-07-08 https://biopharmsignal.com/news/AGIO/tom-kelly-co-inventor-of-the-t-score-on-the-science-of-dxa-and-its-role-in-prote-6c7ab5bb.md 2026-07-08 https://biopharmsignal.com/news/ADXN/addex-announces-publication-of-research-highlighting-therapeutic-potential-of-mg-5eeb2637.md 2026-07-08 https://biopharmsignal.com/news/ACON/aclarion-announces-texas-spine-care-center-as-new-clarity-site-af21995b.md 2026-07-08 https://biopharmsignal.com/news/MKT/maia-biotechnology-reports-strong-initial-efficacy-data-in-third-line-non-small--1bd9a96f.md 2026-07-08 https://biopharmsignal.com/news/DGX/quest-diagnostics-now-the-largest-clinical-reference-lab-to-extend-oncology-test-e734c702.md 2026-07-08 https://biopharmsignal.com/news/LIXT/nomad-increases-voyager-fleet-energy-storage-by-up-to-56-bringing-eagle-and-falc-4f686804.md 2026-07-08 https://biopharmsignal.com/news/AZTA/azenta-completes-sale-of-b-medical-systems-869ef834.md 2026-07-08 https://biopharmsignal.com/news/CMMB/chemomab-therapeutics-and-precision-medicine-pioneer-scipher-medicine-announce-m-14c02ebe.md 2026-07-08 https://biopharmsignal.com/news/EVGN/evogene-and-tel-aviv-university-s-blavatnik-center-for-drug-discovery-announce-j-88938e33.md 2026-07-08 https://biopharmsignal.com/news/KTTA/pasithea-therapeutics-announces-participation-in-b-riley-securities-mind-muscle--c2ef8757.md 2026-07-08 https://biopharmsignal.com/news/TECH/bio-techne-launches-expanded-r-d-systems-ai-engineered-designer-protein-portfoli-21b908e1.md 2026-07-08 https://biopharmsignal.com/news/ACXP/acurx-pharmaceuticals-to-discuss-second-quarter-2026-financial-results-on-august-1f2a139a.md 2026-07-08 https://biopharmsignal.com/news/VREX/white-paper-pyxis-photon-counting-ct-detection-platform-simplifying-the-integrat-9b2cc7b7.md 2026-07-07 https://biopharmsignal.com/news/VREX/replacing-mechanical-motion-in-x-ray-imaging-varex-multi-beam-x-ray-mbx-technolo-15a26bbf.md 2026-07-07 https://biopharmsignal.com/news/ACON/news-aclarion-934d0e75.md 2026-07-07 https://biopharmsignal.com/news/ENLV/enlivex-announces-1-for-15-reverse-stock-split-effective-july-9-2026-b920054c.md 2026-07-07 https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-quarterly-cypath-lung-sales-double-to-new-record-as-com-fee483fe.md 2026-07-07 https://biopharmsignal.com/news/VERU/veru-to-present-at-2026-obesity-weight-loss-drug-development-summit-and-pre-conf-f5d70201.md 2026-07-07 https://biopharmsignal.com/news/OGEN/oragenics-achieves-full-activation-of-australian-phase-iia-trial-network-all-thr-ec4ff0b0.md 2026-07-07 https://biopharmsignal.com/news/NRC/nrc-health-to-report-second-quarter-2026-financial-results-on-july-28th-20318285.md 2026-07-07 https://biopharmsignal.com/news/VANI/vivani-medical-enters-into-agreement-with-novo-nordisk-to-evaluate-npm-139-a-min-9e9275ac.md 2026-07-07 https://biopharmsignal.com/news/AVTX/avalo-therapeutics-to-participate-in-the-leerink-partners-therapeutics-forum-ef62dbcf.md 2026-07-07 https://biopharmsignal.com/news/GLPG/acquisition-of-own-shares-7c1425be.md 2026-07-07 https://biopharmsignal.com/news/TEVA/teva-to-advance-its-anti-il-15-antibody-designed-for-quarterly-dosing-into-phase-505de9a8.md 2026-07-07 https://biopharmsignal.com/news/ALLR/allarity-therapeutics-announces-clia-certification-clearing-the-path-for-advanci-c321a3b5.md 2026-07-07 https://biopharmsignal.com/news/CRNX/vertex-to-acquire-crinetics-pharmaceuticals-crinetics-29e39d07.md 2026-07-06 https://biopharmsignal.com/news/CRIS/curis-consents-first-six-patients-in-takeaim-cll-study-45969449.md 2026-07-06 https://biopharmsignal.com/news/AEMD/aethlon-medical-announces-pricing-of-4-0-million-follow-on-offering-priced-at-th-e3315678.md 2026-07-06 https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-appoints-carl-segerstrom-as-chief-people-officer-1598bf7e.md 2026-07-06 https://biopharmsignal.com/news/NRSN/neurosense-to-participate-in-roth-hosted-kol-webinar-on-the-future-of-als-treatm-467c5922.md 2026-07-06 https://biopharmsignal.com/news/LIXT/lixte-completes-corporate-name-change-to-nomad-power-solutions-inc-to-begin-trad-1e7a1571.md 2026-07-06 https://biopharmsignal.com/news/STIM/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-musc-e3db286d.md 2026-07-06 https://biopharmsignal.com/news/FATE/fate-therapeutics-to-present-preliminary-clinical-data-of-ft819-off-the-shelf-ca-2ca1e01e.md 2026-07-06 https://biopharmsignal.com/news/LENZ/lenz-therapeutics-announces-launch-of-new-telehealth-prescribing-option-to-accel-e7f681dd.md 2026-07-06 https://biopharmsignal.com/news/ICCM/icecure-highlights-expanding-commercial-adoption-of-prosense-cryoablation-in-bra-814ddba1.md 2026-07-06 https://biopharmsignal.com/news/MOR/novartis-agrees-to-acquire-myricx-bio-advancing-next-generation-antibody-drug-co-34dc742d.md 2026-07-06 https://biopharmsignal.com/news/LCTX/lineage-cell-therapeutics-to-present-at-b-riley-securities-2026-mind-muscle-visi-93d042e3.md 2026-07-06 https://biopharmsignal.com/news/CRBP/corbus-pharmaceuticals-appoints-leonardo-viana-nicacio-m-d-as-chief-medical-offi-7e9400c6.md 2026-07-06 https://biopharmsignal.com/news/TGTX/tg-therapeutics-announces-initiation-of-phase-2-trial-evaluating-briumvi-in-pati-4f9159d1.md 2026-07-06 https://biopharmsignal.com/news/SEER/seer-files-investor-presentation-highlighting-strong-momentum-commercial-opportu-e67fff29.md 2026-07-06 https://biopharmsignal.com/news/CNST/newsroom-39164465.md 2026-07-06 https://biopharmsignal.com/news/KURA/kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-32057cde.md 2026-07-03 https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-56-74d5744c.md 2026-07-03 https://biopharmsignal.com/news/SEER/seer-announces-receipt-of-unsolicited-acquisition-proposal-from-omid-farokhzad-m-c91bb35c.md 2026-07-02 https://biopharmsignal.com/news/ORIC/oric-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c--dc394a6b.md 2026-07-02 https://biopharmsignal.com/news/OLMA/olema-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-1a4e8e3e.md 2026-07-02 https://biopharmsignal.com/news/XERS/correcting-and-replacing-xeris-announces-inducement-grants-under-nasdaq-listing--0c3e5deb.md 2026-07-02 https://biopharmsignal.com/news/XERS/xeris-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-713b1411.md 2026-07-02 https://biopharmsignal.com/news/OM/outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-21643aa5.md 2026-07-02 https://biopharmsignal.com/news/XENE/xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-f5979058.md 2026-07-02 https://biopharmsignal.com/news/NAMS/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-3a377d4b.md 2026-07-02 https://biopharmsignal.com/news/IKT/inhibikase-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-56-d71ac313.md 2026-07-02 https://biopharmsignal.com/news/PRAX/praxis-precision-medicines-inc-announces-inducement-grants-under-nasdaq-listing--e14d22b1.md 2026-07-02 https://biopharmsignal.com/news/ARQT/arcutis-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-6524924c.md 2026-07-02 https://biopharmsignal.com/news/GNFT/genfit-announces-u-s-medicare-coverage-and-future-reimbursement-for-nashnext-a-n-2769741e.md 2026-07-02 https://biopharmsignal.com/news/MGNX/macrogenics-completes-sale-of-gmp-manufacturing-operations-to-bora-pharmaceutica-b2889ad8.md 2026-07-02 https://biopharmsignal.com/news/IART/integra-lifesciences-appoints-topaz-kirlew-chief-regulatory-officer-89ac0b20.md 2026-07-02 https://biopharmsignal.com/news/LIXT/lixte-completes-merger-with-nomad-transportable-power-systems-3aa02eed.md 2026-07-02 https://biopharmsignal.com/news/RVMD/revolution-medicines-presents-phase-1-2-clinical-data-for-zoldonrasib-combinatio-b6abe879.md 2026-07-02 https://biopharmsignal.com/news/VANI/vivani-announces-entry-into-merger-agreement-between-wholly-owned-subsidiary-cor-743c93e1.md 2026-07-02 https://biopharmsignal.com/news/ATRC/atricure-to-announce-second-quarter-2026-financial-results-ccf9a74f.md 2026-07-02 https://biopharmsignal.com/news/BCRX/biocryst-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-afb4cc8d.md 2026-07-02 https://biopharmsignal.com/news/KPRX/kiora-pharmaceuticals-to-participate-in-piper-sandler-virtual-ophthalmology-symp-a9cd7ac0.md 2026-07-02 https://biopharmsignal.com/news/OCS/oculis-to-participate-at-the-piper-sandler-virtual-ophthalmology-conference-17f42704.md 2026-07-02 https://biopharmsignal.com/news/PRTC/puretech-founded-entity-celea-therapeutics-completes-180-million-financing-to-ad-3954c132.md 2026-07-02 https://biopharmsignal.com/news/PRTC/puretech-announces-completion-of-180-million-financing-for-founded-entity-celea--b2099580.md 2026-07-02 https://biopharmsignal.com/news/INGN/inogen-announces-the-appointment-of-andy-reding-as-chief-operating-officer-4f2d5fcf.md 2026-07-01 https://biopharmsignal.com/news/KPTI/karyopharm-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-cc27221e.md 2026-07-01 https://biopharmsignal.com/news/MTLS/annual-general-meeting-of-materialise-nv-held-at-the-registered-office-of-the-co-5541f657.md 2026-07-01 https://biopharmsignal.com/news/FATE/fate-therapeutics-to-participate-in-upcoming-third-quarter-2026-conferences-457e2808.md 2026-07-01 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-initiates-phase-2-study-of-crinecerfont-in-pediatric-pati-8fe2e2b9.md 2026-07-01 https://biopharmsignal.com/news/SANA/sana-biotechnology-announces-symposium-presentation-at-the-european-association--26e086a1.md 2026-07-01 https://biopharmsignal.com/news/ARTL/artelo-biosciences-announces-new-data-supporting-art26-12-as-a-potential-first-i-d595235b.md 2026-07-01 https://biopharmsignal.com/news/AMRX/amneal-s-new-u-s-sterile-manufacturing-facility-selected-for-fda-precheck-pilot--2719d102.md 2026-07-01 https://biopharmsignal.com/news/HYPR/hyperfine-announces-european-launch-of-next-generation-swoop-system-eb9cfb69.md 2026-07-01 https://biopharmsignal.com/news/RIGL/rigel-appoints-board-member-alison-l-hannah-m-d-as-chief-medical-officer-c2f47409.md 2026-07-01 https://biopharmsignal.com/news/PCRX/pacira-biosciences-announces-unitedhealthcare-now-provides-separate-reimbursemen-87b0c6a8.md 2026-07-01 https://biopharmsignal.com/news/NAMS/newamsterdam-pharma-announces-upcoming-presentations-at-the-alzheimer-s-associat-5f8e7eb9.md 2026-07-01 https://biopharmsignal.com/news/INTS/intensity-therapeutics-provides-mid-year-update-highlighting-late-stage-developm-93ef635a.md 2026-07-01 https://biopharmsignal.com/news/SYK/stryker-to-announce-second-quarter-2026-financial-results-94b73874.md 2026-07-01 https://biopharmsignal.com/news/ABEO/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listin-68d0b897.md 2026-07-01 https://biopharmsignal.com/news/HLF/herbalife-to-announce-second-quarter-2026-results-on-august-5-b85d8156.md 2026-07-01 https://biopharmsignal.com/news/USNA/kevin-guest-world-cup-determination-shows-the-power-of-grit-preparation-persiste-ce0b681d.md 2026-07-01 https://biopharmsignal.com/news/SEER/seer-prevails-in-european-patent-opposition-as-u-s-itc-opens-investigation-into--47d79284.md 2026-07-01 https://biopharmsignal.com/news/IBIO/ibio-reports-single-dose-of-ibio-610-achieved-near-complete-active-activin-e-inh-15c14063.md 2026-07-01 https://biopharmsignal.com/news/CADL/candel-therapeutics-announces-inducement-grants-under-nasdaq-4.md 2026-07-01 https://biopharmsignal.com/news/MESO/receives-fda-bla-filing-number-and-requests-modular-review-03d96298.md 2026-06-30 https://biopharmsignal.com/news/APTO/aptose-biosciences-announces-completion-of-acquisition-by-hanmi-pharmaceutical-de9f8903.md 2026-06-30 https://biopharmsignal.com/news/CRNX/crinetics-pharmaceuticals-to-report-second-quarter-2026-financial-results-on-aug-6cad0f8c.md 2026-06-30 https://biopharmsignal.com/news/ALXO/alx-oncology-reports-inducement-grant-as-permitted-by-the-nasdaq-listing-rules-b37a2f05.md 2026-06-30 https://biopharmsignal.com/news/EHC/encompass-health-announces-date-of-2026-second-quarter-earnings-call-6ef36947.md 2026-06-30 https://biopharmsignal.com/news/PRGO/perrigo-announces-appointment-of-two-new-independent-directors-to-board-47cee7b5.md 2026-06-30 https://biopharmsignal.com/news/SRPT/sarepta-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635--c021b8ab.md 2026-06-30 https://biopharmsignal.com/news/SERA/sera-prognostics-announces-appointment-of-mark-capone-to-its-board-of-directors-8cc61214.md 2026-06-30 https://biopharmsignal.com/news/ARQT/arcutis-launches-new-virtual-health-platform-supporting-access-to-care-for-indiv-1503fca8.md 2026-06-30 https://biopharmsignal.com/news/SNOA/sonoma-pharmaceuticals-receives-fda-510-k-clearance-expanding-indications-and-pa-421ff719.md 2026-06-30 https://biopharmsignal.com/news/JAGX/presentation-at-espghan-2026-describes-additional-groundbreaking-results-of-eval-34e0fbe8.md 2026-06-30 https://biopharmsignal.com/news/ARTL/artelo-biosciences-presents-evidence-for-a-common-lipid-signaling-link-across-mu-3e4320d0.md 2026-06-30 https://biopharmsignal.com/news/VIRI/dogwood-therapeutics-appoints-iain-dukes-venture-partner-at-orbimed-as-chair-of--8101d663.md 2026-06-30 https://biopharmsignal.com/news/ADPT/imviva-biotech-receives-fda-ide-authorization-for-clonoseq-assay-in-tenacity-01--1f1babe9.md 2026-06-30 https://biopharmsignal.com/news/ASND/children-with-achondroplasia-treated-with-transcon-cnp-showed-continued-improvem-93d02f62.md 2026-06-30 https://biopharmsignal.com/news/SRPT/sarepta-announces-fda-acceptance-of-sndas-for-amondys-45-and-vyondys-53-40aea7f9.md 2026-06-30 https://biopharmsignal.com/news/APVO/aptevo-secures-1-5-million-non-dilutive-research-grant-from-the-andy-hill-care-f-0120aa19.md 2026-06-30 https://biopharmsignal.com/news/DSGN/design-therapeutics-announces-initiation-of-patient-dosing-in-phase-1-multiple-a-1d18e89a.md 2026-06-30 https://biopharmsignal.com/news/COGT/cogent-biosciences-announces-submission-of-new-drug-application-nda-for-bezuclas-2951df92.md 2026-06-30 https://biopharmsignal.com/news/ALXO/alx-oncology-appoints-scott-garland-as-chairman-of-the-board-and-michael-listgar-e952538a.md 2026-06-30 https://biopharmsignal.com/news/MNPR/monopar-therapeutics-receives-fda-rare-pediatric-disease-designation-for-alxn184-4666946b.md 2026-06-30 https://biopharmsignal.com/news/MNOV/medicinova-ceo-provides-shareholder-update-9776ffac.md 2026-06-30 https://biopharmsignal.com/news/SCYX/scynexis-initiates-phase-1-study-of-scy-770-a-novel-ampk-activator-for-the-treat-9e4687ee.md 2026-06-30 https://biopharmsignal.com/news/ANGO/angiodynamics-to-report-fiscal-2026-fourth-quarter-and-full-year-financial-resul-d0a55e66.md 2026-06-30 https://biopharmsignal.com/news/PSTV/plus-therapeutics-provides-mid-year-business-update-including-corporate-rebrandi-b0939053.md 2026-06-30 https://biopharmsignal.com/news/PCRX/pacira-biosciences-announces-agreement-to-divest-its-iovera-business-to-zimmer-b-e7793cda.md 2026-06-30 https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-receives-complete-response-letter-from-fda-regarding-resu-2c152ab0.md 2026-06-30 https://biopharmsignal.com/news/KTTA/pasithea-therapeutics-announces-positive-interim-phase-1-advanced-cancer-study-d-e066723c.md 2026-06-30 https://biopharmsignal.com/news/BEAT/heartbeam-completes-enrollment-in-heart-attack-detection-pilot-study-ahead-of-sc-c3aedd75.md 2026-06-30 https://biopharmsignal.com/news/XERS/xeris-announces-updates-to-its-board-of-directors-f32772e5.md 2026-06-30 https://biopharmsignal.com/news/PRI/primerica-household-budget-index-hbi-gas-prices-continued-to-weigh-on-purchasing-cd4ad354.md 2026-06-30 https://biopharmsignal.com/news/CADL/candel-therapeutics-announces-initiation-global-pivotal-phase-3.md 2026-06-30 https://biopharmsignal.com/news/ALLR/allarity-therapeutics-announces-the-grant-of-essential-u-s-patent-for-its-stenop-be7a5b50.md 2026-06-30 https://biopharmsignal.com/news/ARQT/fda-approves-arcutis-zoryve-roflumilast-cream-0-3-for-the-treatment-of-plaque-ps-597a9084.md 2026-06-29 https://biopharmsignal.com/news/MESO/becoming-a-substantial-holder-3be3e358.md 2026-06-29 https://biopharmsignal.com/news/PRAX/praxis-precision-medicines-announces-extension-period-for-relutrigine-for-treatm-f28fc662.md 2026-06-29 https://biopharmsignal.com/news/YOU/your-travel-day-super-hero-has-arrived-clear-teams-up-with-marvel-animation-s-x--1b04f659.md 2026-06-29 https://biopharmsignal.com/news/MTLS/materialise-share-buy-back-program-772511f8.md 2026-06-29 https://biopharmsignal.com/news/MTLS/materialise-aandeleninkoopprogramma-deec859b.md 2026-06-29 https://biopharmsignal.com/news/VREX/tackling-ct-artifacts-in-multi-material-parts-truespectrum-at-ecndt-2026-varex-i-b14701de.md 2026-06-29 https://biopharmsignal.com/news/NRSN/neurosense-achieves-primary-endpoint-in-phase-2b-als-study-with-statistically-si-6471ada3.md 2026-06-29 https://biopharmsignal.com/news/EBS/emergent-biosolutions-secures-contract-modification-valued-at-approximately-52-7-e7168b1d.md 2026-06-29 https://biopharmsignal.com/news/ARTL/artelo-biosciences-presents-clinical-and-biomarker-data-supportive-of-the-develo-0285995c.md 2026-06-29 https://biopharmsignal.com/news/TNYA/tenaya-therapeutics-appoints-eric-hyllengren-as-chief-financial-officer-bc693f44.md 2026-06-29 https://biopharmsignal.com/news/ACHV/achieve-life-sciences-joins-russell-2000-index-26eba5ff.md 2026-06-29 https://biopharmsignal.com/news/DGX/quest-diagnostics-foundation-commits-nearly-5-million-to-improving-health-outcom-a6539690.md 2026-06-29 https://biopharmsignal.com/news/CRBU/caribou-biosciences-to-participate-in-the-h-c-wainwright-4th-annual-cell-therapy-faa61d70.md 2026-06-29 https://biopharmsignal.com/news/RANI/rani-therapeutics-appoints-nicholas-maestas-as-chief-financial-officer-5b23c7dd.md 2026-06-29 https://biopharmsignal.com/news/REPL/replimune-reports-fiscal-fourth-quarter-and-year-end-2026-financial-results-and--829c51fd.md 2026-06-29 https://biopharmsignal.com/news/ZURA/zura-bio-exceeds-enrollment-target-in-both-hidradenitis-suppurativa-hs-systemic--cfd7a19d.md 2026-06-29 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-announces-first-patient-enrolled-in-phase-2-horizon-study--041b721f.md 2026-06-29 https://biopharmsignal.com/news/DTIL/precision-biosciences-announces-inclusion-in-the-russell-2000-index-expanding-ma-949bcb8c.md 2026-06-29 https://biopharmsignal.com/news/BCRX/biocryst-sharpens-scientific-focus-on-external-innovation-with-wind-down-of-inte-83b84c41.md 2026-06-29 https://biopharmsignal.com/news/RLMD/relmada-therapeutics-joins-russell-2000-and-russell-3000-indexes-f3211c84.md 2026-06-29 https://biopharmsignal.com/news/AORT/artivion-announces-u-s-fda-approval-of-the-amds-hybrid-prosthesis-15da88f3.md 2026-06-29 https://biopharmsignal.com/news/LRMR/larimar-therapeutics-reports-positive-open-label-data-and-submission-of-first-mo-5e1889f2.md 2026-06-29 https://biopharmsignal.com/news/GLPG/lakefront-receives-transparency-notification-from-madison-avenue-partners-747038a0.md 2026-06-29 https://biopharmsignal.com/news/TBPH/theravance-biopharma-enters-into-definitive-agreement-to-be-acquired-by-zymework-7bcac832.md 2026-06-29 https://biopharmsignal.com/news/YOU/clear-to-strengthen-caller-verification-in-contact-centers-with-aws-a6b19977.md 2026-06-29 https://biopharmsignal.com/news/AMRX/zambon-and-amneal-announce-positive-chmp-opinion-for-hopledo-ipx203-for-adults-w-6b0e1405.md 2026-06-29 https://biopharmsignal.com/news/MESO/ceasing-to-be-a-substantial-holder-aff3eb75.md 2026-06-28 https://biopharmsignal.com/news/NKTR/nektar-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-2437a21b.md 2026-06-26 https://biopharmsignal.com/news/MNPR/monopar-presents-new-analyses-of-phase-3-focus-data-at-ean-2026-showing-greater--6b830c10.md 2026-06-26 https://biopharmsignal.com/news/LRMR/larimar-therapeutics-announces-investor-event-on-the-nomlabofusp-program-for-fri-42a5b003.md 2026-06-26 https://biopharmsignal.com/news/ASND/ascendis-joins-multiple-russell-u-s-indexes-including-the-russell-3000-russell-1-d1ad8aa7.md 2026-06-26 https://biopharmsignal.com/news/CAPR/capricor-therapeutics-announces-fda-advisory-committee-meeting-to-review-bla-for-4de22ae1.md 2026-06-26 https://biopharmsignal.com/news/CRIS/curis-announces-eleven-active-clinical-sites-in-takeaim-cll-study-reaffirms-pati-978d906e.md 2026-06-26 https://biopharmsignal.com/news/CAPR/capricor-to-present-positive-five-year-hope-2-ole-data-and-hope-3-phase-3-result-4fe04208.md 2026-06-26 https://biopharmsignal.com/news/MDNA/medicenna-therapeutics-reports-fiscal-year-2026-financial-results-and-operationa-270c22c3.md 2026-06-26 https://biopharmsignal.com/news/LIXT/lixte-joins-russell-microcap-index-2eee8aca.md 2026-06-26 https://biopharmsignal.com/news/AEMD/aethlon-medical-announces-publication-demonstrating-novel-long-covid-biomarker-a-2129c0c1.md 2026-06-26 https://biopharmsignal.com/news/ENSC/ensysce-biosciences-enrolls-first-patient-in-final-phase-of-pf614-mpar-102-clini-3e521199.md 2026-06-26 https://biopharmsignal.com/news/REPL/replimune-announces-fda-acceptance-of-rp1-biologics-license-application-resubmis-9ba52bee.md 2026-06-26 https://biopharmsignal.com/news/VANI/vivani-medical-announces-appointment-of-august-j-moretti-to-board-of-directors-a-38ca0d85.md 2026-06-26 https://biopharmsignal.com/news/AVTX/avalo-therapeutics-to-join-the-russell-2000-and-russell-3000-indexes-3ee6d18b.md 2026-06-26 https://biopharmsignal.com/news/ACAD/daybu-trofinetide-recommended-for-approval-in-the-european-union-by-chmp-b5e699e2.md 2026-06-26 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635-c--9011f3a6.md 2026-06-26 https://biopharmsignal.com/news/CLLS/cellectis-reports-results-from-shareholders-meeting-held-on-june-25-2026-28c487bb.md 2026-06-25 https://biopharmsignal.com/news/REGN/regeneron-to-report-second-quarter-2026-financial-and-operating-results-and-host-c2e371f6.md 2026-06-25 https://biopharmsignal.com/news/TSHA/taysha-gene-therapies-announces-multiple-presentations-highlighting-its-tsha-102-4055adda.md 2026-06-25 https://biopharmsignal.com/news/ASND/ascendis-to-showcase-advances-in-treatment-of-achondroplasia-at-iccbh-2026-cf687b9b.md 2026-06-25 https://biopharmsignal.com/news/VLA/valneva-announces-successful-outcome-of-its-annual-general-meeting-valneva-577e38e0.md 2026-06-25 https://biopharmsignal.com/news/NRSN/neurosense-reports-positive-biomarker-findings-from-phase-2-road-proof-of-concept-study-of-primec-in-alzheimer-s-disease.md 2026-06-25 https://biopharmsignal.com/news/JAGX/jaguar-health-announces-conversion-of-series-o-convertible-preferred-stock-issued-as-recent-one-time-stock-dividend.md 2026-06-25 https://biopharmsignal.com/news/MKT/maia-biotechnology-completes-international-enrollment-in-part-c-of-phase-2-thio-101-expansion-trial-in-third-line-non-small-cell-lung-cancer.md 2026-06-25 https://biopharmsignal.com/news/CADL/candel-therapeutics-appoints-mark-sims-as-chief-commercial-officer.md 2026-06-25 https://biopharmsignal.com/news/ICCM/icecure-regains-compliance-with-nasdaq-minimum-bid-price-requirement.md 2026-06-25 https://biopharmsignal.com/news/LYEL/lyell-immunopharma-announces-participation-in-h-c-wainwright-4th-annual-cell-therapy-virtual-conference.md 2026-06-25 https://biopharmsignal.com/news/PSTV/plus-therapeutics-secures-national-coverage-agreement-with-elevance-health-for-cnsider-cerebrospinal-fluid-assay-for-metastatic-cns-cancer.md 2026-06-25 https://biopharmsignal.com/news/VANI/vivani-medical-receives-regulatory-approval-for-the-initiation-of-slim-1-a-phase-1-clinical-trial-of-npm-139-semaglutide-implant-in-obesity-and-chronic-weight-management.md 2026-06-25 https://biopharmsignal.com/news/AVIR/atea-pharmaceuticals-completes-patient-enrollment-in-phase-3-c-forward-trial-evaluating-bemnifosbuvir-and-ruzasvir-for-treatment-of-hepatitis-c-virus.md 2026-06-25 https://biopharmsignal.com/news/MCRB/seres-therapeutics-to-host-webcast-on-july-8-2026-to-discuss-results-of-investigator-sponsored-trial-of-seres-ser-155-in-immune-checkpoint-inhibitor-related-enterocolitis.md 2026-06-25 https://biopharmsignal.com/news/TECH/merck-kgaa-darmstadt-germany-agrees-to-acquire-bio-techne-strengthening-leadership-position-in-fast-growing-life-sciences-markets.md 2026-06-25 https://biopharmsignal.com/news/TSHA/taysha-gene-therapies-announces-pricing-of-public-offering-of-common-stock-and-pre-funded-warrants.md 2026-06-25 https://biopharmsignal.com/news/MESO/mesoblast-draws-us-50m-from-five-year-non-dilutive-facility.md 2026-06-25 https://biopharmsignal.com/news/RVMD/revolution-medicines-to-present-clinical-data-from-ras-on-inhibitor-combination-trials-in-pancreatic-cancer-at-esmo-gastrointestinal-cancers-congress-2026.md 2026-06-25 https://biopharmsignal.com/news/BEAT/heartbeam-announces-strategic-shift-to-accelerate-global-adoption-of-its-ambulatory-ecg-signal-platform-and-leadership-transition.md 2026-06-25 https://biopharmsignal.com/news/PASG/passage-bio-and-remix-therapeutics-announce-merger-agreement.md 2026-06-25 https://biopharmsignal.com/news/SERA/sera-prognostics-collaborates-on-arpa-h-award-to-advance-point-of-care-diagnostic-for-safer-birth.md 2026-06-25 https://biopharmsignal.com/news/TSHA/taysha-gene-therapies-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants.md 2026-06-25 https://biopharmsignal.com/news/GSK/gsk-announces-commencement-of-tender-offer-to-acquire-nuvalent-inc.md 2026-06-25 https://biopharmsignal.com/news/VRAX/virax-biolabs-group-limited-announces-1-for-25-share-consolidation.md 2026-06-25 https://biopharmsignal.com/news/DGX/quest-diagnostics-receives-new-york-state-approval-for-haystack-mrdr-broadening-patient-access-to-ctdna-minimal-residual-disease-testing.md 2026-06-25 https://biopharmsignal.com/news/BNGO/bionano-announces-hiring-of-chief-scientific-officer.md 2026-06-25 https://biopharmsignal.com/news/LENZ/lenz-therapeutics-and-arrotex-pharmaceuticals-announce-exclusive-license-and-commercialization-agreement-for-vizztm-in-australia-and-new-zealand.md 2026-06-25 https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-listing-of-the-rain-token-on-gate-one-of-the-world-s-largest-cryptocurrency-exchanges-by-spot-trading-volume.md 2026-06-25 https://biopharmsignal.com/news/VKTX/viking-therapeutics-announces-initiation-of-phase-1-study-to-evaluate-novel-amylin-receptor-agonist-vk3019-in-healthy-adults.md 2026-06-25 https://biopharmsignal.com/news/ABSI/absci-announces-pricing-of-100-million-underwritten-offering-with-leading-strategic-and-financial-investors.md 2026-06-25 https://biopharmsignal.com/news/ABSI/absci-announces-positive-interim-phase-1-data-from-the-headlinetm-trial-of-abs-201-a-novel-antibody-targeting-the-prolactin-receptor-prlr.md 2026-06-25 https://biopharmsignal.com/news/MLTX/moonlake-immunotherapeutics-announces-pricing-of-upsized-200-million-public-offering.md 2026-06-25 https://biopharmsignal.com/news/SERA/sera-applauds-illinois-initiative-to-expand-medicaid-coverage-for-proteomic-blood-testing-in-pregnancy.md 2026-06-25 https://biopharmsignal.com/news/CHRS/coherus-and-zumutor-biologics-announce-clinical-collaboration-to-evaluate-zm008-in-combination-with-loqtorzir-toripalimab-tpzi.md 2026-06-25 https://biopharmsignal.com/news/GNFT/genfit-positive-phase-1b-data-with-gns561-in-combination-therapy-in-heavily-pretreated-patients-with-cholangiocarcinoma.md 2026-06-25 https://biopharmsignal.com/news/MXCT/vectorbuilder-partners-with-maxcyter-to-advance-clinical-grade-cell-engineering.md 2026-06-25 https://biopharmsignal.com/news/MNKD/mannkind-awarded-breakthrough-t1d-grant-to-support-advancement-of-inhale-1st-pediatric-trial-of-afrezzar-in-youth-with-newly-diagnosed-t1d.md 2026-06-25 https://biopharmsignal.com/news/JAGX/jaguar-health-completes-submission-of-new-animal-drug-application-for-full-fda-approval-of-crofelemer-for-treatment-of-chemotherapy-induced-diarrhea-cid-in-dogs.md 2026-06-25 https://biopharmsignal.com/news/DMAC/diamedica-therapeutics-announces-first-patients-dosed-in-phase-2-trial-of-dm199-for-the-treatment-of-fetal-growth-restriction.md 2026-06-25 https://biopharmsignal.com/news/ICCM/icecure-highlights-new-peer-reviewed-journal-article-in-leading-surgery-journal-demonstrating-cryoablation-s-advantages-over-radiofrequency-ablation-for-early-stage-breast-cancer.md 2026-06-25 https://biopharmsignal.com/news/PHAT/phathom-pharmaceuticals-completes-patient-enrollment-ahead-of-schedule-in-phase-2-phalcon-eoe-201-study-of-voqueznar-vonoprazan-in-eosinophilic-esophagitis-eoe.md 2026-06-25 https://biopharmsignal.com/news/RVMD/revolution-medicines-begins-treating-patients-in-rasolute-305-a-phase-3-clinical-trial-evaluating-zoldonrasib-in-combination-with-chemotherapy-as-a-first-line-treatment-for-patients-with-ras-g12d-metastatic-pancreatic-cancer.md 2026-06-25 https://biopharmsignal.com/news/IART/integra-lifesciences-announces-key-executive-appointments.md 2026-06-25 https://biopharmsignal.com/news/PSTV/plus-therapeutics-to-provide-business-update-call-on-june-30-2026.md 2026-06-25 https://biopharmsignal.com/news/INSM/insmed-appoints-samuele-butera-as-senior-vice-president-general-manager-global-respiratory.md 2026-06-25 https://biopharmsignal.com/news/AVTX/avalo-therapeutics-appoints-ron-philip-to-board-of-directors.md 2026-06-25 https://biopharmsignal.com/news/BDX/bd-awarded-vizient-innovative-technology-contract-for-centrovena-onetm-insertion-system.md 2026-06-25 https://biopharmsignal.com/news/ENTA/enanta-pharmaceuticals-partner-abbvie-receives-european-commission-approval-of-maviretr-glecaprevir-pibrentasvir-for-people-with-acute-hepatitis-c-virus.md 2026-06-25 https://biopharmsignal.com/news/MGNX/macrogenics-to-receive-milestone-payment-from-sanofi-for-recent-tzieldr-approval.md 2026-06-25 https://biopharmsignal.com/news/HUM/humana-inc-to-release-second-quarter-2026-results-on-july-29-2026.md 2026-06-25 https://biopharmsignal.com/news/DYN/dyne-therapeutics-appoints-barry-greene-to-board-of-directors.md 2026-06-25 https://biopharmsignal.com/news/VANI/vivani-medical-ceo-adam-mendelsohn-to-present-at-the-2026-bio-international-convention.md 2026-06-25 https://biopharmsignal.com/news/CNTA/acquisition-of-centessa-by-lilly-approved-by-the-high-court-of-justice-of-england-and-wales.md 2026-06-25 https://biopharmsignal.com/news/TNGX/tango-therapeutics-appoints-robert-azelby-to-board-of-directors.md 2026-06-25 https://biopharmsignal.com/news/MLTX/moonlake-immunotherapeutics-announces-proposed-public-offering.md 2026-06-25 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-receives-marketing-authorization-in-the-european-union-for-redemplor-plozasiran-to-reduce-triglycerides-in-adults-with-familial-chylomicronemia-syndrome-fcs.md 2026-06-25 https://biopharmsignal.com/news/NRSN/everythingals-to-host-neurosense-in-a-community-event-named-primec-connecting-the-dots.md 2026-06-25 https://biopharmsignal.com/news/JAGX/jaguar-health-announces-plan-to-explore-strategic-alternatives-aligned-with-targeted-nda-filing-for-rare-disease-intestinal-failure-program.md 2026-06-25 https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-rain-holdings-valued-at-approximately-1-14-billion.md 2026-06-25 https://biopharmsignal.com/news/ACHV/achieve-life-sciences-receives-complete-response-letter-from-fda-for-cytisinicline-nda.md 2026-06-25 https://biopharmsignal.com/news/HYPR/hyperfine-forms-global-neurosurgery-advisory-council-to-support-expansion-of-portable-mri-in-neurosurgical-care.md 2026-06-25 https://biopharmsignal.com/news/PRAX/praxis-precision-medicines-receives-fda-breakthrough-therapy-designation-for-elsunersen-for-the-treatment-of-seizures-associated-with-scn2a-developmental-and-epileptic-encephalopathy-caused-by-gain-of-function-variants.md 2026-06-25 https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-announces-first-u-s-patient-dosed-in-the-second-pivotal-clinical-trial-cove-3-of-its-phase-3-program-evaluating-ycanthr-vp-102-for-the-treatment-of-common-warts.md 2026-06-25 https://biopharmsignal.com/news/SRRK/scholar-rock-to-showcase-neuromuscular-research-portfolio-at-2026-annual-cure-sma-research-and-clinical-care-meeting-and-2026-international-research-congress-on-fshd.md 2026-06-25 https://biopharmsignal.com/news/PRME/prime-medicine-receives-u-s-fda-regenerative-medicine-advanced-therapy-rmat-designation-for-pm359-for-the-treatment-of-chronic-granulomatous-disease-cgd.md 2026-06-25 https://biopharmsignal.com/news/RVMD/revolution-medicines-announces-planned-leadership-transition-for-steve-kelsey-m-d.md 2026-06-25 https://biopharmsignal.com/news/EXEL/exelixis-provides-update-on-the-phase-3-stellar-303-trial-evaluating-zanzalintinib-in-combination-with-an-immune-checkpoint-inhibitor-in-patients-with-metastatic-colorectal-cancer.md 2026-06-25 https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-reports-positive-preclinical-findings-showing-proprietary-gene-silencing-technology-is-selectively-cytotoxic-to-squamous-skin-cancer-cells-without-harming-healthy-cells.md 2026-06-25 https://biopharmsignal.com/news/TSHA/taysha-gene-therapies-announces-completion-of-dosing-in-reveal-pivotal-trial-and-reports-longer-term-clinical-data-from-part-a-of-reveal-phase-1-2-trials-evaluating-tsha-102-for-rett-syndrome.md 2026-06-25 https://biopharmsignal.com/news/REGN/cemdisiran-regulatory-submissions-accepted-for-review-by-fda-and-ema-for-the-treatment-of-generalized-myasthenia-gravis-gmg.md 2026-06-25 https://biopharmsignal.com/news/SEER/seer-and-korea-university-present-preliminary-data-at-asms-2026-demonstrating-potential-of-ai-driven-plasma-proteomics-for-multi-cancer-screening.md 2026-06-25 https://biopharmsignal.com/news/MLTX/moonlake-announces-week-52-results-of-sonelokimab-from-its-phase-3-vela-program-in-hidradenitis-suppurativa-and-confirms-investor-day-on-june-22-2026.md 2026-06-25 https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-announces-closing-of-3-2-million-offering.md 2026-06-25 https://biopharmsignal.com/news/INVA/nortiva-bio-launches-to-develop-long-acting-oral-medicines.md 2026-06-25 https://biopharmsignal.com/news/DGX/uti-causing-bacteria-resistant-to-current-drugs-finds-national-study-by-hackensack-meridian-cdi-and-quest-diagnostics.md 2026-06-25 https://biopharmsignal.com/news/JAGX/magdalena-biosciences-a-joint-venture-between-jaguar-health-and-filament-health-announces-positive-results-of-preclinical-study-of-coca-for-weight-gain-prevention.md 2026-06-25 https://biopharmsignal.com/news/MKT/maia-biotechnology-opens-enrollment-for-phase-2-expansion-trial-of-novel-telomere-targeting-agent-at-winship-cancer-institute-of-emory-university.md 2026-06-25 https://biopharmsignal.com/news/GRI/gri-bio-secures-fda-orphan-drug-designation-for-gri-0621-tazarotene-in-idiopathic-pulmonary-fibrosis.md 2026-06-25 https://biopharmsignal.com/news/LIXT/lixte-biotechnology-provides-update-on-nomad-acquisition-transaction-expected-to-close-on-or-about-july-1-2026.md 2026-06-25 https://biopharmsignal.com/news/HYPR/hyperfine-swoopr-system-scan-volume-in-the-united-states-hits-record-milestones-across-multiple-sites-of-care.md 2026-06-25 https://biopharmsignal.com/news/BNGO/bionano-announces-67-year-over-year-growth-in-studies-featuring-optical-genome-mapping-at-eshg-2026-reflecting-expanding-global-adoption.md 2026-06-25 https://biopharmsignal.com/news/PRME/prime-medicine-announces-new-zealand-clearance-of-clinical-trial-application-for-pm577a-in-h1069q-mutated-wilson-disease.md 2026-06-25 https://biopharmsignal.com/news/CRL/charles-river-joins-lilly-tunelab-to-optimize-ai-ml-platform-through-nonclinical-testing-expertise.md 2026-06-25 https://biopharmsignal.com/news/ACST/grace-therapeutics-announces-2026-fiscal-year-end-financial-results-provides-business-update.md 2026-06-25 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-to-host-a-webinar-on-its-cardiometabolic-pipeline-as-part-i-of-the-2026-summer-series-of-randd-webinars.md 2026-06-25 https://biopharmsignal.com/news/ENTA/enanta-pharmaceuticals-announces-advancement-of-its-zelicapavir-clinical-development-program-for-the-treatment-of-respiratory-syncytial-virus-rsv.md 2026-06-25 https://biopharmsignal.com/news/TMCI/treace-announces-first-surgical-case-with-the-hyperplatetm-xm-dynamic-compression-locking-implant-system.md 2026-06-25 https://biopharmsignal.com/news/BEAM/beam-therapeutics-announces-clearance-of-investigational-new-drug-application-for-beam-304-for-the-treatment-of-phenylketonuria-pku-by-the-united-states-u-s-food-and-drug-administration.md 2026-06-25 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-to-report-results-for-second-quarter-2026-on-july-30-2026.md 2026-06-25 https://biopharmsignal.com/news/KPRX/kiora-pharmaceuticals-reports-its-ion-channel-modulator-kio-300-suppressed-seizure-activity-in-preclinical-epilepsy-model.md 2026-06-25 https://biopharmsignal.com/news/CERT/certara-announces-cfo-transition.md 2026-06-25 https://biopharmsignal.com/news/CORT/corcept-resubmits-new-drug-application-for-relacorilant-as-a-treatment-for-patients-with-cushing-s-syndrome.md 2026-06-25 https://biopharmsignal.com/news/ALKS/alkermes-presents-detailed-positive-results-from-vibrance-2-phase-2-study-of-alixorexton-in-adults-with-narcolepsy-type-2-at-sleep-2026.md 2026-06-25 https://biopharmsignal.com/news/MTLS/materialise-nv-resultaten-van-de-jaarlijkse-algemene-aandeelhoudersvergadering-van-16-juni-2026.md 2026-06-25 https://biopharmsignal.com/news/MTLS/materialise-nv-results-of-annual-general-shareholders-meeting-of-16-june-2026.md 2026-06-25 https://biopharmsignal.com/news/ICCM/icecure-announces-pricing-of-5-5-million-private-placement-priced-at-a-premium-to-the-market-price-with-a-single-healthcare-focused-institutional-investor.md 2026-06-25 https://biopharmsignal.com/news/SPRO/utebzi-tebipenem-pivoxil-approved-in-the-us-for-adults-with-complicated-urinary-tract-infections-cutis.md 2026-06-25 https://biopharmsignal.com/news/GSK/utebzi-tebipenem-pivoxil-approved-in-the-us-for-adults-with-complicated-urinary-tract-infections-cutis.md 2026-06-25 https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-announces-pricing-of-3-2-million-offering.md 2026-06-25 https://biopharmsignal.com/news/DGX/quest-diagnostics-to-release-second-quarter-financial-results-on-july-23-2026.md 2026-06-25 https://biopharmsignal.com/news/ANGO/angiodynamics-receives-fda-ide-approval-for-relief-feasibility-study-evaluating-nanoknife-ire-platform-as-minimally-invasive-treatment-for-benign-prostatic-hyperplasia-bph.md 2026-06-25 https://biopharmsignal.com/news/ICCM/icecure-reports-70-growth-in-active-u-s-commercial-install-base-for-breast-cancer-cryoablation-following-fda-clearance.md 2026-06-25 https://biopharmsignal.com/news/DYN/dyne-therapeutics-announces-expanded-debt-facility-of-up-to-400-million-with-hercules-capital-inc.md 2026-06-25 https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-corporation-prices-upsized-300-million-convertible-senior-notes-offering.md 2026-06-25 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-yujiro-s-hata-elected-chairman-of-its-board-of-directors.md 2026-06-25 https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-to-report-second-quarter-2026-financial-results-on-july-22-2026.md 2026-06-25 https://biopharmsignal.com/news/SNOA/sonoma-pharmaceuticals-reports-fiscal-year-and-fourth-quarter-2026-financial-results.md 2026-06-25 https://biopharmsignal.com/news/RIGL/rigel-announces-closing-of-licensing-agreement-for-veppanutm-vepdegestrant.md 2026-06-25 https://biopharmsignal.com/news/YOU/clear-launches-at-indianapolis-international-airport.md 2026-06-25 https://biopharmsignal.com/news/DGX/quest-diagnostics-unveils-achievements-in-healthcare-access-employee-engagement-and-environmental-sustainability-in-2025-corporate-responsibility-report.md 2026-06-25 https://biopharmsignal.com/news/AVCO/chief-patrick-flannelly-highlights-ketoairtm-progress-in-supporting-the-nevada-first-responders-holistic-health-reset-program.md 2026-06-25 https://biopharmsignal.com/news/DMAC/diamedica-receives-fda-feedback-on-dm199-preeclampsia-nonclinical-program.md 2026-06-25 https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-announces-program-to-advance-veteran-lung-health-philips-bioaffinity-technologies-and-4dmedical-highlight-new-approaches-to-lung-health-screening-for-u-s-veterans.md 2026-06-25 https://biopharmsignal.com/news/OTLK/outlook-therapeutics-announces-fda-acceptance-of-resubmitted-biologics-license-application-for-ons-5010-lytenavatm-bevacizumab-vikg-as-a-treatment-for-wet-amd.md 2026-06-25 https://biopharmsignal.com/news/INVA/innoviva-specialty-therapeutics-announces-distribution-and-licensing-agreement-with-dr-reddy-s-for-xacduror-in-select-international-markets.md 2026-06-25 https://biopharmsignal.com/news/USNA/usana-celebrates-10-years-of-making-the-world-a-better-place-during-world-service-week.md 2026-06-25 https://biopharmsignal.com/news/KTTA/pasithea-therapeutics-announces-amendments-to-clinical-study-protocol-for-phase-1-1b-nf1-clinical-trial.md 2026-06-25 https://biopharmsignal.com/news/AVTX/avalo-therapeutics-expands-pipeline-with-avtx-010-a-long-acting-next-generation-anti-il-1-antibody.md 2026-06-25 https://biopharmsignal.com/news/EMBC/embecta-appoints-nimish-muzumdar-as-svp-and-president-north-america.md 2026-06-25 https://biopharmsignal.com/news/PTCT/ptc-therapeutics-announces-pricing-of-convertible-notes-offering-to-refinance-2026-convertible-notes.md 2026-06-25 https://biopharmsignal.com/news/ELVN/enliven-therapeutics-announces-closing-of-upsized-public-offering-of-common-stock-and-pre-funded-warrants-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares.md 2026-06-25 https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-announces-plan-to-separate-its-mrd-and-immune-medicine-businesses.md 2026-06-25 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-presents-first-retrospective-case-series-of-crenessityr-crinecerfont-in-patients-with-classic-congenital-adrenal-hyperplasia-due-to-11-hydroxylase-deficiency-at-endo-2026.md 2026-06-25 https://biopharmsignal.com/news/NBIX/soleno-therapeutics-presents-new-vykatr-xr-diazoxide-choline-data-at-endo-2026-demonstrating-meaningful-and-durable-improvements-in-hyperphagia-and-behavioral-symptoms-in-prader-willi-syndrome-following-randomized-withdrawal-period.md 2026-06-25 https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-corporation-announces-proposed-convertible-senior-notes-offering.md 2026-06-25 https://biopharmsignal.com/news/IRON/disc-medicine-presents-positive-clinical-updates-at-the-2026-european-hematology-association-eha-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/GNFT/genfit-june-15-2026-combined-shareholders-meeting-results.md 2026-06-25 https://biopharmsignal.com/news/INBX/inhibrx-announces-u-s-fda-acceptance-of-bla-for-ozekibart-in-patients-with-conventional-chondrosarcoma.md 2026-06-25 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-presents-new-two-year-crenessityr-crinecerfont-data-demonstrating-improved-growth-measures-in-pediatric-patients-with-classic-congenital-adrenal-hyperplasia-at-endo-2026.md 2026-06-25 https://biopharmsignal.com/news/FATE/fate-therapeutics-appoints-laura-hamill-to-board-of-directors.md 2026-06-25 https://biopharmsignal.com/news/IART/integra-lifesciences-to-present-at-the-2026-truist-securities-medtech-conference.md 2026-06-25 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-presents-new-two-year-crenessityr-crinecerfont-data-demonstrating-improvements-in-cardiometabolic-outcomes-in-adults-with-classic-congenital-adrenal-hyperplasia-at-endo-2026.md 2026-06-25 https://biopharmsignal.com/news/SNSE/sensei-biotherapeutics-announces-name-change-to-faeth-therapeutics-focused-on-advancing-piktor-an-oral-therapy-targeting-one-of-the-most-frequently-altered-pathways-in-cancer.md 2026-06-25 https://biopharmsignal.com/news/HUMA/humacyte-s-bioengineered-blood-vessel-outperforms-the-standard-of-care-for-women-on-dialysis-in-phase-3-results-presented-at-the-society-for-vascular-surgery-vascular-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/ENLV/enlivex-announces-issuance-of-australian-patent-covering-the-use-of-allocetratm-in-patients-with-osteoarthritis.md 2026-06-25 https://biopharmsignal.com/news/BRLI/preclinical-data-for-opko-biologics-opk8801001-in-acromegaly-presented-at-endo-2026.md 2026-06-25 https://biopharmsignal.com/news/IMRX/immuneering-appoints-andrew-gengos-as-chief-financial-officer.md 2026-06-25 https://biopharmsignal.com/news/APTO/aptose-presents-safety-response-and-mrd-clinical-data-from-tuscany-phase-1-2-clinical-trial-of-tuspetinib-triplet-therapy-in-newly-diagnosed-aml-at-the-2026-eha-congress-in-oral-presentation.md 2026-06-25 https://biopharmsignal.com/news/PTCT/ptc-therapeutics-announces-proposed-convertible-notes-offering-to-refinance-2026-convertible-notes.md 2026-06-25 https://biopharmsignal.com/news/ALKS/alkermes-announces-orphan-drug-designations-for-alixorexton-in-the-u-s-and-europe.md 2026-06-25 https://biopharmsignal.com/news/KTTA/pasithea-therapeutics-announces-exhibit-at-children-s-tumor-foundation-2026-nf-conference.md 2026-06-25 https://biopharmsignal.com/news/SEER/seer-board-of-directors-issues-letter-to-shareholders-highlighting-the-company-s-significant-scientific-progress-and-addressing-radoff-and-torok-s-short-sighted-campaign.md 2026-06-25 https://biopharmsignal.com/news/CNTX/context-therapeutics-announces-positive-interim-efficacy-and-safety-results-from-ongoing-phase-1-clinical-trial-for-ctim-76.md 2026-06-25 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-ide892-a-potential-best-in-class-mta-cooperative-prmt5-inhibitor-initiates-a-phase-1-2-clinical-combination-study-in-mtap-deleted-pancreatic-and-lung-cancers.md 2026-06-25 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-presents-late-breaking-data-on-lorundrostat-and-heart-failure-risk-biomarkers-at-the-endocrine-society-annual-meeting-endo-2026.md 2026-06-25 https://biopharmsignal.com/news/ASND/phase-3-data-show-transconr-pth-replicated-systemic-actions-of-endogenous-pth-through-week-182-in-adults-with-hypoparathyroidism.md 2026-06-25 https://biopharmsignal.com/news/NTLA/intellia-therapeutics-reports-additional-positive-phase-3-results-for-lonvoguran-ziclumeran-lonvo-z-in-patients-with-hereditary-angioedema.md 2026-06-25 https://biopharmsignal.com/news/XOMA/xoma-royalty-corporation-declares-quarterly-preferred-stock-dividend-and-announces-redemption-of-its-perpetual-preferred-stock-and-cvr-dividend-record-date.md 2026-06-25 https://biopharmsignal.com/news/LYEL/lyell-immunopharma-presents-updated-safety-data-and-translational-insights-for-rondecabtagene-autoleucel-ronde-cel-in-patients-with-large-b-cell-lymphoma-at-european-hematology-association-2026-congress.md 2026-06-25 https://biopharmsignal.com/news/JAGX/jaguar-health-presenting-june-24-2026-at-the-life-sciences-virtual-investor-forum-to-provide-updates-on-company-s-crofelemer-development-program-for-rare-intestinal-failure-diseases.md 2026-06-25 https://biopharmsignal.com/news/LIXT/lixte-biotechnology-to-acquire-nomad-transportable-power-systems-the-market-leader-in-mobile-utility-grade-battery-energy-storage-systems-bess.md 2026-06-25 https://biopharmsignal.com/news/COGT/cogent-biosciences-announces-detailed-data-from-apex-pivotal-trial-of-bezuclastinib-in-patients-with-advanced-systemic-mastocytosis-at-the-2026-european-hematology-association-eha-congress.md 2026-06-25 https://biopharmsignal.com/news/COGT/cogent-biosciences-announces-preclinical-data-from-novel-jak2-v617f-inhibitor-at-the-2026-european-hematology-association-eha-congress.md 2026-06-25 https://biopharmsignal.com/news/BCRX/biocryst-presents-new-clinical-data-and-real-world-evidence-demonstrating-impact-of-hae-portfolio-at-the-2026-european-academy-of-allergy-and-clinical-immunology-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/RCKT/rocket-pharmaceuticals-announces-closing-of-sale-of-rare-pediatric-disease-priority-review-voucher-for-180-million.md 2026-06-25 https://biopharmsignal.com/news/GSK/gsk-s-momelotinib-granted-orphan-drug-designations-in-the-us-and-eu-for-vexas-syndrome.md 2026-06-25 https://biopharmsignal.com/news/ELVN/enliven-therapeutics-announces-pricing-of-upsized-public-offering-of-common-stock-and-pre-funded-warrants.md 2026-06-25 https://biopharmsignal.com/news/XERS/xeris-biopharma-announces-notice-of-allowance-from-u-s-patent-and-trademark-office-for-new-patent-covering-keveyisr.md 2026-06-25 https://biopharmsignal.com/news/ELVN/enliven-therapeutics-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants.md 2026-06-25 https://biopharmsignal.com/news/TMCI/treace-to-present-at-the-sidoti-small-cap-conference.md 2026-06-25 https://biopharmsignal.com/news/ASND/5-year-phase-2-data-show-transconr-pth-replicated-systemic-actions-of-endogenous-pth-in-adults-with-hypoparathyroidism.md 2026-06-25 https://biopharmsignal.com/news/AZYO/elutia-to-present-at-planet-microcap-showcase-2026-on-june-17th.md 2026-06-25 https://biopharmsignal.com/news/PRI/survey-reveals-85-of-canadians-trust-professional-financial-advice-over-social-media-finfluencers.md 2026-06-25 https://biopharmsignal.com/news/FBIO/journey-medical-corporation-to-participate-in-a-g-p-s-annual-virtual-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/PAVM/lucid-diagnostics-provides-business-update-and-reports-first-quarter-2026-financial-results.md 2026-06-25 https://biopharmsignal.com/news/DERM/journey-medical-corporation-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights.md 2026-06-25 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-announces-nmpa-acceptance-of-new-drug-application-for-f351-hydronidone-for-chb-induced-liver-fibrosis-treatment.md 2026-06-25 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-reports-first-quarter-2026-results-and-provides-business-update.md 2026-06-25 https://biopharmsignal.com/news/DERM/journey-medical-corporation-to-announce-first-quarter-2026-financial-results-on-may-13-2026.md 2026-06-25 https://biopharmsignal.com/news/CBIO/gyre-therapeutics-completes-acquisition-of-cullgen-to-create-u-s-and-china-based-fully-integrated-biopharmaceutical-company.md 2026-06-25 https://biopharmsignal.com/news/LUCD/lucid-diagnostics-to-hold-first-quarter-2026-business-update-conference-call-and-webcast-on-may-14-2026.md 2026-06-25 https://biopharmsignal.com/news/PAVM/lucid-diagnostics-announces-closing-of-18-million-underwritten-offering-of-common-stock.md 2026-06-25 https://biopharmsignal.com/news/PAVM/lucid-diagnostics-announces-18-million-underwritten-offering-of-common-stock.md 2026-06-25 https://biopharmsignal.com/news/FBIO/journey-medical-corporation-secures-contract-with-third-major-gpo-for-emrositm.md 2026-06-25 https://biopharmsignal.com/news/PAVM/lucid-diagnostics-to-participate-in-fireside-chat-at-the-25th-annual-needham-virtual-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/DERM/journey-medical-corporation-reports-full-year-2025-financial-results-and-recent-corporate-highlights.md 2026-06-25 https://biopharmsignal.com/news/DERM/journey-medical-corporation-to-announce-year-end-2025-financial-results-on-march-25-2026.md 2026-06-25 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-announces-china-s-nmpa-grants-priority-review-to-the-nda-for-hydronidone-f351-for-chb-induced-liver-fibrosis-treatment.md 2026-06-25 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-update.md 2026-06-25 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-enters-into-agreement-to-acquire-cullgen-to-gain-targeted-protein-degradation-platform-and-pipeline.md 2026-06-25 https://biopharmsignal.com/news/ATXI/avenue-therapeutics-enters-into-exclusive-worldwide-license-agreement-for-atx-04-for-the-treatment-of-pompe-disease.md 2026-06-25 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-announces-alignment-with-china-s-cde-on-conditional-approval-pathway-and-priority-review-eligibility-for-hydronidone-following-pre-nda-meeting.md 2026-06-25 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-reports-third-quarter-2025-and-year-to-date-financial-results-and-provides-business-update.md 2026-06-25 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-announces-completion-of-patient-enrollment-in-phase-3-clinical-trial-of-pirfenidone-capsules-for-the-treatment-of-pneumoconiosis.md 2026-06-25 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-to-present-results-from-positive-phase-3-clinical-trial-evaluating-hydronidone-for-the-treatment-of-liver-fibrosis-in-chronic-hepatitis-b-at-aasld-the-liver-meetingr-2025.md 2026-06-25 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference.md 2026-06-25 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-announces-the-appointment-of-dan-weng-m-d-to-board-of-directors.md 2026-06-25 https://biopharmsignal.com/news/NRSN/neurosense-granted-south-korean-patent-covering-primec-composition-for-als.md 2026-06-25 https://biopharmsignal.com/news/KALV/chiesi-group-completes-acquisition-of-kalvista-pharmaceuticals.md 2026-06-25 https://biopharmsignal.com/news/LQDA/liquidia-announces-poster-presentations-at-the-pha-2026-international-ph-conference-and-scientific-sessions.md 2026-06-25 https://biopharmsignal.com/news/RNXT/renovorx-highlights-peer-reviewed-publication-supporting-intra-arterial-gemcitabine-delivery-via-tamptm-in-locally-advanced-pancreatic-cancer.md 2026-06-25 https://biopharmsignal.com/news/HRMY/harmony-biosciences-announces-poster-presentations-at-2026-sleep-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/BNGO/bionano-announces-multiple-publications-in-2026-describing-unique-utility-of-ogm-in-studies-of-reproductive-health-and-prenatal-genetic-disorders.md 2026-06-25 https://biopharmsignal.com/news/CRBU/caribou-biosciences-reports-dose-escalation-durability-data-for-cb-011-at-the-2026-european-hematology-association-eha-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/CRBU/caribou-biosciences-reports-long-term-vispa-cel-data-in-second-line-large-b-cell-lymphoma-at-eha-2026.md 2026-06-25 https://biopharmsignal.com/news/OSUR/orasure-technologies-inc-announces-fda-clearance-that-expands-patient-friendly-access-to-testing-for-sexually-transmitted-infections.md 2026-06-25 https://biopharmsignal.com/news/KURA/kura-oncology-and-kyowa-kirin-report-encouraging-long-term-results-for-ziftomenib-7-3-combination-in-newly-diagnosed-aml.md 2026-06-25 https://biopharmsignal.com/news/ELVN/enliven-therapeutics-announces-updated-positive-phase-1-clinical-data-and-alignment-with-fda-on-key-phase-3-trial-design-components.md 2026-06-25 https://biopharmsignal.com/news/IMRX/immuneering-announces-first-patient-dosed-in-pivotal-phase-3-mapkeeper-301-trial-of-atebimetinib-mgnp-in-first-line-pancreatic-cancer.md 2026-06-25 https://biopharmsignal.com/news/SNDX/syndax-showcases-revuforjr-revumenib-clinical-activity-in-multiple-acute-leukemia-subtypes-and-settings-at-eha-2026.md 2026-06-25 https://biopharmsignal.com/news/VKTX/viking-therapeutics-announces-appointment-of-hubert-c-chen-m-d-as-chief-medical-officer.md 2026-06-25 https://biopharmsignal.com/news/MDNA/medicenna-strengthens-u-s-patent-estate-with-newly-issued-and-allowed-patents-across-its-il-2-il-4-and-il-13-superkine-platforms.md 2026-06-25 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-to-attend-btig-infectious-disease-day-2026.md 2026-06-25 https://biopharmsignal.com/news/XERS/xeris-biopharma-announces-private-exchange-of-convertible-notes.md 2026-06-25 https://biopharmsignal.com/news/NRIX/nurix-therapeutics-to-report-updated-phase-1a-b-results-for-btk-degrader-bexobrutideg-highlighting-durable-responses-in-relapsed-refractory-cll-sll-and-promising-activity-in-earlier-lines-of-therapy.md 2026-06-25 https://biopharmsignal.com/news/SNDX/syndax-announces-publication-of-save-data-on-revuforjr-revumenib-in-combination-with-decitabine-cedazuridine-and-venetoclax-in-relapsed-refractory-npm1m-kmt2ar-and-nup98r-aml-in-the-journal-of-clinical-oncology.md 2026-06-25 https://biopharmsignal.com/news/FMS/interwell-health-delivers-strong-quality-scores-and-shared-savings-in-cms-value-based-kidney-care-model.md 2026-06-25 https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-cns-drug-development-veteran-michael-quirk-as-senior-advisor-for-sepranolone-program.md 2026-06-25 https://biopharmsignal.com/news/OCS/oculis-to-present-privosegtor-at-upcoming-clinical-trials-at-the-summit-2026.md 2026-06-25 https://biopharmsignal.com/news/IRON/disc-medicine-provides-update-from-fda-type-a-meeting-for-bitopertin-in-erythropoietic-protoporphyria.md 2026-06-25 https://biopharmsignal.com/news/CLLS/cellectis-presents-final-phase-1-results-of-lasme-cel-and-preliminary-results-on-eti-cel-at-eha-2026-congress.md 2026-06-25 https://biopharmsignal.com/news/HUMA/humacyte-inc-announces-pricing-of-public-offering-of-common-stock.md 2026-06-25 https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4.md 2026-06-25 https://biopharmsignal.com/news/FENC/fennec-announces-results-of-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/HUM/humana-announces-agreement-to-divest-minority-interest-in-gentiva.md 2026-06-25 https://biopharmsignal.com/news/MOH/molina-healthcare-wins-illinois-medicaid-contract.md 2026-06-25 https://biopharmsignal.com/news/AEMD/aethlon-medical-announces-fiscal-year-end-march-31-2026-financial-results-and-corporate-update.md 2026-06-25 https://biopharmsignal.com/news/HUMA/humacyte-atev-met-superiority-primary-endpoint-compared-to-standard-of-care-av-fistula-in-interim-analysis-of-v012-phase-3-study-in-female-dialysis-access-patients.md 2026-06-25 https://biopharmsignal.com/news/HUMA/humacyte-inc-announces-proposed-public-offering-of-common-stock.md 2026-06-25 https://biopharmsignal.com/news/AORT/artivion-to-participate-in-the-2026-truist-securities-medtech-conference.md 2026-06-25 https://biopharmsignal.com/news/IDYA/ideaya-announces-closing-of-public-offering-including-full-exercise-of-underwriters-option-to-purchase-additional-shares.md 2026-06-25 https://biopharmsignal.com/news/PRTC/results-of-annual-general-meeting.md 2026-06-25 https://biopharmsignal.com/news/MKT/maia-biotechnology-activates-and-opens-enrollment-at-second-u-s-clinical-site-for-international-phase-2-thio-101-expansion-trial.md 2026-06-25 https://biopharmsignal.com/news/LSTA/lisata-therapeutics-announces-commencement-of-tender-offer-by-kuva-labs-inc.md 2026-06-25 https://biopharmsignal.com/news/ARTL/artelo-biosciences-presents-art26-12-human-metabolite-data-demonstrating-favorable-drug-metabolism-characteristics-associated-with-clinical-development-success.md 2026-06-25 https://biopharmsignal.com/news/PLSE/pulse-biosciences-inc-announces-planned-redemption-of-warrants.md 2026-06-25 https://biopharmsignal.com/news/TNGX/tango-therapeutics-announces-pricing-of-600-million-upsized-public-offering.md 2026-06-25 https://biopharmsignal.com/news/APLT/applied-therapeutics-announces-acceptance-of-late-breaking-abstract-for-oral-presentation-at-the-peripheral-nerve-society-2025-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/APLT/applied-therapeutics-reports-first-quarter-2025-financial-results.md 2026-06-25 https://biopharmsignal.com/news/APLT/applied-therapeutics-presents-full-12-month-clinical-results-and-new-topline-data-from-inspire-phase-2-3-trial-of-govorestat-in-cmt-sord-in-late-breaking-oral-presentation-at-the-peripheral-nerve-society-2025-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/APLT/applied-therapeutics-announces-key-leadership-appointments.md 2026-06-25 https://biopharmsignal.com/news/APLT/applied-therapeutics-reports-second-quarter-2025-financial-results.md 2026-06-25 https://biopharmsignal.com/news/APLT/applied-therapeutics-provides-update-following-meeting-with-fda.md 2026-06-25 https://biopharmsignal.com/news/APLT/applied-therapeutics-reports-third-quarter-2025-financial-results.md 2026-06-25 https://biopharmsignal.com/news/APLT/applied-therapeutics-announces-corporate-updates.md 2026-06-25 https://biopharmsignal.com/news/APLT/cycle-pharmaceuticals-to-acquire-applied-therapeutics.md 2026-06-25 https://biopharmsignal.com/news/APLT/applied-therapeutics-shares-letter-to-stockholders-recommending-tender-of-shares-following-offer-expiration-extension.md 2026-06-25 https://biopharmsignal.com/news/PCRX/pacira-biosciences-announces-stockholders-have-elected-all-three-of-the-company-s-director-nominees-at-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/CLLS/cellectis-receives-fda-rmat-designation-for-lasme-cel-the-first-allogeneic-car-t-therapy-in-a-pivotal-trial-for-patients-with-r-r-b-all.md 2026-06-25 https://biopharmsignal.com/news/IRIX/iridex-to-present-at-the-planet-microcap-las-vegas-2026-conference.md 2026-06-25 https://biopharmsignal.com/news/EHC/eastside-rehabilitation-hospital-now-open-in-georgia.md 2026-06-25 https://biopharmsignal.com/news/NRSN/neurosense-therapeutics-receives-japanese-patent-grant-for-primec-novel-composition.md 2026-06-25 https://biopharmsignal.com/news/CVRX/cvrx-announces-chief-financial-officer-transition.md 2026-06-25 https://biopharmsignal.com/news/TGTX/tg-therapeutics-announces-positive-topline-phase-1-data-for-subcutaneous-briumvi-in-patients-with-myasthenia-gravis-and-initiation-of-potential-registration-directed-randomized-phase-2-trial.md 2026-06-25 https://biopharmsignal.com/news/CRVS/corvus-pharmaceuticals-announces-additional-investment-in-angel-pharmaceuticals-to-advance-the-development-of-soquelitinib-in-china.md 2026-06-25 https://biopharmsignal.com/news/PSNL/personalis-enables-global-biopharma-support-with-ce-ivd-marked-specimen-collection-kits.md 2026-06-25 https://biopharmsignal.com/news/OCS/oculis-announces-first-patient-randomized-in-predict-1-registrational-trial-of-licaminlimab-advancing-precision-medicine-in-dry-eye-disease.md 2026-06-25 https://biopharmsignal.com/news/PRTC/puretech-founded-entity-seaport-therapeutics-reports-positive-multiple-ascending-dose-data-from-phase-1-proof-of-concept-trial-of-glyphagotm-in-healthy-volunteers.md 2026-06-25 https://biopharmsignal.com/news/GSK/gsk-enters-agreement-to-acquire-nuvalent-inc.md 2026-06-25 https://biopharmsignal.com/news/IDYA/ideaya-announces-pricing-of-300-million-offering-of-common-stock-and-pre-funded-warrants.md 2026-06-25 https://biopharmsignal.com/news/ASND/ascendis-to-showcase-advances-in-treatment-of-rare-endocrine-diseases-at-endo-2026.md 2026-06-25 https://biopharmsignal.com/news/PRGO/perrigo-announces-leadership-transition.md 2026-06-25 https://biopharmsignal.com/news/JAGX/jaguar-health-reports-approval-of-all-proposals-at-2026-annual-meeting-of-stockholders.md 2026-06-25 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/IDYA/ideaya-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants.md 2026-06-25 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-presents-new-clinically-meaningful-response-data-on-treatment-of-tardive-dyskinesia-reinforcing-the-efficacy-of-ingrezzar-valbenazine-capsules-across-a-broad-range-of-patients.md 2026-06-25 https://biopharmsignal.com/news/TNGX/tango-therapeutics-announces-proposed-500-million-public-offering.md 2026-06-25 https://biopharmsignal.com/news/OCS/oculis-to-present-at-the-47th-annual-goldman-sachs-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/GNFT/genfit-nashnextr-powered-by-genfit-s-non-invasive-diagnostic-technology-nis4r-launched-via-labcorp-s-ondemand-offering-for-identification-of-at-risk-mash.md 2026-06-25 https://biopharmsignal.com/news/CAPR/capricor-therapeutics-to-present-at-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-presents-new-data-highlighting-functional-and-socio-emotional-improvements-with-ingrezzar-valbenazine-capsules-in-individuals-with-tardive-dyskinesia-and-intellectual-and-developmental-disabilities.md 2026-06-25 https://biopharmsignal.com/news/LQDA/liquidia-corporation-announces-inclusion-in-the-sandp-smallcap-600r-index.md 2026-06-25 https://biopharmsignal.com/news/MNOV/medicinova-receives-notice-of-allowance-for-new-patent-covering-use-of-mn-166-in-combination-with-anti-pd-1-immune-checkpoint-inhibitor-for-glioblastoma-treatment.md 2026-06-25 https://biopharmsignal.com/news/SNGX/soligenix-applying-for-vaccine-development-funding-for-bundibugyo-ebola-vaccine.md 2026-06-25 https://biopharmsignal.com/news/BMY/mariska-hargitay-partners-with-bristol-myers-squibb-for-investigating-myeloma-awareness-campaign-to-honor-her-father-20-years-after-losing-him-to-the-disease.md 2026-06-25 https://biopharmsignal.com/news/TNGX/tango-therapeutics-announces-combination-of-vopimetostat-and-daraxonrasib-demonstrated-92-objective-response-rate-in-pancreatic-cancer.md 2026-06-25 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-secures-second-commercial-payer-agreement-for-tonmyar-expanding-total-commercial-coverage-to-52-million-u-s-lives.md 2026-06-25 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-to-present-late-breaking-data-on-lorundrostat-at-the-endocrine-society-annual-meeting-endo-2026.md 2026-06-25 https://biopharmsignal.com/news/USNA/usana-s-celavive-contouring-face-and-neck-creme-named-among-canada-s-top-skincare-products.md 2026-06-25 https://biopharmsignal.com/news/LYEL/lyell-immunopharma-provides-update-on-safety-profile-of-lyl273-in-relapsed-or-refractory-metastatic-colorectal-cancer-and-amends-phase-1-trial-to-phase-1-2-expansion.md 2026-06-25 https://biopharmsignal.com/news/NRIX/nurix-therapeutics-announces-global-collaboration-with-roche-to-co-develop-and-co-commercialize-potential-best-in-class-btk-degrader-bexobrutideg-across-malignant-hematology-immunology-and-neurology.md 2026-06-25 https://biopharmsignal.com/news/LENZ/lenz-therapeutics-announces-everest-medicines-acquired-rights-to-develop-and-commercialize-vizzr-lnz100-in-greater-china.md 2026-06-25 https://biopharmsignal.com/news/CORT/corcept-presents-new-data-at-ada-improved-outcomes-in-patients-receiving-a-glp-1-with-difficult-to-control-type-2-diabetes-and-hypercortisolism-treated-with-korlymr.md 2026-06-25 https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-announces-closing-of-up-to-23-7-million-private-placement-priced-at-the-market-under-nasdaq-rules.md 2026-06-25 https://biopharmsignal.com/news/MNKD/data-at-ada-2026-highlights-key-findings-from-clinical-and-real-world-studies-of-mannkind-s-afrezzar-inhaled-insulin-across-pediatric-care-pregnancy-and-use-with-automated-insulin-delivery-aid-systems.md 2026-06-25 https://biopharmsignal.com/news/BMEA/biomea-fusion-presents-new-clinical-and-translational-data-for-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions-and-announces-expansion-of-ongoing-phase-i-bmf-650-study.md 2026-06-25 https://biopharmsignal.com/news/GPCR/structure-therapeutics-announces-publication-in-nature-medicine-highlighting-phase-2b-access-program-of-aleniglipron-for-obesity.md 2026-06-25 https://biopharmsignal.com/news/PCRX/pacira-biosciences-reminds-stockholders-to-vote-the-blue-proxy-card-for-the-election-of-the-company-s-highly-qualified-nominees-ahead-of-its-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/AMRX/amneal-announces-full-study-population-interim-phase-4-elevate-pd-results-reinforcing-previously-reported-benefits-of-crexontr-in-parkinson-s-disease.md 2026-06-25 https://biopharmsignal.com/news/FHTX/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026.md 2026-06-25 https://biopharmsignal.com/news/MCRB/seres-therapeutics-announces-two-transactions-to-strengthen-balance-sheet-reduce-on-going-lease-costs-and-extend-projected-operating-cash-runway-well-into-the-first-quarter-of-2027.md 2026-06-25 https://biopharmsignal.com/news/TPST/tempest-therapeutics-appoints-drake-richey-and-john-yee-md-mph-to-board-of-directors.md 2026-06-25 https://biopharmsignal.com/news/LYEL/lyell-immunopharma-to-present-phase-1-2-safety-and-translational-data-for-ronde-cel-in-large-b-cell-lymphoma-at-the-european-hematology-association-2026-congress.md 2026-06-25 https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-truist-securities-2026-medtech-conference-on-june-16-2026.md 2026-06-25 https://biopharmsignal.com/news/PRAX/praxis-precision-medicines-to-participate-in-goldmans-sachs-47th-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/FATE/fate-therapeutics-showcases-data-from-ft819-and-ft839-programs-at-the-european-congress-of-rheumatology-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/PNTG/the-pennant-group-and-hartford-healthcare-expand-collaboration-to-advance-home-based-care-in-connecticut.md 2026-06-25 https://biopharmsignal.com/news/MKT/maia-biotechnology-reports-strong-enrollment-and-dosing-momentum-in-pivotal-phase-3-non-small-cell-lung-cancer-trial.md 2026-06-25 https://biopharmsignal.com/news/EBS/emergent-biosolutions-supports-victoria-s-voice-foundation-s-national-naloxone-awareness-day-to-help-save-lives-from-opioid-overdose.md 2026-06-25 https://biopharmsignal.com/news/NXGL/nexgel-to-present-at-planet-microcap-conference-las-vegas-on-june-16th-18th.md 2026-06-25 https://biopharmsignal.com/news/XBIO/xenetic-biosciences-inc-announces-that-its-collaboration-partner-received-approval-from-the-israeli-ministry-of-health-to-conduct-exploratory-investigator-initiated-study-of-dnase-i-in-combination-with-anti-cd19-car-t-cells-in-large-b-cell-lymphoma.md 2026-06-25 https://biopharmsignal.com/news/RNXT/renovorx-ceo-shaun-bagai-to-present-at-the-iaccess-alpha-virtual-best-ideas-summer-investment-conference-2026-on-june-23rd.md 2026-06-25 https://biopharmsignal.com/news/AMRX/amneal-announces-u-s-fda-approval-of-romidepsin-injection-solution.md 2026-06-25 https://biopharmsignal.com/news/STSA/satsuma-pharmaceuticals-announces-presentation-of-two-clinical-program-abstracts-at-the-american-headache-society-s-68th-annual-scientific-meeting.md 2026-06-25 https://biopharmsignal.com/news/AVCO/avalon-globocare-appoints-seasoned-ai-and-finance-executive-as-chief-financial-officer.md 2026-06-25 https://biopharmsignal.com/news/ARVN/arvinas-joins-the-michael-j-fox-foundation-s-lite-and-ppmi-programs-to-advance-new-therapies-targeting-lrrk2-for-parkinson-s-disease.md 2026-06-25 https://biopharmsignal.com/news/LPCN/lipocine-inc-to-host-virtual-kol-event-highlighting-unmet-needs-in-postpartum-depression-and-the-clinical-profile-of-lpcn-1154.md 2026-06-25 https://biopharmsignal.com/news/PSTV/plus-therapeutics-announces-cap-accreditation-of-cnsider-diagnostics-clinical-laboratory.md 2026-06-25 https://biopharmsignal.com/news/TECH/bio-techne-and-refeyn-close-critical-gap-in-bispecific-antibody-and-biosimilar-characterization.md 2026-06-25 https://biopharmsignal.com/news/ANTX/an2-therapeutics-reports-positive-enabling-data-supporting-advancement-of-oral-an2-502998-to-phase-2-study-for-chronic-chagas-disease.md 2026-06-25 https://biopharmsignal.com/news/GHRS/gh-research-announces-publication-of-phase-2a-postpartum-depression-results.md 2026-06-25 https://biopharmsignal.com/news/SNDX/syndax-announces-private-placement-of-250-0-million-of-convertible-senior-notes.md 2026-06-25 https://biopharmsignal.com/news/INSM/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-06-25 https://biopharmsignal.com/news/OPCH/option-care-health-appoints-robert-okunski-as-vice-president-investor-relations.md 2026-06-25 https://biopharmsignal.com/news/BRKR/bruker-showcases-expanding-microbiology-and-infection-diagnostics-portfolio-at-asm-microbe-2026.md 2026-06-25 https://biopharmsignal.com/news/REGN/regeneron-to-highlight-progress-across-its-metabolic-disease-ophthalmology-and-rare-disease-pipelines-at-ada-and-endo.md 2026-06-25 https://biopharmsignal.com/news/ALKS/alkermes-to-present-new-data-on-alixorexton-and-lumryzr-sodium-oxybate-at-sleep-2026-highlighting-breadth-of-sleep-medicine-research.md 2026-06-25 https://biopharmsignal.com/news/USNA/usana-earns-dual-best-of-state-honors-for-product-innovation-and-development.md 2026-06-25 https://biopharmsignal.com/news/IRON/disc-medicine-launches-expanded-access-program-for-bitopertin-for-epp-patients.md 2026-06-25 https://biopharmsignal.com/news/IRON/disc-medicine-presents-updated-positive-data-from-rally-mf-phase-2-trial-in-patients-with-myelofibrosis-mf-and-anemia-at-the-2026-american-society-of-clinical-oncology-asco-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/SEER/seer-files-definitive-proxy-materials-and-mails-letter-to-stockholders.md 2026-06-25 https://biopharmsignal.com/news/MD/pediatrix-medical-group-announces-publication-of-new-research-addressing-urgent-questions-in-neonatology.md 2026-06-25 https://biopharmsignal.com/news/HLF/herbalife-named-to-three-2026-usa-today-most-trusted-brands-lists.md 2026-06-25 https://biopharmsignal.com/news/KPTI/karyopharm-to-participate-in-webcast-featuring-endometrial-cancer-key-opinion-leader-on-june-8-2026.md 2026-06-25 https://biopharmsignal.com/news/ALKS/alkermes-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/IOVA/iovance-s-amtagvir-lifileucel-granted-approval-for-the-treatment-of-advanced-melanoma-in-australia.md 2026-06-25 https://biopharmsignal.com/news/ELVN/enliven-therapeutics-to-host-webcast-conference-call-to-discuss-phase-1-elvn-001-clinical-data-being-presented-at-eha-2026-congress.md 2026-06-25 https://biopharmsignal.com/news/ALHC/alignment-healthcare-named-to-the-fortune-1000-2026-list-for-second-consecutive-year.md 2026-06-25 https://biopharmsignal.com/news/MKT/maia-biotechnology-receives-fda-clearance-to-open-u-s-enrollment-in-ongoing-phase-2-thio-101-trial-expansion.md 2026-06-25 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-to-present-new-two-year-crenessityr-crinecerfont-data-on-key-clinical-and-patient-reported-outcome-measures-at-endo-2026.md 2026-06-25 https://biopharmsignal.com/news/LIXT/lixte-biotechnology-announces-16-566-027-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-strengthening-balance-sheet-for-next-phase-of-strategic-growth.md 2026-06-25 https://biopharmsignal.com/news/INAB/in8bio-announces-publication-in-nature-communications-highlighting-advances-in-gamma-delta-t-cell-engineering-and-combination-therapies.md 2026-06-25 https://biopharmsignal.com/news/NAMS/newamsterdam-pharma-announces-upcoming-presentations-at-the-national-lipid-association-nla-2026-scientific-sessions.md 2026-06-25 https://biopharmsignal.com/news/ARQT/new-expert-consensus-provides-age-specific-guidance-for-improving-care-for-individuals-with-genital-psoriasis-published-in-the-american-journal-of-clinical-dermatology.md 2026-06-25 https://biopharmsignal.com/news/BMEA/biomea-fusion-announces-research-collaboration-with-university-of-leicester-to-evaluate-icovamenib-in-combination-with-semaglutide-in-obesity.md 2026-06-25 https://biopharmsignal.com/news/PRME/prime-medicine-to-present-at-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/CTMX/cytomx-announces-expansion-of-strategic-research-collaboration-with-regeneron-in-the-field-of-conditional-bispecific-therapeutics-for-the-treatment-of-cancer.md 2026-06-25 https://biopharmsignal.com/news/DYN/dyne-therapeutics-announces-completion-of-enrollment-in-registrational-expansion-cohort-of-achieve-trial-of-z-basivarsen-for-myotonic-dystrophy-type-1-dm1.md 2026-06-25 https://biopharmsignal.com/news/TGTX/tg-therapeutics-announces-positive-results-from-phase-1-trial-evaluating-subcutaneous-briumvir-ublituximab-xiiy.md 2026-06-25 https://biopharmsignal.com/news/CABA/cabaletta-bio-announces-new-rese-cel-data-and-development-updates-across-autoimmune-portfolio-including-encouraging-early-pc-free-lupus-findings-at-eular-2026-congress.md 2026-06-25 https://biopharmsignal.com/news/PNTG/pennant-expands-senior-living-presence-with-pleasant-hill-california-community.md 2026-06-25 https://biopharmsignal.com/news/TNYA/tenaya-therapeutics-announces-interim-data-from-mypeaktm-1-showing-treatment-of-mybpc3-associated-hcm-with-tn-201-gene-therapy-resulted-in-consistent-signs-of-cardiac-remodeling-and-reductions-in-symptoms.md 2026-06-25 https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-kinexus-worldwide-a-unified-digital-platform-to-support-home-dialysis.md 2026-06-25 https://biopharmsignal.com/news/MDNA/medicenna-s-mdna11-potential-in-earlier-line-melanoma-setting-highlighted-in-presentation-of-the-neo-cyt-trial-at-asco-2026.md 2026-06-25 https://biopharmsignal.com/news/KURA/kura-oncology-highlights-darlifarnib-s-potential-as-a-foundational-combination-platform-for-kras-mutant-cancers-and-outlines-development-strategy.md 2026-06-25 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-announces-pricing-of-150-million-underwritten-offering-of-common-stock.md 2026-06-25 https://biopharmsignal.com/news/MNKD/mannkind-enters-data-rich-development-period-with-completion-of-randomization-in-phase-1b-inflo-1-study-and-enrollment-of-first-patient-in-phase-2-inflo-2-trial-for-nintedanib-dpi-in-patients-with-ipf.md 2026-06-25 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-announces-repurchase-of-royalty-obligations-in-tanabe-license-agreement-and-concurrent-financing.md 2026-06-25 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-clinical-collaboration-with-roche-in-mtap-deleted-ras-mutant-pancreatic-cancer.md 2026-06-25 https://biopharmsignal.com/news/TNYA/tenaya-therapeutics-to-announce-new-interim-data-from-mypeaktm-1-phase-1b-2-trial-of-tn-201-for-adults-with-mybpc3-associated-hcm-on-wednesday-june-3-2026.md 2026-06-25 https://biopharmsignal.com/news/STIM/neuronetics-appoints-robert-greene-as-senior-vice-president-sales.md 2026-06-25 https://biopharmsignal.com/news/PCVX/vaxcyte-doses-first-participant-in-phase-1-study-evaluating-vax-a1-for-the-prevention-of-disease-caused-by-group-a-streptococcus-in-healthy-adults.md 2026-06-25 https://biopharmsignal.com/news/IBIO/ibio-to-participate-in-upcoming-healthcare-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/SNDX/syndax-highlights-revuforjr-revumenib-data-presented-at-asco-2026-including-an-oral-presentation-of-post-transplant-data.md 2026-06-25 https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-announces-up-to-23-6-million-private-placement-priced-at-the-market-under-nasdaq-rules.md 2026-06-25 https://biopharmsignal.com/news/BRKR/bruker-launches-new-timsmrms-mass-spectrometry-platform-for-unique-ultra-complex-mixture-applications-in-the-energy-industry.md 2026-06-25 https://biopharmsignal.com/news/KPTI/karyopharm-s-phase-3-sentry-trial-of-selinexor-plus-ruxolitinib-in-myelofibrosis-selected-for-late-breaking-oral-presentation-at-eha-2026.md 2026-06-25 https://biopharmsignal.com/news/MKT/maia-biotechnology-announces-open-market-purchases-by-ceo-and-director.md 2026-06-25 https://biopharmsignal.com/news/MOH/molina-healthcare-announces-second-quarter-2026-earnings-release-and-conference-call-dates.md 2026-06-25 https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-publication-calling-for-updated-fda-approaches-to-als-rare-diseases-and-regenerative-medicine.md 2026-06-25 https://biopharmsignal.com/news/KPTI/karyopharm-to-present-results-from-phase-3-sentry-trial-of-selinexor-plus-ruxolitinib-in-myelofibrosis-in-late-breaking-oral-presentation-at-asco-2026-with-simultaneous-publication-in-the-journal-of-clinical-oncology.md 2026-06-25 https://biopharmsignal.com/news/KURA/kura-oncology-and-kyowa-kirin-announce-publication-in-blood-of-ziftomenib-plus-venetoclax-azacitidine-combination-in-patients-with-r-r-npm1-m-aml.md 2026-06-25 https://biopharmsignal.com/news/ICCM/icecure-medical-announces-1-for-30-reverse-share-split-to-support-nasdaq-compliance.md 2026-06-25 https://biopharmsignal.com/news/STIM/neuronetics-highlights-continued-advancements-in-tms-research-at-ctmss-2026.md 2026-06-25 https://biopharmsignal.com/news/ACHV/achieve-life-sciences-appoints-jeffrey-farrow-and-reid-waldman-md-to-board-of-directors.md 2026-06-25 https://biopharmsignal.com/news/CADL/candel-therapeutics-announces-publication-in-the-lancet-oncology-of-pivotal-phase-3-data-demonstrating-significant-improvement-in-disease-free-survival-with-aglatimagene-besadenovec-can-2409-in-localized-prostate-cancer.md 2026-06-25 https://biopharmsignal.com/news/URGN/urogen-announces-agreement-resolving-patent-litigation-relating-to-jelmytor-mitomycin-for-pyelocalyceal-solution.md 2026-06-25 https://biopharmsignal.com/news/TCMD/tactile-medical-launches-next-generation-afflovestr-airway-clearance-therapy.md 2026-06-25 https://biopharmsignal.com/news/ALHC/alignment-healthcare-shows-how-earlier-coordinated-care-leads-to-better-health-and-fewer-emergencies-in-2025-impact-report.md 2026-06-25 https://biopharmsignal.com/news/PROK/prokidney-appoints-kenneth-locke-as-chief-technical-officer.md 2026-06-25 https://biopharmsignal.com/news/BMY/izalontamab-brengitecan-iza-bren-demonstrates-statistically-significant-and-clinically-meaningful-improvements-in-overall-survival-and-progression-free-survival-in-patients-with-triple-negative-breast-cancer-and-esophageal-squamous-cell-carcinoma.md 2026-06-25 https://biopharmsignal.com/news/ENLV/enlivex-to-present-quality-longevity-model-powered-by-prediction-markets-treasury-at-proof-of-talk-2026.md 2026-06-25 https://biopharmsignal.com/news/AEMD/aethlon-medical-to-release-fiscal-year-end-financial-results-and-host-conference-call-on-june-10-2026.md 2026-06-25 https://biopharmsignal.com/news/BIAF/multidisciplinary-physician-panel-to-share-real-world-benefits-of-bioaffinity-technologies-noninvasive-cypath-lung-cancer-test-in-upcoming-society-for-advanced-bronchoscopy-webinar.md 2026-06-25 https://biopharmsignal.com/news/BFRG/bullfrog-ai-announces-new-commercial-leadership-team-to-execute-growth-strategy-for-its-integrated-pharma-ai-platform.md 2026-06-25 https://biopharmsignal.com/news/AVAH/aveanna-healthcare-holdings-completes-acquisition-of-family-first-homecare-and-updates-full-year-2026-guidance.md 2026-06-25 https://biopharmsignal.com/news/IART/integra-lifesciences-to-present-at-the-2026-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-to-participate-in-upcoming-june-2026-events.md 2026-06-25 https://biopharmsignal.com/news/TGTX/tg-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/HLF/herbalife-chief-financial-officer-to-present-at-east-coast-ideas-conference-on-june-11.md 2026-06-25 https://biopharmsignal.com/news/KTTA/pasithea-therapeutics-announces-orphan-drug-designation-by-fda-of-pas-004-for-treatment-of-amyotrophic-lateral-sclerosis-als.md 2026-06-25 https://biopharmsignal.com/news/IBIO/ibio-becomes-a-clinical-stage-company-with-first-participant-dosed-in-phase-1-clinical-trial-of-ibio-600-in-adults-with-obesity.md 2026-06-25 https://biopharmsignal.com/news/BEAT/heartbeam-announces-new-peer-reviewed-article-demonstrating-potential-to-help-identify-heart-attack-risk-at-home.md 2026-06-25 https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-and-argonaut-manufacturing-services-announce-strategic-partnership.md 2026-06-25 https://biopharmsignal.com/news/PSNL/personalis-highlights-early-colorectal-cancer-recurrence-detection-and-ultrasensitive-mrd-performance-across-a-broad-set-of-tumor-types-at-asco-2026.md 2026-06-25 https://biopharmsignal.com/news/MESO/asx-ceo-connect-presentation.md 2026-06-25 https://biopharmsignal.com/news/FLGT/fulgent-presents-updated-fid-007-data-at-asco-2026.md 2026-06-25 https://biopharmsignal.com/news/EMBC/embecta-to-participate-in-investor-events.md 2026-06-25 https://biopharmsignal.com/news/PCRX/pacira-biosciences-highlights-leading-independent-proxy-advisory-firm-iss-recommendation-to-vote-for-all-of-pacira-s-director-nominees.md 2026-06-25 https://biopharmsignal.com/news/SRPT/sarepta-therapeutics-to-participate-in-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/PRAX/praxis-precision-medicines-provides-vormatrigine-program-update.md 2026-06-25 https://biopharmsignal.com/news/URGN/urogen-pharma-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/NERV/minerva-neurosciences-establishes-scientific-advisory-board-to-advance-development-of-roluperidone-and-future-pipeline-programs.md 2026-06-25 https://biopharmsignal.com/news/SERA/sera-prognostics-announces-board-transition.md 2026-06-25 https://biopharmsignal.com/news/KPTI/karyopharm-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4.md 2026-06-25 https://biopharmsignal.com/news/LUNG/pulmonx-corporation-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-06-25 https://biopharmsignal.com/news/IBRX/immunitybio-presents-new-clinical-and-comparative-data-across-lung-and-bladder-cancer-at-asco-2026.md 2026-06-25 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-and-servier-provide-complete-data-from-phase-2-3-registrational-optimum-02-trial-of-the-darovasertib-combination-in-first-line-hla-a2-01-negative-metastatic-uveal-melanoma-in-a-late-breaking-oral-presentation-at-asco.md 2026-06-25 https://biopharmsignal.com/news/FATE/fate-therapeutics-showcases-clinical-data-for-ft836-at-the-american-society-of-cancer-oncology-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/XBIO/xenetic-biosciences-showcases-compelling-asco-2026-data-demonstrating-dnase-i-significantly-enhances-car-t-cell-persistence-tumor-control-and-survival.md 2026-06-25 https://biopharmsignal.com/news/XGN/exagen-announces-publication-of-systematic-review-confirming-robust-real-world-performance-of-avise-lupus.md 2026-06-25 https://biopharmsignal.com/news/LIXT/lixte-biotechnology-announces-strategic-transformation-into-ai-energy-infrastructure-equipment-and-services-stuart-d-porter-founder-of-denham-capital-to-join-board-of-directors.md 2026-06-25 https://biopharmsignal.com/news/OTLK/outlook-therapeutics-announces-resubmission-of-biologics-license-application-to-u-s-fda-for-ons-5010-lytenavatm-bevacizumab-vikg.md 2026-06-25 https://biopharmsignal.com/news/INAB/in8bio-presents-updated-overall-survival-data-surpassing-19-5-months-for-deltex-dri-in-newly-diagnosed-glioblastoma-at-asco-2026.md 2026-06-25 https://biopharmsignal.com/news/PYPD/polypid-completes-new-drug-application-submission-to-fda-for-d-plex.md 2026-06-25 https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-presents-flamingo-01-phase-iii-trial-open-label-data-published-at-asco-meeting-2026.md 2026-06-25 https://biopharmsignal.com/news/CRL/charles-river-laboratories-to-present-at-william-blair-and-jefferies-conferences.md 2026-06-25 https://biopharmsignal.com/news/AMRX/amneal-to-participate-in-goldman-sachs-47th-annual-global-healthcare-conference-2026.md 2026-06-25 https://biopharmsignal.com/news/CLRB/cellectar-biosciences-to-highlight-compelling-new-efficacy-data-from-phase-2b-clover-wam-study-of-iopofosine-i-131-in-r-r-waldenstroem-macroglobulinemia-at-the-american-society-of-clinical-oncology-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/APRE/aprea-therapeutics-presents-updated-phase-1-data-on-wee1-inhibitor-apr-1051-at-asco-2026-demonstrating-early-monotherapy-activity-and-manageable-tolerability-in-advanced-solid-tumors.md 2026-06-25 https://biopharmsignal.com/news/NCNA/nucana-appoints-ian-webster-as-chief-financial-officer.md 2026-06-25 https://biopharmsignal.com/news/RLYB/rallybio-corporation-and-avenzo-therapeutics-announce-merger-agreement-to-advance-next-generation-oncology-therapies-and-215-million-concurrent-private-placement.md 2026-06-25 https://biopharmsignal.com/news/ALXO/alx-oncology-to-present-at-the-2026-jefferies-global-healthcare-conference-in-new-york.md 2026-06-25 https://biopharmsignal.com/news/BTMD/biote-appoints-komal-bajaj-md-ms-as-chief-medical-officer.md 2026-06-25 https://biopharmsignal.com/news/LYEL/lyell-immunopharma-announces-participation-in-goldman-sachs-47th-annual-global-healthcare-conference-2026.md 2026-06-25 https://biopharmsignal.com/news/IMTX/immatics-presents-clinical-activity-and-response-dynamics-of-anzu-cel-prame-cell-therapy-at-2026-asco-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/ENLV/allocetra-shows-durable-6-month-efficacy-in-knee-osteoarthritis-phase-iia-trial-oral-presentation-at-eular-2026.md 2026-06-25 https://biopharmsignal.com/news/MKT/maia-biotechnology-presents-trial-in-progress-poster-for-pivotal-phase-3-clinical-trial-of-novel-telomere-targeting-agent-at-2026-annual-meeting-of-american-society-of-clinical-oncology.md 2026-06-25 https://biopharmsignal.com/news/NTLA/intellia-therapeutics-to-report-additional-phase-3-haelo-data-for-lonvoguran-ziclumeran-lonvo-z-in-late-breaking-oral-presentation-at-eaaci-2026.md 2026-06-25 https://biopharmsignal.com/news/TGTX/tg-therapeutics-announces-publication-of-post-hoc-data-from-the-phase-3-ultimate-i-and-ii-trials-in-treatment-naive-patients-with-relapsing-forms-of-ms-published-in-frontiers-in-immunology.md 2026-06-25 https://biopharmsignal.com/news/IOVA/iovance-biotherapeutics-announces-clearance-of-investigational-new-drug-ind-application-for-il-12-tethered-til-therapy-iov-5001.md 2026-06-25 https://biopharmsignal.com/news/IMRX/immuneering-presents-compelling-17-3-month-median-overall-survival-and-favorable-tolerability-with-atebimetinib-chemotherapy-in-first-line-pancreatic-cancer-patients-at-asco.md 2026-06-25 https://biopharmsignal.com/news/KPTI/karyopharm-to-host-investor-conference-call-featuring-expert-perspectives-on-the-phase-3-sentry-trial-in-myelofibrosis-following-2026-asco-presentation.md 2026-06-25 https://biopharmsignal.com/news/USNA/kevin-guest-encourages-professionals-to-prioritize-wellness-during-professional-wellness-month.md 2026-06-25 https://biopharmsignal.com/news/SNDX/syndax-to-host-randd-day-highlighting-its-late-stage-programs-and-early-stage-assets-on-july-14-2026.md 2026-06-25 https://biopharmsignal.com/news/OPCH/option-care-health-awarded-time-s-world-s-most-impactful-companies-2026-ranking.md 2026-06-25 https://biopharmsignal.com/news/BRKR/bruker-announces-major-strides-in-4d-proteomics-performance-further-advances-in-intact-and-top-down-functional-proteoform-analysis-and-innovations-in-hybrid-qual-quant-4d-metabolomics-all-to-enable-deeper-insights-into-disease-biology.md 2026-06-25 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-announces-opdivor-nivolumab-in-combination-with-avd-receives-expanded-eu-label-with-approval-in-frontline-advanced-classical-hodgkin-lymphoma.md 2026-06-25 https://biopharmsignal.com/news/BMY/u-s-food-and-drug-administration-accepts-for-priority-review-bristol-myers-squibb-s-supplemental-new-drug-application-for-camzyos-mavacamten-to-treat-adolescents-with-symptomatic-obstructive-hypertrophic-cardiomyopathy-ohcm.md 2026-06-25 https://biopharmsignal.com/news/MNPR/monopar-presents-phase-2-alxn1840-data-demonstrating-liver-disease-stabilization-and-neurologic-improvement-in-treatment-experienced-wilson-disease-patients-at-easl-2026.md 2026-06-25 https://biopharmsignal.com/news/YOU/concierge-powered-by-clear-launched-at-mia-to-elevate-travel-experiences-at-florida-s-busiest-airport-for-international-passengers.md 2026-06-25 https://biopharmsignal.com/news/IMTX/immatics-presents-data-on-ima401-magea4-8-bispecific-at-2026-asco-annual-meeting-with-simultaneous-publication-in-nature-medicine-supporting-development-of-ima401-ima402-combination-in-lung-cancer.md 2026-06-25 https://biopharmsignal.com/news/RVMD/revolution-medicines-announces-asco-plenary-presentation-highlighting-unprecedented-results-from-pivotal-phase-3-rasolute-302-clinical-trial-of-daraxonrasib-in-previously-treated-metastatic-pancreatic-cancer.md 2026-06-25 https://biopharmsignal.com/news/REPL/replimune-presents-final-first-in-human-data-for-rp2-in-advanced-solid-tumors-during-oral-presentation-at-the-2026-american-society-of-clinical-oncology-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/IMCR/immunocore-presents-updated-phase-1-data-of-brenetafusp-in-patients-with-heavily-pretreated-advanced-melanoma.md 2026-06-25 https://biopharmsignal.com/news/BMY/global-data-for-biontech-and-bristol-myers-squibb-s-pd-l1xvegf-a-bispecific-pumitamig-shows-encouraging-efficacy-in-patients-with-non-small-cell-lung-cancer-in-rosetta-lung-02-trial.md 2026-06-25 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-presents-new-data-from-the-phase-3-launch-htn-trial-of-lorundrostat-in-participants-with-hypertension-and-chronic-kidney-disease-at-european-meeting-on-hypertension-and-cardiovascular-protection-esh-2026.md 2026-06-25 https://biopharmsignal.com/news/EXEL/exelixis-announces-results-from-subgroup-analysis-of-phase-3-cabinet-pivotal-trial-evaluating-cabometyxr-cabozantinib-in-non-functional-and-functional-neuroendocrine-tumors-at-asco-2026.md 2026-06-25 https://biopharmsignal.com/news/IMTX/immatics-presents-clinical-activity-of-ima203cd8-prame-cell-therapy-in-hard-to-treat-gynecologic-cancers-at-2026-asco-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/COGT/cogent-biosciences-announces-detailed-clinical-data-from-peak-phase-3-trial-with-bezuclastinib-in-combination-with-sunitinib-in-gastrointestinal-stromal-tumors-gist-at-2026-american-society-of-clinical-oncology-asco-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/REPL/replimune-presents-3-year-landmark-overall-survival-analysis-from-ignyte-clinical-trial-during-oral-presentation-at-the-2026-american-society-of-clinical-oncology-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/EBS/emergent-biosolutions-receives-64-5-million-contract-modification-for-batr-botulism-antitoxin-heptavalent-a-b-c-d-e-f-g-equine-to-support-u-s-biodefense-strategy.md 2026-06-25 https://biopharmsignal.com/news/CORT/corcept-presents-new-data-at-asco-2026-lifyorlitm-overall-survival-across-all-subgroups-of-patients-with-platinum-resistant-ovarian-cancer-including-those-with-recent-taxane-exposure.md 2026-06-25 https://biopharmsignal.com/news/ARVN/arvinas-to-present-at-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/KNSA/kiniksa-pharmaceuticals-to-present-at-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/OCS/oculis-announces-topline-results-from-diamond-phase-3-trials-with-ocs-01-in-diabetic-macular-edema.md 2026-06-25 https://biopharmsignal.com/news/MNKD/mannkind-to-host-conference-call-today-to-discuss-afrezza-pediatric-approval.md 2026-06-25 https://biopharmsignal.com/news/MNKD/mannkind-announces-fda-approval-of-afrezzar-the-first-and-only-inhaled-mealtime-insulin-for-use-in-children-and-adolescents-aged-6-and-older-living-with-diabetes.md 2026-06-25 https://biopharmsignal.com/news/EHC/encompass-health-to-build-36-bed-inpatient-rehabilitation-hospital-in-bridgeport-west-virginia.md 2026-06-25 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-announces-celmod-mezigdomide-reduces-risk-of-disease-progression-or-death-by-more-than-50-vs-standard-of-care-in-relapsed-or-refractory-multiple-myeloma.md 2026-06-25 https://biopharmsignal.com/news/TPST/tempest-therapeutics-announces-warrant-exercise-for-approximately-2-million-in-gross-proceeds.md 2026-06-25 https://biopharmsignal.com/news/SABS/sab-bio-to-present-data-on-sab-142-at-the-american-diabetes-association-s-2026-scientific-sessions-and-focis-2026-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/TNYA/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026.md 2026-06-25 https://biopharmsignal.com/news/REPL/replimune-announces-planned-rp1-bla-resubmission-following-productive-discussion-with-fda.md 2026-06-25 https://biopharmsignal.com/news/ADPT/at-asco-and-eha-2026-new-data-reinforce-the-pivotal-role-of-clonoseqr-mrd-testing-across-hematology-clinical-practice-and-research.md 2026-06-25 https://biopharmsignal.com/news/SEER/seer-files-itc-complaint-against-nanomics.md 2026-06-25 https://biopharmsignal.com/news/CAPR/capricor-therapeutics-expands-commercial-leadership-team.md 2026-06-25 https://biopharmsignal.com/news/ALLO/allogene-therapeutics-announces-planned-ceo-succession.md 2026-06-25 https://biopharmsignal.com/news/ISRG/intuitive-announces-new-chief-commercial-and-marketing-officer-taylor-patton.md 2026-06-25 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-presented-retrospective-u-s-real-world-claims-analysis-of-opioid-use-in-patients-with-fibromyalgia-at-the-2026-american-society-of-clinical-psychopharmacology-ascp-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/PCRX/leading-independent-proxy-advisory-firm-glass-lewis-recommends-stockholders-vote-for-all-of-pacira-s-director-nominees.md 2026-06-25 https://biopharmsignal.com/news/ASMB/assembly-biosciences-announces-upcoming-investor-conference-presentations.md 2026-06-25 https://biopharmsignal.com/news/OTLK/outlook-therapeutics-announces-pricing-of-5-0-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules.md 2026-06-25 https://biopharmsignal.com/news/REGN/regeneron-s-ebola-antibody-recommended-by-world-health-organization-for-investigational-use-in-response-to-current-bundibugyo-ebolavirus-outbreak.md 2026-06-25 https://biopharmsignal.com/news/ANGO/angiodynamics-expands-patient-access-to-nanoknife-ire-for-prostate-and-liver-cancer-as-medicare-coverage-framework-takes-effect.md 2026-06-25 https://biopharmsignal.com/news/JAGX/jaguar-health-research-in-ethnobotanical-medicine-helps-advance-crofelemer-development-for-genetically-defined-rare-congenital-gastrointestinal-disorders.md 2026-06-25 https://biopharmsignal.com/news/MDNA/medicenna-announces-closing-of-public-offering-of-units-raising-cdn-4-44-million-to-support-lead-programs.md 2026-06-25 https://biopharmsignal.com/news/BTMD/biote-names-bob-peterson-current-chief-financial-and-chief-business-officer-as-interim-ceo.md 2026-06-25 https://biopharmsignal.com/news/PGNY/new-progyny-study-shows-growing-demand-for-human-guidance-in-an-increasingly-digital-healthcare-system.md 2026-06-25 https://biopharmsignal.com/news/VANI/vivani-medical-ceo-adam-mendelsohn-to-present-at-the-jefferies-global-healthcare-conference-on-june-4-2026.md 2026-06-25 https://biopharmsignal.com/news/RNXT/renovorx-announces-fda-orphan-drug-designation-granted-oxaliplatin-for-the-treatment-of-pancreatic-cancer.md 2026-06-25 https://biopharmsignal.com/news/VRCA/verrica-to-participate-in-the-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/APVO/aptevo-therapeutics-appoints-mary-j-janatpour-ph-d-as-senior-vice-president-and-chief-scientific-officer.md 2026-06-25 https://biopharmsignal.com/news/AVAH/aveanna-healthcare-announces-successful-debt-repricing.md 2026-06-25 https://biopharmsignal.com/news/BNGO/bionano-announces-full-retirement-of-outstanding-senior-secured-convertible-debentures.md 2026-06-25 https://biopharmsignal.com/news/DSGN/design-therapeutics-to-participate-in-2026-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/COGT/cogent-biosciences-announces-fda-acceptance-of-new-drug-application-nda-with-priority-review-for-bezuclastinib-in-combination-with-sunitinib-for-patients-with-gist.md 2026-06-25 https://biopharmsignal.com/news/NAMS/newamsterdam-pharma-to-participate-at-upcoming-investor-conferences-in-june.md 2026-06-25 https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-participate-in-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-rain-holdings-valued-at-approximately-1-16-billion-rain-foundation-appoints-industry-leaders-to-advisory-board.md 2026-06-25 https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-appoints-former-fda-associate-commissioner-peter-j-pitts-to-board-of-directors.md 2026-06-25 https://biopharmsignal.com/news/TGTX/tg-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/KPTI/karyopharm-to-participate-at-the-2026-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/ENTA/enanta-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/FMS/fresenius-medical-care-highlights-new-renal-research-and-innovation-at-era-congress-2026.md 2026-06-25 https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-first-tranche-of-its-share-buyback-program-of-up-to-eur-600-million.md 2026-06-25 https://biopharmsignal.com/news/RLMD/relmada-therapeutics-to-present-at-the-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/BTAI/bioxcel-therapeutics-presents-new-data-from-serenity-at-home-phase-3-trial-for-agitation-associated-with-bipolar-disorders-or-schizophrenia-at-2026-ascp-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/KALV/kalvista-pharmaceuticals-presents-new-data-highlighting-the-burden-of-injectable-on-demand-treatment-in-young-children-with-hereditary-angioedema.md 2026-06-25 https://biopharmsignal.com/news/GSK/bepirovirsen-achieves-unprecedented-functional-cure-rates-with-potential-to-redefine-treatment-for-chronic-hepatitis-b.md 2026-06-25 https://biopharmsignal.com/news/PRI/primerica-household-budget-indextm-hbitm-rising-gas-prices-limit-purchasing-power-of-middle-income-americans-in-april.md 2026-06-25 https://biopharmsignal.com/news/NKTR/nektar-therapeutics-to-participate-in-the-2026-jefferies-global-healthcare-conference-in-new-york.md 2026-06-25 https://biopharmsignal.com/news/DMAC/diamedica-therapeutics-to-present-at-the-jefferies-global-healthcare-conference-2026.md 2026-06-25 https://biopharmsignal.com/news/CVRX/cvrx-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-participate-in-june-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/CLPT/clearpoint-neuro-enters-into-10-year-focused-ultrasound-development-partnership-with-sungkyunkwan-university-south-korea-further-expanding-our-drug-delivery-ecosystem-and-global-footprint.md 2026-06-25 https://biopharmsignal.com/news/PCRX/pacira-biosciences-mails-letter-to-stockholders-reiterating-confidence-in-the-company-s-strategic-direction-and-highly-qualified-nominees.md 2026-06-25 https://biopharmsignal.com/news/ORIC/oricr-pharmaceuticals-to-participate-in-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/CRBU/caribou-biosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/PLSE/pulse-biosciences-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-2026.md 2026-06-25 https://biopharmsignal.com/news/SANA/sana-biotechnology-to-present-at-june-2026-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/EXEL/exelixis-to-webcast-fireside-chats-as-part-of-upcoming-investor-conferences-in-june.md 2026-06-25 https://biopharmsignal.com/news/MNKD/mannkind-to-present-at-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/ATRC/atricure-to-participate-in-the-goldman-sachs-47th-annual-global-health-care-conference.md 2026-06-25 https://biopharmsignal.com/news/IRWD/fda-approves-use-of-linzessr-linaclotide-in-pediatric-patients-two-years-of-age-and-older-with-functional-constipation-fc.md 2026-06-25 https://biopharmsignal.com/news/JAGX/jaguar-health-compliant-with-nasdaq-bid-price-rule.md 2026-06-25 https://biopharmsignal.com/news/MNKD/mannkind-to-showcase-new-data-at-ada-2026-advancing-understanding-of-inhaled-insulin-afrezzar-in-pediatric-care-pregnancy-and-use-with-automated-insulin-delivery-aid-systems.md 2026-06-25 https://biopharmsignal.com/news/GDRX/goodrx-launches-goodrx-companion-a-new-subscription-designed-to-lower-everyday-healthcare-costs.md 2026-06-25 https://biopharmsignal.com/news/PRVA/privia-health-enters-new-jersey.md 2026-06-25 https://biopharmsignal.com/news/ANGO/angiodynamics-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/RIGL/rigel-to-present-at-the-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/ANNX/annexon-to-participate-in-upcoming-june-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/COGT/cogent-biosciences-announces-participation-in-the-2026-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/PCRX/pacira-biosciences-reports-real-world-study-showing-exparelr-use-was-associated-with-reduced-opioid-use-and-healthcare-costs-in-patients-undergoing-total-shoulder-arthroplasty.md 2026-06-25 https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-rain-protocol-jumps-into-top-three-global-prediction-markets-in-league-table-following-100m-in-additional-liquidity.md 2026-06-25 https://biopharmsignal.com/news/CORT/corcept-to-resubmit-its-new-drug-application-for-relacorilant-as-a-treatment-for-patients-with-cushing-s-syndrome.md 2026-06-25 https://biopharmsignal.com/news/APVO/aptevo-and-niowave-launch-strategic-collaboration-for-radiopharmaceutical-therapeutic-development-includes-strategic-equity-investment-by-niowave-at-closing.md 2026-06-25 https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-announces-notification-of-mexico-patent-allowance-covering-novel-lung-cancer-detection-methods-using-cypathr-lung-technology.md 2026-06-25 https://biopharmsignal.com/news/ERAS/erasca-to-present-at-the-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/TWST/twist-bioscience-to-present-at-william-blair-46th-annual-growth-stock-conference.md 2026-06-25 https://biopharmsignal.com/news/TGTX/tg-therapeutics-announces-positive-topline-results-from-phase-3-enhance-trial.md 2026-06-25 https://biopharmsignal.com/news/CNTX/context-therapeutics-to-present-at-the-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-announces-publication-of-phase-1-clinical-data-of-tnx-1500-an-fc-modified-anti-cd40l-cd154-monoclonal-antibody-in-the-peer-reviewed-journal-of-clinical-immunology.md 2026-06-25 https://biopharmsignal.com/news/AVIR/atea-pharmaceuticals-presents-new-drug-drug-interaction-results-supporting-potential-best-in-class-profile-of-the-regimen-of-bemnifosbuvir-and-ruzasvir-for-the-treatment-of-hepatitis-c-virus-at-easl-congress-2026.md 2026-06-25 https://biopharmsignal.com/news/BCRX/biocryst-to-present-new-hae-data-from-orladeyor-berotralstat-and-navenibart-at-the-2026-european-academy-of-allergy-and-clinical-immunology-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/INSM/insmed-to-present-at-the-2026-goldman-sachs-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-presents-new-clinical-data-on-rnai-based-obesity-and-mash-candidate-aro-inhbe-at-easl-2026.md 2026-06-25 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/ALGS/aligos-therapeutics-presents-positive-data-at-the-easl-congress-2026.md 2026-06-25 https://biopharmsignal.com/news/DTIL/precision-biosciences-announces-new-and-late-breaking-pbgene-hbv-clinical-data-from-the-eliminate-b-study-at-european-association-for-the-study-of-the-liver-congress-2026.md 2026-06-25 https://biopharmsignal.com/news/MNOV/medicinova-announces-completion-of-last-patient-last-visit-in-the-mn-001-natg-202-clinical-trial-of-mn-001-tipelukast.md 2026-06-25 https://biopharmsignal.com/news/GPCR/structure-therapeutics-announces-participation-in-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/MDRX/veradigm-files-2023-and-2024-form-10-k.md 2026-06-25 https://biopharmsignal.com/news/ASMB/assembly-biosciences-announces-the-closing-of-its-offering-of-common-stock-and-pre-funded-warrants-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares.md 2026-06-25 https://biopharmsignal.com/news/DCTH/delcath-systems-announces-two-asco-2026-investigator-initiated-trials-in-progress-abstracts.md 2026-06-25 https://biopharmsignal.com/news/SEER/seer-to-showcase-ai-driven-multi-cancer-screening-approach-and-next-generation-proteomics-capabilities-at-asms-2026.md 2026-06-25 https://biopharmsignal.com/news/ARQT/arcutis-management-to-present-at-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-to-present-at-upcoming-investor-conferences-in-june.md 2026-06-25 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-presents-new-positive-clinical-cardiometabolic-data-at-the-94th-european-atherosclerosis-society-eas-congress.md 2026-06-25 https://biopharmsignal.com/news/SRRK/scholar-rock-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/GSK/gsk-to-showcase-long-term-outcomes-and-pipeline-expansion-with-latest-oncology-research-at-asco-and-eha.md 2026-06-25 https://biopharmsignal.com/news/RNXT/renovorx-announces-promising-pharmacokinetic-data-using-the-tamptm-platform-presented-at-the-2026-asco-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/ABEO/abeona-therapeuticsr-announces-participation-in-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/ALLO/allogene-therapeutics-announces-participation-in-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-oppenheimer-26th-annual-consumer-growth-and-e-commerce-conference.md 2026-06-25 https://biopharmsignal.com/news/HYPR/hyperfine-to-join-russell-2000r-and-russell-3000r-indexes.md 2026-06-25 https://biopharmsignal.com/news/HUMA/humacyte-announces-presentation-at-vasa-meeting-of-research-highlighting-self-repair-of-atev-after-cannulation-for-dialysis-access.md 2026-06-25 https://biopharmsignal.com/news/MDRX/veradigm-to-release-business-update-may-26th-and-host-investor-call-may-27th.md 2026-06-25 https://biopharmsignal.com/news/PCRX/pacira-biosciences-sets-the-record-straight-regarding-doma-s-misleading-statements-about-pacira-s-intellectual-property-strategy.md 2026-06-25 https://biopharmsignal.com/news/PGNY/progyny-inc-announces-share-repurchase-program.md 2026-06-25 https://biopharmsignal.com/news/YOU/clear-partners-with-samsung-bringing-clear-id-to-samsung-wallet.md 2026-06-25 https://biopharmsignal.com/news/LENZ/lenz-therapeutics-to-participate-in-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/ESPR/esperion-presents-new-data-from-clear-outcomes-and-the-clear-path-phase-2-pediatric-study-at-the-european-atherosclerosis-society-congress-2026.md 2026-06-25 https://biopharmsignal.com/news/RANI/rani-therapeutics-holdings-inc-announces-pricing-of-20-0-million-registered-direct-offering-of-class-a-common-stock-priced-at-the-market-under-nasdaq-rules.md 2026-06-25 https://biopharmsignal.com/news/BNGO/bionano-announces-largest-ogm-study-of-t-cell-acute-lymphoblastic-leukemia.md 2026-06-25 https://biopharmsignal.com/news/DYN/dyne-therapeutics-announces-submission-of-biologics-license-application-bla-to-u-s-fda-for-z-rostudirsen-in-exon-51-duchenne-muscular-dystrophy-dmd.md 2026-06-25 https://biopharmsignal.com/news/TGTX/tg-therapeutics-announces-data-presentations-for-briumvir-at-the-2026-consortium-of-multiple-sclerosis-centers-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/SNGX/suitability-of-vaccine-platform-for-bundibugyo-virus-cause-of-the-ebola-outbreak-in-congo.md 2026-06-25 https://biopharmsignal.com/news/VRAX/virax-biolabs-reports-positive-early-clinical-data-for-viraximmunetm-in-long-covid-and-related-post-acute-infection-syndromes.md 2026-06-25 https://biopharmsignal.com/news/PSTV/plus-cnside-diagnostic-platform-demonstrates-substantial-healthcare-cost-reduction-in-patients-with-leptomeningeal-metastases.md 2026-06-25 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-presented-retrospective-u-s-real-world-claims-analysis-characterizing-patients-with-fibromyalgia-at-the-professional-society-for-health-economics-and-outcomes-research-ispor-2026-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/OLMA/olema-oncology-announces-clinical-trial-collaboration-and-supply-agreement-with-bayer-to-evaluate-op-3136-in-combination-with-nubeqar-darolutamide-in-metastatic-castration-resistant-prostate-cancer.md 2026-06-25 https://biopharmsignal.com/news/OTLK/outlook-therapeutics-wins-appeal-following-formal-dispute-resolution-process-for-ons-5010-lytenavatm-bevacizumab-vikg.md 2026-06-25 https://biopharmsignal.com/news/BRKR/champalimaud-foundation-s-neuroscience-and-oncology-research-benefits-from-18-tesla-ultra-high-field-mri.md 2026-06-25 https://biopharmsignal.com/news/FMS/fresenius-medical-care-announces-new-share-buyback-program-with-a-total-volume-of-around-eur-1-billion-with-phased-execution-over-12-months.md 2026-06-25 https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-reports-updated-crb-701-phase-1-2-clinical-data-demonstrating-robust-activity-in-2l-oropharyngeal-and-cervical-cancers.md 2026-06-25 https://biopharmsignal.com/news/ALKS/alkermes-to-showcase-leadership-in-psychiatry-and-orexin-biology-with-new-data-at-the-american-society-of-clinical-psychopharmacology-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/KURA/kura-oncology-reports-strong-clinical-activity-and-safety-with-darlifarnib-adagrasib-in-kras-g12c-mutated-solid-tumors.md 2026-06-25 https://biopharmsignal.com/news/PSNL/personalis-to-highlight-breadth-of-next-personalr-ultra-sensitive-ctdna-data-at-asco-2026-annual-meeting-including-podium-presentation-from-tracerx-consortium.md 2026-06-25 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-participation-at-the-2026-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/GNFT/genfit-highlights-broad-scientific-and-strategic-presence-at-easl-congress-2026.md 2026-06-25 https://biopharmsignal.com/news/IMMX/immix-biopharma-announces-closing-of-150-million-underwritten-offering-of-common-stock.md 2026-06-25 https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-receipt-of-nasdaq-notice-regarding-late-form-10-q-filing.md 2026-06-25 https://biopharmsignal.com/news/SCYX/scynexis-announces-one-for-eight-reverse-stock-split.md 2026-06-25 https://biopharmsignal.com/news/AVTX/avalo-therapeutics-announces-inducement-grant-to-new-employee-under-nasdaq-listing-rule-5635-c-4.md 2026-06-25 https://biopharmsignal.com/news/HYPR/hyperfine-announces-presentation-of-results-from-the-prime-study-showing-portable-mri-substantially-reduces-time-to-imaging-in-emergency-departments.md 2026-06-25 https://biopharmsignal.com/news/IBRX/immunitybio-highlights-patient-survey-data-at-ispor-2026-showing-majority-of-uk-adults-living-with-nmibc-favor-bladder-preservation.md 2026-06-25 https://biopharmsignal.com/news/IBRX/immunitybio-presents-health-economic-analysis-at-ispor-2026-showing-anktivar-plus-bcg-delivers-lower-cost-per-sustained-complete-response-versus-tar-200-in-bcg-unresponsive-nmibc-cis.md 2026-06-25 https://biopharmsignal.com/news/FMS/fresenius-medical-care-annual-general-meeting-strengthening-performance-and-advancing-innovation-in-kidney-care.md 2026-06-25 https://biopharmsignal.com/news/REGN/otarmenitm-lunsotogene-parvec-receives-ema-filing-acceptance-for-genetic-hearing-loss.md 2026-06-25 https://biopharmsignal.com/news/ASMB/assembly-biosciences-announces-expansion-of-abi-6250-clinical-development-into-cholestatic-liver-diseases.md 2026-06-25 https://biopharmsignal.com/news/ASMB/assembly-biosciences-announces-pricing-of-100-million-offering-of-common-stock-and-pre-funded-warrants.md 2026-06-25 https://biopharmsignal.com/news/MDNA/medicenna-announces-the-filing-of-its-prospectus-supplement-and-investment-term-sheet.md 2026-06-25 https://biopharmsignal.com/news/IPHA/outcome-of-innate-pharma-s-2026-annual-general-meeting.md 2026-06-25 https://biopharmsignal.com/news/FENC/fennec-pharmaceuticals-announces-new-research-supporting-integration-and-use-of-pedmarkr-at-the-2026-asco-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/PLRX/pliant-therapeutics-announces-upcoming-presentation-at-the-2026-american-society-of-clinical-oncology-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/BDTX/black-diamond-therapeutics-announces-positive-phase-2-results-for-silevertinib-in-frontline-nsclc-patients-with-egfr-non-classical-mutations.md 2026-06-25 https://biopharmsignal.com/news/RIGL/rigel-announces-oral-and-poster-presentations-at-the-2026-asco-annual-meeting-and-eha2026-congress.md 2026-06-25 https://biopharmsignal.com/news/FLGT/fulgent-announces-rapid-oral-full-abstract-publication-for-fid-007-within-the-head-and-neck-cancer-track-session-at-the-asco-2026-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/IMRX/immuneering-reports-17-3-months-median-overall-survival-in-first-line-metastatic-pancreatic-cancer-patients-treated-with-atebimetinib-plus-chemotherapy.md 2026-06-25 https://biopharmsignal.com/news/OLMA/olema-oncology-announces-encouraging-initial-clinical-data-from-the-phase-1-study-of-op-3136-a-kat6-inhibitor-at-2026-asco-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/SNDX/syndax-announces-four-revuforjr-revumenib-abstracts-accepted-for-asco-2026-including-an-oral-presentation-of-post-transplant-data.md 2026-06-25 https://biopharmsignal.com/news/EXEL/exelixis-announces-presentations-at-asco-2026-highlighting-ongoing-studies-in-diverse-tumor-types.md 2026-06-25 https://biopharmsignal.com/news/REGN/lynozyficr-linvoseltamab-monotherapy-demonstrates-deep-and-rapid-responses-in-all-treated-patients-with-second-line-plus-systemic-amyloid-light-chain-amyloidosis.md 2026-06-25 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-to-unveil-new-data-at-ascor-2026-demonstrating-strength-and-breadth-of-scientific-innovation-across-oncology-portfolio-and-next-generation-pipeline.md 2026-06-25 https://biopharmsignal.com/news/SEER/seer-board-of-directors-unanimously-rejects-further-revised-unsolicited-proposal-from-radoff-jec-group.md 2026-06-25 https://biopharmsignal.com/news/ELVN/enliven-therapeutics-to-present-at-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/RVMD/revolution-medicines-to-host-investor-conference-call-on-positive-rasolute-302-results-following-2026-asco-presentation.md 2026-06-25 https://biopharmsignal.com/news/AZTA/azenta-publishes-2025-environmental-social-and-governance-esg-report.md 2026-06-25 https://biopharmsignal.com/news/GNFT/genfit-reports-first-quarter-2026-financial-information-and-provides-a-corporate-update.md 2026-06-25 https://biopharmsignal.com/news/ISRG/intuitive-announces-innovations-to-advance-quintuple-aim.md 2026-06-25 https://biopharmsignal.com/news/MDXG/mimedx-to-participate-in-craig-hallum-23rd-annual-institutional-investor-conference.md 2026-06-25 https://biopharmsignal.com/news/FATE/fate-therapeutics-announces-presentations-at-2026-asco-and-eular-annual-meetings-highlighting-off-the-shelf-car-t-cell-therapy-pipeline-for-cancer-and-autoimmune-diseases.md 2026-06-25 https://biopharmsignal.com/news/IOVA/iovance-biotherapeutics-to-present-at-upcoming-conference.md 2026-06-25 https://biopharmsignal.com/news/AEMD/aethlon-medical-monitoring-current-ebola-outbreak-and-reaffirms-outbreak-pandemic-preparedness.md 2026-06-25 https://biopharmsignal.com/news/CTMX/cytomx-therapeutics-to-present-at-upcoming-june-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-announces-the-appointment-of-nishant-saxena-as-chief-business-officer-and-schedules-a-pre-2026-asco-crb-701-data-conference-call.md 2026-06-25 https://biopharmsignal.com/news/ACRV/acrivon-therapeutics-to-present-at-td-cowen-s-7th-annual-oncology-innovation-summit.md 2026-06-25 https://biopharmsignal.com/news/FMS/fresenius-medical-care-reappoints-chief-financial-officer-martin-fischer.md 2026-06-25 https://biopharmsignal.com/news/ALKS/alkermes-showcases-data-from-psychiatry-portfolio-and-sleep-research-into-real-world-patient-experience-at-spring-2026-scientific-conferences.md 2026-06-25 https://biopharmsignal.com/news/DTIL/precision-biosciences-to-host-investor-webcast-to-discuss-late-breaking-pbgene-hbv-data-from-eliminate-b-trial-presented-at-european-association-for-the-study-of-the-liver-congress-2026.md 2026-06-25 https://biopharmsignal.com/news/ANTX/an2-therapeutics-to-present-at-2026-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/PEPG/pepgen-announces-presentations-at-the-15th-international-myotonic-dystrophy-consortium-highlighting-clinical-data-from-the-pgn-edodm1-program.md 2026-06-25 https://biopharmsignal.com/news/BDX/bd-delivers-kidney-stone-care-for-urology-teams-with-the-elyratm-thulium-fiber-laser-system.md 2026-06-25 https://biopharmsignal.com/news/IMMX/immix-biopharma-announces-pricing-of-150-million-underwritten-offering-of-common-stock.md 2026-06-25 https://biopharmsignal.com/news/IMMX/immix-biopharma-announces-95-complete-response-rate-in-interim-update-from-relapsed-refractory-al-amyloidosis-clinical-trial-nexicart-2.md 2026-06-25 https://biopharmsignal.com/news/JAGX/jaguar-health-reports-first-quarter-2026-financials.md 2026-06-25 https://biopharmsignal.com/news/CLLS/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026.md 2026-06-25 https://biopharmsignal.com/news/CVRX/cvrx-to-present-at-the-william-blair-46th-annual-growth-stock-conference.md 2026-06-25 https://biopharmsignal.com/news/TCMD/tactile-medical-to-present-at-the-william-blair-46th-annual-growth-stock-conference.md 2026-06-25 https://biopharmsignal.com/news/CRVS/corvus-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-conference-and-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/JAGX/jaguar-health-to-hold-investor-webcast-may-26-regarding-q1-2026-financials-and-corporate-updates-jaguar-ceo-lisa-conte-presenting-may-28-at-lytham-partners-spring-2026-investor-conference.md 2026-06-25 https://biopharmsignal.com/news/DMAC/diamedica-therapeutics-announces-75-enrollment-milestone-in-remedy2-phase-2-3-acute-ischemic-stroke-trial.md 2026-06-25 https://biopharmsignal.com/news/PYPD/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference.md 2026-06-25 https://biopharmsignal.com/news/TARA/protara-therapeutics-to-present-at-the-td-cowen-7th-annual-oncology-innovation-summit-insights-for-asco-and-eha.md 2026-06-25 https://biopharmsignal.com/news/SRRK/scholar-rock-to-present-at-the-2026-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/EBS/emergent-biosolutions-to-participate-in-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/HUMA/humacyte-announces-symvessr-is-now-under-contract-with-the-strategic-acquisition-center-sac-of-the-u-s-department-of-veterans-affairs.md 2026-06-25 https://biopharmsignal.com/news/PHAT/phathom-pharmaceuticals-highlights-breadth-of-independent-vonoprazan-research-at-digestive-disease-week-2026-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/DYN/dyne-therapeutics-announces-initiation-of-phase-3-forzetto-trial-of-z-rostudirsen-in-duchenne-muscular-dystrophy-dmd-ahead-of-planned-bla-submission-for-u-s-accelerated-approval.md 2026-06-25 https://biopharmsignal.com/news/SNDX/syndax-announces-participation-in-upcoming-investor-conferences.md 2026-06-25 https://biopharmsignal.com/news/IMVT/immunovant-provides-corporate-updates-and-reports-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026.md 2026-06-25 https://biopharmsignal.com/news/ROIV/roivant-reports-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provides-business-update.md 2026-06-25 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-announces-strategic-agreement-with-anthropic-to-position-claude-enterprise-as-the-shared-intelligence-platform-across-its-global-operations.md 2026-06-25 https://biopharmsignal.com/news/PCRX/pacira-biosciences-files-investor-presentation-highlighting-successful-execution-of-its-long-term-strategy-to-drive-value-for-all-stockholders.md 2026-06-25 https://biopharmsignal.com/news/PSNL/personalis-secures-fourth-medicare-coverage-decision-for-next-personalr-expanding-breast-cancer-coverage-to-pre-surgical-treatment-monitoring.md 2026-06-25 https://biopharmsignal.com/news/YOU/clear-and-gdit-announce-strategic-collaboration-agreement.md 2026-06-25 https://biopharmsignal.com/news/IBRX/immunitybio-announces-fda-acceptance-of-supplemental-bla-for-anktivar-plus-bcg-in-bcg-unresponsive-non-muscle-invasive-bladder-cancer-with-papillary-disease-pdufa-date-set-for-january-6-2027.md 2026-06-25 https://biopharmsignal.com/news/MNPR/monopar-announces-publication-of-phase-2-study-demonstrating-alxn1840-significantly-improves-copper-balance-in-patients-with-wilson-disease.md 2026-06-25 https://biopharmsignal.com/news/YOU/clear-partners-with-expedia-to-bring-a-more-seamless-airport-experience-to-travelers.md 2026-06-25 https://biopharmsignal.com/news/DERM/journey-medical-corporation-to-participate-in-a-g-p-s-annual-virtual-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/DGX/quest-diagnostics-declares-quarterly-cash-dividend.md 2026-06-25 https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-stifel-2026-virtual-ophthalmology-forum.md 2026-06-25 https://biopharmsignal.com/news/IRIX/iridex-reports-first-quarter-2026-financial-results.md 2026-06-25 https://biopharmsignal.com/news/KURA/kura-oncology-to-present-at-td-cowen-7th-annual-oncology-innovation-summit.md 2026-06-25 https://biopharmsignal.com/news/ACHV/achieve-life-sciences-presents-safety-data-from-52-weeks-of-continuous-cytisinicline-treatment.md 2026-06-25 https://biopharmsignal.com/news/NXGL/nexgel-reports-positive-data-from-randomized-single-center-irb-study-to-evaluate-the-effectiveness-and-safety-of-a-hydrogel-laser-treatment-patch-in-laser-hair-removal-with-a-95-6-reduction-in-plume-concentration.md 2026-06-25 https://biopharmsignal.com/news/JAGX/jaguar-health-announces-active-treatment-only-continuation-of-pivotal-multicenter-clinical-trial-in-pediatric-patients-with-microvillus-inclusion-disease-mvid-to-support-a-new-drug-application-nda-for-liquid-oral-crofelemer.md 2026-06-25 https://biopharmsignal.com/news/OGEN/oragenics-to-present-at-sidoti-s-micro-cap-virtual-investor-conference-may-20-21.md 2026-06-25 https://biopharmsignal.com/news/RNXT/renovorx-to-present-at-the-alliance-global-partners-virtual-annual-healthcare-company-showcase-on-may-20th.md 2026-06-25 https://biopharmsignal.com/news/ICCM/icecure-s-prosenser-reports-nearly-90-recurrence-free-rate-for-cryoablation-of-kidney-cancer-data-presented-at-ecio-2026-and-first-ever-breast-cryoablation-master-class-overbooked.md 2026-06-25 https://biopharmsignal.com/news/PTIX/protagenic-therapeutics-engages-floyd-regulatory-strategic-consulting-as-regulatory-affairs-advisor-and-danforth-health-as-strategic-operations-partner.md 2026-06-25 https://biopharmsignal.com/news/EXEL/exelixis-announces-clinical-development-collaboration-with-merck-for-phase-3-stellar-316-pivotal-trial-for-patients-with-colorectal-cancer.md 2026-06-25 https://biopharmsignal.com/news/LPCN/lipocine-announces-lpcn-1154-phase-3-data-accepted-for-oral-presentation-at-2026-ascp-annual-meeting.md 2026-06-25 https://biopharmsignal.com/news/BDTX/black-diamond-therapeutics-to-host-webcast-for-investors-highlighting-updated-results-from-phase-2-trial-of-silevertinib-in-1l-egfrm-nsclc.md 2026-06-25 https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-aggregate-of-400-000-in-private-placements-priced-at-premium-to-market.md 2026-06-25 https://biopharmsignal.com/news/IBRX/immunitybio-presents-favorable-comparative-effectiveness-data-in-complete-response-rates-of-nai-bcg-versus-nadofaragene-and-tar-200-at-aua-2026.md 2026-06-25 https://biopharmsignal.com/news/PSTV/plus-therapeutics-partners-with-ephemeral-technologies-to-deploy-ai-execution-platform-for-cns-oncology.md 2026-06-25 https://biopharmsignal.com/news/MDNA/medicenna-announces-the-finalization-of-the-terms-of-its-public-offering-of-securities.md 2026-06-25 https://biopharmsignal.com/news/BSX/fracture-ide-trial-of-the-boston-scientific-seismiqtm-4ce-coronary-intravascular-lithotripsy-catheter-meets-primary-safety-and-effectiveness-endpoints.md 2026-06-25 https://biopharmsignal.com/news/IPHA/innate-pharma-to-participate-in-the-jefferies-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-announces-pricing-of-up-to-approximately-32-million-underwritten-offering.md 2026-06-25 https://biopharmsignal.com/news/PNTG/pennant-group-to-participate-in-the-2026-rbc-global-healthcare-conference.md 2026-06-25 https://biopharmsignal.com/news/PNTG/pennant-announces-an-acquisition-of-senior-living-community-in-arizona.md 2026-06-25 https://biopharmsignal.com/news/FENC/fennec-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-06-25 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-announces-presentation-of-new-data-from-the-phase-3-launch-htn-trial-of-lorundrostat-at-the-35th-european-meeting-on-hypertension-and-cardiovascular-protection-esh-2026.md 2026-06-25 https://biopharmsignal.com/news/BEAM/beam-therapeutics-presents-recently-reported-topline-clinical-data-for-beam-302-in-alpha-1-antitrypsin-deficiency-aatd-at-the-american-thoracic-society-ats-2026-international-conference.md 2026-06-25 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-presents-real-world-data-highlighting-functional-impact-of-mild-tardive-dyskinesia-severity-and-improvement-with-ingrezzar-valbenazine-capsules.md 2026-06-25